<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71705</article-id><article-id pub-id-type="doi">10.7554/eLife.71705</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-228251"><name><surname>Kiparaki</surname><given-names>Marianthi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0157-9064</contrib-id><email>kiparaki@fleming.gr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266523"><name><surname>Khan</surname><given-names>Chaitali</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7344-8605</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="fn1">‡</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269776"><name><surname>Folgado-Marco</surname><given-names>Virginia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-267674"><name><surname>Chuen</surname><given-names>Jacky</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4781-6907</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-203843"><name><surname>Moulos</surname><given-names>Panagiotis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4199-0333</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-198232"><name><surname>Baker</surname><given-names>Nicholas E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4250-3488</contrib-id><email>nicholas.baker@einsteinmed.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Department of Genetics, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">The Bronx</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013x0ky90</institution-id><institution>Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center &quot;Alexander Fleming”</institution></institution-wrap><addr-line><named-content content-type="city">Vari</named-content></addr-line><country>Greece</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Department of Developmental and Molecular Biology, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">The Bronx</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cf8a891</institution-id><institution>Department of Opthalmology and Visual Sciences, Albert Einstein College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">The Bronx</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Manley</surname><given-names>James L</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Cell and Developmental Biology Center, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, United States</p></fn><fn fn-type="other" id="fn1"><label>‡</label><p>This author made a significant contribution</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>02</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e71705</elocation-id><history><date date-type="received" iso-8601-date="2021-06-27"><day>27</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-02-09"><day>09</day><month>02</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-07-12"><day>12</day><month>07</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.07.12.452023"/></event></pub-history><permissions><copyright-statement>© 2022, Kiparaki et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Kiparaki et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71705-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-71705-figures-v3.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.74047"/><abstract><p>Ribosomal Protein (<italic>Rp</italic>) gene haploinsufficiency affects translation rate, can lead to protein aggregation, and causes cell elimination by competition with wild type cells in mosaic tissues. We find that the modest changes in ribosomal subunit levels observed were insufficient for these effects, which all depended on the AT-hook, bZip domain protein Xrp1. Xrp1 reduced global translation through PERK-dependent phosphorylation of eIF2α. eIF2α phosphorylation was itself sufficient to enable cell competition of otherwise wild type cells, but through Xrp1 expression, not as the downstream effector of Xrp1. Unexpectedly, many other defects reducing ribosome biogenesis or function (depletion of TAF1B, eIF2, eIF4G, eIF6, eEF2, eEF1α1, or eIF5A), also increased eIF2α phosphorylation and enabled cell competition. This was also through the Xrp1 expression that was induced in these depletions. In the absence of Xrp1, translation differences between cells were not themselves sufficient to trigger cell competition. Xrp1 is shown here to be a sequence-specific transcription factor that regulates transposable elements as well as single-copy genes. Thus, Xrp1 is the master regulator that triggers multiple consequences of ribosomal stresses and is the key instigator of cell competition.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ribosome</kwd><kwd>ribosomopathy</kwd><kwd>ribosomal protein</kwd><kwd>cell competition</kwd><kwd>xrp1 gene</kwd><kwd>translation</kwd><kwd>copia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>research project grant GM120451</award-id><principal-award-recipient><name><surname>Baker</surname><given-names>Nicholas E</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>instrumentation grant S10OD023591</award-id><principal-award-recipient><name><surname>Baker</surname><given-names>Nicholas E</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Ribosomal protein mutations, mutations that affect ribosomal RNA synthesis, or function of the mature ribosome, trigger a transcriptional response mediated by Xrp1 expression which reduces cellular translation via eIF2-alpha phosphorylation and renders cells liable to competition with wild-type neighbors.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>It would be difficult to exaggerate the importance of ribosomes. Eukaryotic ribosomes comprise 4 rRNAs and 80 proteins combined into Large and Small subunits (LSU and SSU) that, together with multiple initiation and elongation factors, constitute the translational apparatus for protein synthesis (<xref ref-type="bibr" rid="bib44">Jackson et al., 2010</xref>; <xref ref-type="bibr" rid="bib102">Thomson et al., 2013</xref>). Ribosome biogenesis, and the regulation of translation, are important targets of cellular regulation, and defects affecting ribosomes and translation are implicated in many diseases, from neurodegeneration to cancer (<xref ref-type="bibr" rid="bib3">Aspesi and Ellis, 2019</xref>; <xref ref-type="bibr" rid="bib39">Hetman and Slomnicki, 2019</xref>; <xref ref-type="bibr" rid="bib32">Genuth and Barna, 2018</xref>; <xref ref-type="bibr" rid="bib43">Ingolia et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Joazeiro, 2019</xref>; <xref ref-type="bibr" rid="bib85">Phillips and Miller, 2020</xref>). Mutations affecting rRNA synthesis, ribosomal protein genes (Rp genes), and some other ribosome biogenesis factors give rise to ribosomopathies, a family of translation-related diseases (<xref ref-type="bibr" rid="bib51">Kampen et al., 2020</xref>). The ribosomopathy Diamond Blackfan Anemia (DBA) most commonly results from heterozygosity for mutations in Rp genes, and is characterized by early onset anemia, cancer predisposition, and sometimes diminished growth and skeletal defects (<xref ref-type="bibr" rid="bib27">Draptchinskaia et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Choesmel et al., 2007</xref>; <xref ref-type="bibr" rid="bib23">Danilova and Gazda, 2015</xref>; <xref ref-type="bibr" rid="bib22">Da Costa et al., 2018</xref>). Most ribosomal protein genes are also haploinsufficient in <italic>Drosophila</italic>, where their dominant ‘Minute’ phenotype was named by Bridges and Morgan on account of the small, thin cuticular bristles observed, in addition to developmental delay (<xref ref-type="bibr" rid="bib15">Bridges and Morgan, 1923</xref>; <xref ref-type="bibr" rid="bib55">Lambertsson, 1998</xref>; <xref ref-type="bibr" rid="bib66">Marygold et al., 2007</xref>) .</p><p><italic>Rp</italic> gene loci were recently proposed to be important indicators of aneuploidy (<xref ref-type="bibr" rid="bib46">Ji et al., 2021</xref>). Aneuploid cells can be selectively eliminated from embryonic and developing mammalian tissues, but the mechanisms responsible have been uncertain (<xref ref-type="bibr" rid="bib11">Bolton et al., 2016</xref>; <xref ref-type="bibr" rid="bib68">McCoy, 2017</xref>). In <italic>Drosophila</italic>, cells heterozygous for mutations in <italic>Rp</italic> genes are selectively eliminated from mosaic imaginal discs, where they are replaced by neighboring wild-type cells (<xref ref-type="bibr" rid="bib73">Morata and Ripoll, 1975</xref>; <xref ref-type="bibr" rid="bib95">Simpson, 1979</xref>). This phenomenon, named ‘cell competition’, represents a process whereby cells that present differences from their neighbors can be eliminated from growing tissues, thought to enable the removal of cells that might be deleterious to the tissue (<xref ref-type="bibr" rid="bib73">Morata and Ripoll, 1975</xref>; <xref ref-type="bibr" rid="bib58">Lawlor et al., 2020</xref>; <xref ref-type="bibr" rid="bib6">Baker, 2020</xref>; <xref ref-type="bibr" rid="bib109">Vishwakarma and Piddini, 2020</xref>; <xref ref-type="bibr" rid="bib65">Marques-Reis and Moreno, 2021</xref>; <xref ref-type="bibr" rid="bib74">Morata, 2021</xref>). Because <italic>Rp</italic> gene dose is likely to be affected whenever one or more chromosomes or substantial chromosome regions are monosomic, cell competition could help eliminate aneuploid cells on the basis of altered <italic>Rp</italic> gene dose (<xref ref-type="bibr" rid="bib70">McNamee and Brodsky, 2009</xref>). This mechanism indeed occurs in <italic>Drosophila</italic> imaginal discs (<xref ref-type="bibr" rid="bib46">Ji et al., 2021</xref>). Such a role of cell competition is potentially significant for tumor surveillance, since tumors almost always consist of aneuploid cells, and for healthy aging, since aneuploid cells accumulate during aging (<xref ref-type="bibr" rid="bib33">Hanahan and Weinberg, 2011</xref>; <xref ref-type="bibr" rid="bib63">López-Otín et al., 2013</xref>). In addition to their mutation in DBA, this provides another reason why it is important to understand the cellular effects of <italic>Rp</italic> mutations, and how they lead to cell competition.</p><p>Unsurprisingly, <italic>Rp</italic> mutant heterozygosity generally leads to reduced translation (<xref ref-type="bibr" rid="bib12">Boring et al., 1989</xref>; <xref ref-type="bibr" rid="bib80">Oliver et al., 2004</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). It might be expected that a 50% reduction in ribosome subunit biogenesis would be responsible, but remarkably, in <italic>Drosophila</italic> this and many other features of <italic>Rp</italic> haploinsufficiency, including cell competition in the presence of wild-type cells, depend on a bZip, AT-hook putative transcription factor encoded by the <italic>Xrp1</italic> gene (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). <italic>Xrp1</italic> is responsible for &gt;80% of the transcriptional changes that are seen in <italic>Rp<sup>+/-</sup></italic>wing imaginal discs (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Thus, reduced translation, which is a feature of Rp haploinsufficiency from yeast to mice and humans, may have a transcriptional basis (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Accordingly, we could detect only modest reductions in SSU concentration in heterozygous <italic>RpS3</italic>, <italic>RpS17,</italic> or <italic>RpS18</italic> mutants, although <italic>RpL27A</italic> haploinsufficiency reduced steady state LSU numbers by ~30% (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Some of these findings now have support from yeast studies, where deletion of single <italic>Rp</italic> loci present in paralogous pairs (a recent genome duplication has left yeast with many such <italic>Rp</italic> gene pairs) potentially mimics heterozygosity for a single copy gene in diploid organisms. The large majority of translational changes described by ribosome profiling of such yeast pseudo-heterozygotes turned out to reflect changes in mRNA abundance, implicating a predominantly transcriptional response to <italic>Rp</italic> mutations in yeast also (<xref ref-type="bibr" rid="bib20">Cheng et al., 2019</xref>). Mass spectrometry and rRNA measurements of the yeast strains further suggested that ribosome numbers are little affected in most <italic>RpL</italic> gene deletion strains, whereas some <italic>RpS</italic> deletions increase LSU concentrations by up to 1.5 x (<xref ref-type="bibr" rid="bib20">Cheng et al., 2019</xref>). There is also evidence from mice, where it is now suggested that reduced translation in <italic>RpS6<sup>+/-</sup></italic> mouse cells depends on the transcription factor p53 (<xref ref-type="bibr" rid="bib103">Tiu et al., 2021</xref>).</p><p>These findings raise many mechanistic questions. How does <italic>Rp</italic> haploinsufficiency activate <italic>Xrp1</italic> gene expression?How does this putative transcription factor control overall translation, if not through altered ribosome numbers? Are differences in translation rate between cells the cause of cell competition, or is cell competition due to other consequences of Xrp1 activity?</p><p>Alternative views of the <italic>Rp</italic> mutant phenotype have also been presented. Aside from the idea that reduced ribosome levels alter translation directly and are predominantly responsible for human DBA (<xref ref-type="bibr" rid="bib71">Mills and Green, 2017</xref>; <xref ref-type="bibr" rid="bib52">Khajuria et al., 2018</xref>), two recent studies propose that degradation of excess orphan Rp suppresses proteasome and autophagic flux in <italic>Drosophila Rp</italic> mutants, leading to protein aggregation and proteotoxic stress. They propose that proteotoxic stress suppresses translation, and renders <italic>Rp</italic><sup>+/-</sup> cells subject to competition with wild-type cells through a further oxidative stress response (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>). In addition, in concluding that autophagy is protective for <italic>Rp</italic> mutant cells (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>), these studies contradict previous conclusions that autophagy is only increased in <italic>Rp</italic> mutant cells next to wild-type cells, where it promotes cell death (<xref ref-type="bibr" rid="bib76">Nagata et al., 2019</xref>).</p><p>Here, we further investigate the basis of the <italic>Rp</italic> mutant phenotype in <italic>Drosophila</italic>. The results reaffirm the central role of Xrp1 in multiple aspects of the <italic>Rp</italic> mutant phenotype. We confirm the modest effects of <italic>Rp</italic> haploinsufficiency on numbers of mature ribosome subunits, and show directly that ribosome precursors accumulate in <italic>Rp</italic> mutants. We find that translation is reduced in <italic>Rp</italic> mutant cells through eIF2α phosphorylation, but both this and the protein aggregation observed (which appears specific for mutations affecting SSU proteins) require Xrp1 and so are not direct post-transcriptional consequences of ribosome assembly defects, as had been suggested (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>). We report that interfering with translation, whether through eIF2α phosphorylation or by multiple other routes disrupting ribosome assembly or function, can subject otherwise wild-type cells to competition with normal cells. This is not because translation differences between cells cause cell competition directly, however, but because defects in both ribosome biogenesis and function that affect translation are all found to activate Xrp1, which then mediates the cell competition engendered by these translational stresses. We then show that Xrp1 is a sequence-specific transcription factor that is required for cell competition in response to multiple triggers and is responsible for multiple aspects of the <italic>Rp</italic> mutant phenotype, potentially including transcription of genes that have previously been taken as reporters of oxidative stress. Altogether, these studies clarify discrepancies in previously published work, and refocus attention on transcriptional responses to ribosome and translation defects mediated by Xrp1, with implications for the mechanisms and therapy of multiple ribosomopathies, and for the surveillance of aneuploid cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Ribosome Levels in <italic>Rp<bold><sup>+/-</sup></bold></italic> Cells</title><p>Abnormal cellular levels of ribosome subunits has been proposed as the basis for reduced translation in ribosomopathies (<xref ref-type="bibr" rid="bib71">Mills and Green, 2017</xref>). Multiple models of DBA accordingly seek to reduce steady-state Rp concentration to 50% of normal (<xref ref-type="bibr" rid="bib37">Heijnen et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Khajuria et al., 2018</xref>). By measuring <italic>Drosophila</italic> rRNA levels in northern blots, however, we had previously concluded that whereas cellular levels of ribosome subunits were affected in heterozygotes for an <italic>RpL27A</italic> mutant, multiple <italic>Rp</italic> mutations affecting SSU proteins led only to ~10% reduction in SSU levels that was not statistically significant (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). A caveat to this conclusion was the use of tubulin mRNA and actin mRNA as loading controls. While mRNA-seq shows that the proportions of actin and tubulin mRNAs are not much affected in <italic>Rp</italic><sup>+/-</sup> genotypes (<xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>), it could be that total mRNA amounts are altered by <italic>Rp</italic> mutations, which would affect the conclusions regarding rRNA when mRNA standards are used. In bacteria, it is well-established that ribosomes protect mRNA from turnover, so that reduced ribosome numbers reduce overall mRNA levels as well (<xref ref-type="bibr" rid="bib116">Yarchuk et al., 1992</xref>; <xref ref-type="bibr" rid="bib42">Hui et al., 2014</xref>). The situation in eukaryotic cells may not be the same as in bacteria (<xref ref-type="bibr" rid="bib8">Belasco, 2010</xref>). Still, we decided to measure rRNA levels again using a non-coding RNA as loading control. We chose the 7SL RNA component of Signal Recognition Particle, an abundant non-coding RNA that is expressed in all cells.</p><p>Changes in LSU and SSU levels inferred from 5.8 S and 18 S rRNA abundance, normalized to 7SL RNA levels, are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, and a representative northern blot in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. Similar to what was observed previously, Xrp1 mutations had no effect on apparent LSU or SSU levels in the wild type or in heterozygotes for any of four mutant loci, <italic>RpS18</italic>, <italic>RpS3</italic>, <italic>RpL27A</italic>, and <italic>RpL14</italic>, reaffirming that Xrp1 is unlikely to affect translation rate through an effect on ribosome subunit concentrations (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). Accordingly, <italic>Xrp1<sup>+/+</sup></italic> and <italic>Xrp1<sup>+/-</sup></italic> data were combined together to compare the effects of <italic>Rp</italic> mutations. We confirmed that LSU numbers were reduced in the <italic>RpL27A</italic> mutant, and extended this observation to mutation in a second RpL gene, <italic>RpL14</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Unlike our previous study, SSU levels were reduced 20%–30% in <italic>RpS18</italic>, <italic>RpS3,</italic> and <italic>RpL14</italic> mutants when normalized to the non-coding 7SL RNA, and these reductions were significantly different from the control (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). By contrast, <italic>RpL27A</italic> did not change SSU numbers (<xref ref-type="fig" rid="fig1">Figure 1E</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Modest changes in ribosomal subunit concentrations in <italic>Rp</italic> mutant wing discs.</title><p>(<bold>A</bold>) Similar amounts of wing disc RNA from indicated genotypes separated and transferred for northern blotting with, in this case, probes specific for the 18 S rRNA of the ribosomal SSU, the 7SL non-coding RNA for the Signal Recognition Particle, and the 5.8 S rRNA of the ribosomal LSU. Right-most two lanes show serial dilutions of the wild type sample. Panels B-E show signal quantification from multiple such northerns. (<bold>B</bold>) <italic>Xrp1</italic> mutation did not affect LSU concentration in any <italic>Rp</italic> genotype. Significance shown only for <italic>Xrp1<sup>+/+</sup></italic> to <italic>Xrp1<sup>+/-</sup></italic> between otherwise similar genotypes. Padj values were one in all cases. (<bold>C</bold>) <italic>Xrp1</italic> mutation did not affect SSU concentration in any <italic>Rp</italic> genotype. Significance shown only for <italic>Xrp1<sup>+/+</sup></italic> to <italic>Xrp1<sup>+/-</sup></italic> between otherwise similar genotypes. Padj values were one in all cases. (<bold>D</bold>) Two <italic>RpL</italic> mutations reduced LSU concentrations. Significance shown only for comparisons between mutant genotypes and the wild type. Exact Padj values were: 0.00423, 0.0117, 0.0877, 0.858 respectively. (<bold>E</bold>) Two <italic>RpS</italic> mutations, as well as <italic>RpL14</italic>, reduced SSU concentrations. Significance shown only for comparisons between mutant genotypes and the wild type. Exact Padj values were: 0.135, 0.000218, 0.000395, 0.000602 respectively. WT genotype: p{hs:FLP}/w118; p{arm:LacZ} FRT80B/+, Xrp1<sup>+/-</sup> genotype: p{hs:FLP}/w118; FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>/+, <italic>L27A</italic><sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; <italic>RpL27A</italic>- p{arm:LacZ}FRT40/+; FRT80B/+, <italic>L27A</italic><sup>+/-</sup>; <italic>Xrp1</italic><sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; <italic>RpL27A</italic>- p{arm:LacZ}FRT40/+; FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>/+, <italic>L14</italic><sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42/+; <italic>RpL14</italic><sup>1</sup> /+, <italic>L14</italic><sup>+/-</sup>; <italic>Xrp1</italic><sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42/+; <italic>RpL14<sup>1</sup></italic>/ FRT82 B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, S3<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42/+; FRT82 <italic>RpS3</italic> p{arm:LacZ}/+, S3<sup>+/-</sup>; Xrp1<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ}/FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, <italic>S18</italic><sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{ubi:GFP} /+; FRT80B/+, <italic>S18</italic><sup>+/-</sup>; Xrp1<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{ubi:GFP} /+; FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>/+ Panels F-I show comparisons between antibody labelings of 5.8 S rRNA, anti-RpL9, or anti-RpS12 between wild type and <italic>Rp<sup>+/-</sup></italic> cells in mosaic wing imaginal discs. (<bold>F,F’</bold>) <italic>RpL27A</italic> mutation reduced levels of 5.8SrRNA. (<bold>G,G’</bold>) <italic>RpS3</italic> mutation had negligible effect on 5.8 S rRNA levels. (<bold>H,H’,H”</bold>) <italic>RpL27A</italic> mutation reduced levels of the LSU component RpL9 but a small effect on the SSU component RpS12. (<bold>I,I’,I”</bold>) <italic>RpS18</italic> mutation reduced levels of the SSU component RpS12 but not of the LSU component RpL9. Statistics:One-way Anova with Bonferroni-Holm multiple comparison correction was performed for panels B-E, which were each based on three biological replicates. ns - p ≥ 0.05.* - p &lt; 0.05.** - p &lt; 0.01. Genotypes: F, H: p{hs:FLP}/ p{hs:FLP}; RpL27A<sup>-</sup> p{arm:LacZ} FRT40/FRT40, G: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B, I: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Full and unedited blots corresponding to panel A.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71705-fig1-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Northern data underlying panels B-E.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig1-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cytoplasmic location of ribosome components.</title><p>Specimens including those from <xref ref-type="fig" rid="fig1">Figure 1F and G</xref> showing the nuclear channel that was recorded simultaneously in many experiments. (<bold>A</bold>) This very apical confocal plane passes through only a few nuclei, particularly in wild type cells, verifying that the anti-5.8S rRNA signal is predominantly cytoplasmic, consistent with mature LSU. (<bold>B</bold>) This very apical confocal plane largely excludes nuclei, verifying that the anti-5.8S rRNA signal is predominantly cytoplasmic, consistent with mature LSU. (<bold>C</bold>) This slightly less apical focal plane predominantly grazes nuclei only of wild type cells, verifying that little anti-5.8S rRNA signal is nuclear. (<bold>D</bold>) This very basal confocal plane, which largely excludes nuclei for wild type regions, shows no discernible difference in cytoplasmic anti-5.8S rRNA signal between wild type and <italic>RpS17</italic>/+ cells. Genotypes: A: p{hs:FLP}/ p{hs:FLP}; RpL27A<sup>-</sup> p{arm:LacZ} FRT40/FRT40, B,C: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B, D: p{hs:FLP}/+; <italic>RpS17</italic> p{arm:LacZ} FRT80B/FRT80B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>More examples of ribosome levels in <italic>Rp</italic> mutant genotypes.</title><p>Panels (<bold>A–E</bold>) show mosaic wing discs containing <italic>Rp<sup>+/+</sup></italic> cells (black) and cells of indicated <italic>Rp<sup>+/-</sup></italic> genotypes (white). Panels (<bold>A’-E’ and E’’</bold>) show these same discs labelled with the antibodies against the indicated Rp. Panel E’’’ indicates DNA, in these cases indicating an apical confocal plane above most nuclei. (<bold>A</bold>) <italic>RpL27A<sup>+/-</sup></italic> cells contained less of the LSU component RpL10Ab. (<bold>B</bold>) <italic>RpS18<sup>+/-</sup></italic> cell contained more of the LSU component RpL10Ab. (<bold>C</bold>) <italic>RpS18<sup>+/-</sup> Xrp1<sup>+/-</sup></italic> cells contained more of the LSU component RpL10Ab than <italic>RpS18<sup>+/+</sup>Xrp1<sup>+/-</sup></italic> cells. (<bold>D</bold>) <italic>RpS17<sup>+/-</sup></italic> cell contained less of the SSU component Rack1. (<bold>E</bold>) <italic>RpS17<sup>+/-</sup></italic> cell contained less of the SSU component RpS12 but levels of the LSU component RpL9 were indistinguishable from <italic>RpS17<sup>+/+</sup></italic> cells. Genotypes: A: p{hs:FLP}/ p{hs:FLP}; RpL27A<sup>-</sup> p{arm:LacZ} FRT40/FRT40, B: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42, C: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42; FRT82B Xrp1<sup>M2-73</sup>/+,D-E: p{hs:FLP}/+; <italic>RpS17</italic> p{arm:LacZ} FRT80B/FRT80B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig1-figsupp2-v3.tif"/></fig></fig-group><p>To confirm these findings using an independent method, we performed tissue staining with a monoclonal antibody, mAbY10B, that recognizes rRNA, and particularly a structure in the 5.8 S rRNA that is part of the LSU (<xref ref-type="bibr" rid="bib60">Lerner et al., 1981</xref>). Consistent with Northern analysis, immunostaining of mosaic wing imaginal discs confirmed lower 5.8 S rRNA levels in <italic>Rp27A</italic><sup>+/-</sup> cells compared to <italic>Rp27A</italic><sup>+/+</sup> cells in the same wing discs (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). By contrast, no reduction in mAbY10B staining was observed in cell mutated for either of two SSU components, <italic>RpS3</italic> or <italic>RpS17</italic>, consistent with the northern blot measurements of 5.8 S rRNA levels (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B-D</xref>).</p><p>To gain further support for these findings, we compared Rp protein levels by immunostaining mutant and control cells in the same imaginal discs. We used antibodies against RpL10Ab as markers for LSU, and against RpS12 and RACK1 as markers for SSU. <italic>RpL27A</italic> mutant cells contained lower levels of LSU protein, and slightly lower levels of SSU protein (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). <italic>RpS17</italic>, and <italic>RpS18</italic> mutant cells contained lower levels of the SSU protein, and <italic>RpS18</italic> slightly higher levels of the LSU protein RpL10Ab, even in the Xrp1 mutant background (<xref ref-type="fig" rid="fig1">Figure 1I</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B-E</xref>). These tissue staining experiments qualitatively support the conclusion that levels of SSU components are generally reduced in <italic>RpS<sup>+/-</sup></italic> cells, whereas LSU levels were only reduced in <italic>RpL<sup>+/-</sup></italic> cells (<italic>RpL27A<sup>+/-</sup>),</italic> in comparison to wild type cells within the same preparation, and that these changes are modest and unaffected by Xrp1, even though <italic>Xrp1</italic> mutation restores normal global translation rate (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>).</p></sec><sec id="s2-2"><title>Ribosome Precursors Accumulate in <italic>Rp<sup>+/-</sup></italic> Cells</title><p>An additional, or alternative, potential effect of <italic>Rp</italic> mutations is the accumulation of unused ribosome precursors and assembly intermediates. In yeast, depleting almost any Rp arrests ribosome biogenesis at some stage, reflecting individual requirements for ribosome assembly (<xref ref-type="bibr" rid="bib29">Ferreira-Cerca et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Ferreira-Cerca et al., 2007</xref>; <xref ref-type="bibr" rid="bib88">Pöll et al., 2009</xref>; <xref ref-type="bibr" rid="bib114">Woolford and Baserga, 2013</xref>; <xref ref-type="bibr" rid="bib38">Henras et al., 2015</xref>). <italic>Rp</italic> haploinsufficiency might delay biogenesis at these same steps, perhaps leading to accumulation of particular precursor states. To assess ribosome biogenesis in <italic>Rp<sup>+/-</sup></italic> mutants, intermediates were quantified by Northern blotting using probes specific for sequences that are excised from the rRNA as the ribosomes assemble and mature. In <italic>Drosophila</italic>, two parallel pathways A and B excise ITS1, ITS2, and the N-terminal EXT sequences, and process the resulting rRNAs, until the mature 28 S (processed into 28Sa and 28 Sb in <italic>Drosophila</italic>), 18 S and 5.8 S rRNAs are produced by the end of ribosome biogenesis (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; <xref ref-type="bibr" rid="bib62">Long and Dawid, 1980</xref>). We used specific probes to identify rRNA intermediates on northern blots (<xref ref-type="fig" rid="fig2">Figure 2A–D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). As predicted, intermediates accumulated in each of the <italic>Rp<sup>+/-</sup></italic> genotypes (see <xref ref-type="fig" rid="fig2">Figure 2</xref> legend for details). These findings support the idea that <italic>Rp</italic> gene haploinsufficiency leads to ribosome biogenesis delays, and corresponding accumulation of assembly intermediates. In no case did <italic>Xrp1</italic> mutation eliminate the accumulation of intermediates in <italic>Rp</italic> mutant genotypes (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). There were some changes noted in the intermediates that accumulated, however. For example, in <italic>RpS17<sup>+/-</sup></italic> and <italic>RpS13<sup>+/-</sup></italic> it seems that more band f accumulates when <italic>Xrp1</italic> is mutated, and less band a (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Ribosome biogenesis defects and their consequences.</title><p>(<bold>A</bold>) Two pathways of rRNA processing and the intermediates that result were characterized in <italic>D. melanogaster</italic> embryos by Long and Dawid. Mature 18 S, 5.8 S and 28Sa,b rRNAs are processed from the pre-RNA, along with the removal of two interval sequences ITS1 and ITS2. The cleavages sites were described by Long and Dawid. Colored boxes indicate the probes used in the present study. The 5.8 S probe overlaps with 147 bases at 3’of the ITS1 region, excluding cleavage site 3. Additional intermediates f and <bold>f’</bold> were observed in the wing imaginal disc samples. These were recognized by ITS1, 5.8 S (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and 18 S probe and therefore extended beyond the cleavage site 3, although whether beyond site four was uncertain. (<bold>B–D</bold>) Northern blots of total RNA purified from wild-type and Rp<sup>+/-</sup> wing discs, probed as indicated. (<bold>B</bold>) Reprobed with ITS1 after an initial actin probe. (<bold>C</bold>) Reprobed with ITS2 and then 18 S probes after an initial tubulin probe. Intermediates b, f and the 28 S rRNA (which in <italic>Drosophila</italic> is a precursor to the mature 28Sa and 28 Sb rRNAs) were detected in wild type and <italic>Xrp1<sup>+/-</sup></italic> wing discs, other intermediates only in <italic>Rp<sup>+/-</sup></italic> genotypes. <italic>RpS3<sup>+/-</sup></italic> and <italic>RpS17<sup>+/-</sup></italic> had lower levels of pre-RNA and intermediate (<bold>f</bold>) but accumulate intermediates (<bold>a</bold>) and (<bold>f</bold>’), which might indicate delays in cleavages 2 and 3. <italic>RpS18<sup>+/-</sup></italic> had increased levels of pre-RNA and intermediate (<bold>f</bold>). <italic>RpL27<sup>+/-</sup></italic> accumulated bands (<bold>b</bold>, <bold>c</bold>, <bold>e</bold>, and <bold>f</bold>) and 28 S. The effect on (<bold>f</bold>) suggests crosstalk between RpL27A and SSU processing. (<bold>E–I</bold>) show single confocal planes from mosaic third instar wing imaginal discs. (<bold>E</bold>) TAF1B depletion (green) increased Xrp1-HA levels in <italic>RpS17</italic><sup>+/-</sup> discs (magenta, see also E’). (<bold>F</bold>) TAF1B depletion (green) increased in <italic>RpS17</italic><sup>+/-</sup> discs led to cell death at the boundaries with undepleted cells (active Dcp1 staining in magenta, see also F’). (<bold>G</bold>) TAF1B depletion (green) also increased Xrp1 protein levels in <italic>RpS17</italic><sup>+/+</sup> discs (magenta, see also G’). (<bold>H</bold>) TAF1B depletion (green) led to cell death at the boundaries with undepleted cells (active Dcp1 staining in magenta, see also H’). (<bold>I</bold>) Co-depletion of Xrp1 with TAF1B (green) largely abolished cell death at the clone interfaces (active Dcp1 staining in magenta, see also I’). (<bold>J</bold>) Clones of cells depleted for TAF1B in parallel with panel I, showing reduced clones size and number (green), and competitive cells death at boundaries magenta, see also J’. Additional data related to this Figure is presented in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. Genotypes: Northerns: similar to <xref ref-type="fig" rid="fig1">Figure 1</xref> and additionally: S17<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT42/+; FRT80 <italic>RpS17</italic> p{arm:LacZ} /+, S17<sup>+/-</sup>; Xrp1<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; FRT80 <italic>RpS17</italic> p{arm:LacZ} /FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, S17<sup>+/-</sup>, L27A<sup>+/-</sup> genotype: p{hs:FLP}/ p{hs:FLP}; RpL27A<sup>-</sup> p{arm:LacZ} FRT40/+; FRT80 <italic>RpS17</italic> p{arm:LacZ} /+, E, F: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /+;<italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v105873), G, H: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /+;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 61957), I: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /UAS-RNAi<sup>Xrp1</sup>;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 61957), J: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /TRE-dsRed;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 61957) (processed in parallel with 2I).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Full and unedited blots corresponding to panel B.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71705-fig2-data1-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Full and unedited blots corresponding to panel C.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71705-fig2-data2-v3.pdf"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Full and unedited blots corresponding to panel D.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71705-fig2-data3-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Additional northern blots detecting rRNA intermediates.</title><p>Northern blots of total RNA purified from wild-type and Rp<sup>+/-</sup>wing discs, reprobed with 5.8 S probe and then 18 S probe after an initial 7SL probe.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Full and unedited blots corresponding to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-71705-fig2-figsupp1-data1-v3.pdf"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig2-figsupp1-v3.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Nucleoli in wild type and <italic>Rp</italic> mutant cells.</title><p>(<bold>A</bold>) Confocal section of Xrp1-HA wing disc showing many nuclei labelled for DNA. (<bold>A’</bold>) HA labeling reveals minimal Xrp1 expression in this otherwise wild type wing disc. Xrp1-HA is not obvious in nucleoli. (<bold>B</bold>) Mosaic wing disc containing <italic>RpS18</italic><sup>+/-</sup> cells (green). Anti-fibrillarin labeling of nucleoli reveals no obvious differences between <italic>RpS18</italic><sup>+/-</sup> and <italic>RpS18</italic><sup>+/+</sup> cells (projected in magenta; see also B’). (<bold>C</bold>) Mosaic eye disc containing <italic>RpS17</italic><sup>+/-</sup> cells (green). Anti-fibrillarin labeling of nucleoli reveals no obvious differences between <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS17</italic><sup>+/+</sup> cells (projected in magenta; see also (<bold>C’</bold>)). (<bold>D</bold>) Peripodial membrane from mosaic eye eye disc containing <italic>RpS17</italic><sup>+/-</sup> cells (green). Anti-fibrillarin labeling of nucleoli reveals no obvious differences between <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS17</italic><sup>+/+</sup> cells (projected in magenta; see also (<bold>D’</bold>)). Genotypes::A: p{hs:FLP}/ p{hs:FLP}; FRT42/FRT42; Xrp1-HA/Xrp1-HA B: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42, C,D: p{hs:FLP}/+; <italic>RpS17</italic> p{Ubi:GFP} FRT80B/FRT80B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig2-figsupp2-v3.tif"/></fig></fig-group><p>In mammalian cells with <italic>Rp</italic> haploinsufficiency, unincorporated 5 S RNP, comprising RpL5, RpL11 and the 5 S rRNA, activates the transcription factor and tumor suppressor p53 by inhibiting the p53 ubiquitin ligase MDM2 (<xref ref-type="bibr" rid="bib83">Pelava et al., 2016</xref>). P53 is responsible for at least some consequences of <italic>Rp</italic> haploinsufficiency in mice, perhaps even including the reduction in translation (<xref ref-type="bibr" rid="bib103">Tiu et al., 2021</xref>). P53 is also implicated in cell competition in mammals, although not in <italic>Drosophila</italic>, where Xrp1 may acquire some of its functions (<xref ref-type="bibr" rid="bib49">Kale et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Baker et al., 2019</xref>). In <italic>Drosophila</italic> it seems that RpS12 is particularly critical for activating Xrp1, through an unknown mechanism (<xref ref-type="bibr" rid="bib50">Kale et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Boulan et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>). If a ribosome biogenesis intermediate, which might include RpS12, induced Xrp1 expression, then we predicted that its accumulation and signaling could be prevented by restricting rRNA biogenesis. To test this model, we reduced rRNA synthesis by knockdown of TAF1B, an accessory factor for RNA polymerase I (<xref ref-type="bibr" rid="bib53">Knutson and Hahn, 2011</xref>). We predicted that Xrp1 expression would be reduced when TAF1B was knocked down in an <italic>Rp</italic><sup>+/-</sup> background, and that the knockdown cells would be more competitive than their <italic>Rp</italic><sup>+/-</sup> neighbors. Contrary to these predictions, Xrp1 expression was actually higher in <italic>RpS17</italic><sup>+/-</sup>dsRNA<sup>TAF1B</sup> cells than <italic>RpS17</italic><sup>+/-</sup>cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), and <italic>RpS17</italic><sup>+/-</sup> dsRNA<sup>TAF1B</sup> cells underwent cell death at boundaries with <italic>RpS17</italic><sup>+/-</sup> territories, suggesting they were less competitive, not more so (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). To understand this result, the effect of TAF1B knockdown in otherwise wild-type cells was examined, and found to resemble that of <italic>RpS17</italic><sup>+/-</sup>dsRNA<sup>TAF1B</sup> cells. That is, dsRNA<sup>TAF1B</sup> cells strongly activated Xrp1 expression, and underwent apoptosis at interfaces with wild type cells (<xref ref-type="fig" rid="fig2">Figure 2G, H and J</xref>). This boundary cell death was Xrp1-dependent (<xref ref-type="fig" rid="fig2">Figure 2I and J</xref>). Thus, far from rRNA being required for Xrp1 expression and cell competition, as expected if an RNP containing RpS12 activates Xrp1, rRNA depletion appeared to have similar effects to Rp depletion.</p><p>It has been suggested that Xrp1 might normally be sequestered in nucleoli, only to be released by nucleolar disruption in <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref>). We were unable to detect Xrp1 protein sequestered either in nucleoli or elsewhere in wild-type cells, and nucleoli appeared grossly normal in Rp<sup>+/-</sup> cells by anti-fibrillarin staining, revealing no sign of nucleolar stress (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A-D</xref>). It is important to compare <italic>Rp<sup>+/-</sup></italic> cells wild-type cells at a level where nuclei are present in both, since in mosaic wing discs <italic>Rp<sup>+/-</sup></italic> nuclei can be displaced basally compared to wild-type cells (eg <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, D</xref>).</p></sec><sec id="s2-3"><title>Reduced protein synthesis is due to PERK-dependent eIF2α phosphorylation in <italic>Rp<sup>+/-</sup></italic> cells</title><p><italic>Rp</italic> mutations may lead to surplus unused Rp. In yeast, aggregation of unused Rp rapidly affects specific transcription factors, leading to a transcriptional stress response (<xref ref-type="bibr" rid="bib2">Albert et al., 2019</xref>; <xref ref-type="bibr" rid="bib106">Tye et al., 2019</xref>). To explore how Xrp1 reduces translation, if not through reduced ribosome levels, we investigated the phosphorylation of eIF2α, a key mechanism of global regulation of CAP-dependent translation that responds to proteotoxic stress, among other influences (<xref ref-type="bibr" rid="bib41">Hinnebusch and Lorsch, 2012</xref>). Strikingly, phosphorylation of eIF2α was increased in a cell-autonomous manner in <italic>Rp<sup>+/-</sup></italic> cells compared to <italic>Rp<sup>+/+</sup></italic> cells (RpS3, RpS17, RpS18, and RpL27A were examined) (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>). Control clones lacking Rp mutations did not affect p-eIF2α levels or global translation rate (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1M and N</xref>). Normal p-eIF2α levels were restored in <italic>Rp<sup>+/-</sup></italic> cells, when even one copy of the <italic>Xrp1</italic> gene was mutated, as expected for the Xrp1-dependent process that reduces translation in <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C-E</xref>). To verify that eIF2α regulation by Xrp1 was cell-autonomous, we used clonal knockdown with an <italic>Xrp1</italic> dsRNA previously shown to restore normal growth to <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="bibr" rid="bib10">Blanco et al., 2020</xref>). As predicted, <italic>Xrp1</italic> knockdown decreased eIF2α phosphorylation and increased translation rate in a cell-autonomous way (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>), as did knocking-down the gene encoding the Xrp1 heterodimer partner, Irbp18 (<xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Blanco et al., 2020</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F, G</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>eIF2α is phosphorylated in ribosomal protein mutants via Xrp1 and PERK.</title><p>Panels A-J show single confocal planes from third instar wing imaginal discs. (<bold>A</bold>) Mosaic of <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS17</italic><sup>+/+</sup> cells. p-eIF2α levels were increased in <italic>RpS17</italic><sup>+/-</sup> cells (see A’). (<bold>B</bold>) Mosaic of <italic>RpL27A</italic><sup>+/-</sup> and <italic>RpL27A</italic><sup>+/+</sup> cells. p-eIF2α levels were increased in <italic>RpL27A</italic><sup>+/-</sup> cells (see B’). (<bold>C</bold>) Clones of cells expressing Xrp1-RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white p-eIF2α levels were reduced by Xrp1 depletion (see C’). (<bold>D</bold>) Clones of cells expressing Xrp1-RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. Translation rate was restored by Xrp1 depletion (see D’). (<bold>E</bold>) Clones of cells over-expressing PPP1R15 in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by PPP1R15 over-expression (see E’). (<bold>F</bold>) Clones of cells over-expressing PPP1R15 in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. Translation rate was restored by PPP1R15 over-expression (see F’). (<bold>G</bold>) Clones of cells expressing PERK-RNAi in an otherwise wild type wing disc in white. p-eIF2α levels were unaffected (see G’). Note that in this and some other panels mitotic cells are visible near the apical epithelial surface. Mitotic figures, which lack OPP incorporation, are labeled by the anti-p- eIF2α antibody from Thermofisher, but not by the anti-p- eIF2α antibody from Cell Signaling Technologies. (<bold>H</bold>) Clones of cells expressing PERK-RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in whiite. p-eIF2α levels were reduced by PERK knockdown (see H’). (<bold>I</bold>) Clones of cells expressing PERK-RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. Translation rate was restored by PERK knockdown (see I’). (<bold>J</bold>) Clones of cells expressing Gcn2-RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were not reduced by Gcn2 knockdown (see J’). Further data relevant to this Figure are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Genotypes: A: p{hs:FLP}/+; <italic>RpS17</italic> p{arm:LacZ} FRT80B/FRT80B, B: p{hs:FLP}/ p{hs:FLP}; RpL27A<sup>-</sup> p{arm:LacZ} FRT40/FRT40, C, D: p{hs:FLP}/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /UAS- RNAi<sup>Xrp1</sup>, E,F: p{hs:FLP}/+; UAS-<italic>PPP1R15</italic>/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /+, G: p{hs:FLP}/+; UAS- RNAi<sup>PERK</sup> /+;act&gt; CD2&gt; Gal4, UAS-GFP /+, H, I: p{hs:FLP}/+; UAS- RNAiPERK /+; RpS17, act&gt; CD2&gt; Gal4, UAS-GFP /+, J: p{hs:FLP}/+; UAS- RNAi<sup>Gcn2</sup>/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /+.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>eIF2α phosphorylation in <italic>Rp<sup>+/-</sup></italic> cell depends on Xrp1 and Irbp18.</title><p>Panels A-L show single confocal planes from third instar wing imaginal discs. (<bold>A</bold>) Mosaic of <italic>RpS3</italic><sup>+/-</sup> and <italic>RpS3</italic><sup>+/+</sup> cells. p-eIF2α levels were increased in <italic>RpS3</italic><sup>+/-</sup> cells (see A’). (<bold>B</bold>) Mosaic of <italic>RpS18</italic><sup>+/-</sup> and <italic>RpS18</italic><sup>+/+</sup> cells. p-eIF2α levels were increased in <italic>RpS18</italic><sup>+/-</sup> cells (see B’). (<bold>C</bold>) Mosaic of <italic>RpS3</italic><sup>+/-</sup><italic>Xrp1</italic>+/-and <italic>RpS3</italic><sup>+/+</sup><italic>Xrp<sup>-/-</sup></italic> cells. p-eIF2α levels were unaffected in <italic>RpS3</italic><sup>+/-</sup> cells when <italic>Xrp1</italic> was mutated (see C’). (<bold>D</bold>) Mosaic of <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS17</italic><sup>+/+</sup> cells (the latter brighter white, having two copies of β-gal transgene). p-eIF2α levels were increased in <italic>RpS17</italic><sup>+/-</sup> cells (see D’). (<bold>E</bold>) Mosaic of <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS17</italic><sup>+/+</sup> cells in an <italic>Xrp1<sup>+/-</sup></italic> disc, (<italic>RpS17</italic><sup>+/+</sup> brighter white, having two copies of β-gal transgene). p-eIF2α levels were unaffected in <italic>RpS17</italic><sup>+/-</sup> cells (see E’). (<bold>F</bold>) Clones of cells expressing Irbp18 RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by Irbp18 knock-down (see F’). (<bold>G</bold>) Clones of cells expressing Irbp18 RNAi in a <italic>RpS17</italic><sup>+/-</sup> wing disc in white. Translation rate was restored by Irbp18 knock-down (see G’). (<bold>H</bold>) Cells over-expressing PPP1R15 in the posterior compartment of a <italic>RpS3</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by PPP1R15 over-expression (see H’). (<bold>I</bold>). Cells over-expressing PPP1R15 in the posterior compartment of a <italic>RpS18</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by PPP1R15 over-expression (see I’). (<bold>J</bold>) Cells expressing PERK RNAi in the posterior compartment of a <italic>RpS3</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by PERK knock-down (see J’). (<bold>K</bold>). Cells expressing PERK RNAi in the posterior compartment of a <italic>RpS18</italic><sup>+/-</sup> wing disc in white. p-eIF2α levels were reduced by PERK knock-down (see K’). (<bold>L</bold>) Clones of cells expressing PERK RNAi in a <italic>RpS18</italic><sup>+/-</sup> wing disc in white. Translation rate was restored by PERK knock-down (see L’). (<bold>M</bold>) Neutral clones expressing or lacking LacZ expression did not affect p-eIF2α levels (see M’). (<bold>N</bold>) Neutral clones expressing or lacking LacZ expression did not affect OPP incorporation (see N’). Genotypes: A: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B, B: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42, C: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B Xrp1<sup>M2-73</sup>, D: p{hs:FLP}/ p{hs:FLP}; <italic>RpS17</italic> FRT80B/p{arm:LacZ} FRT80B, E: p{hs:FLP}/ p{hs:FLP}; <italic>RpS17</italic> FRT80B/p{arm:LacZ} FRT80B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, F-G: p{hs:FLP}/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /UAS- RNAi<italic><sup>Irbp18</sup>,</italic> H: en-GAL4, UAS-GFP /UAS-PPP1R15; FRT82 <italic>RpS3</italic>/+, I: <italic>RpS18</italic><sup>-</sup>,en-GAL4, UAS-GFP /UAS-PPP1R15, J: en-GAL4, UAS-GFP / UAS- RNAi<sup>PERK</sup>; FRT82 <italic>RpS3</italic>/+, K: <italic>RpS18</italic><sup>-</sup>,en-GAL4, UAS-GFP /UAS- RNAi<sup>PERK</sup>, L: p{hs:FLP}/+; UAS- RNAi<sup>PERK</sup> / <italic>RpS18</italic><sup>-</sup>; act&gt; CD2&gt; Gal4, UAS-His-RFP/+, M, N: p{hs:FLP}/ p{hs:FLP}; FRT80B/p{arm:LacZ} FRT80B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig3-figsupp1-v3.tif"/></fig></fig-group><p>If eIF2α phosphorylation is how Xrp1 reduces translation in <italic>Rp<sup>+/-</sup></italic> cells, we expected translation to be restored by overexpressed PPP1R15, the <italic>Drosophila</italic> protein homologous to the mammalian p-eIF2α phosphatases, Gadd34 (PPP1R15a) and CReP (PPP1R15b) (<xref ref-type="bibr" rid="bib36">Harding et al., 2009</xref>; <xref ref-type="bibr" rid="bib64">Malzer et al., 2013</xref>). Indeed, PPP1R15 cell-autonomously reduced p-eIF2α levels and cell-autonomously restored overall translation levels in multiple <italic>Rp</italic> genotypes, as measured using the Click reagent <italic>o</italic>-propargyl puromycin (OPP) (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H, I</xref>). These data indicate that it is eIF2α phosphorylation that suppresses translation in <italic>Rp<sup>+/-</sup></italic> cells.</p><p><italic>Drosophila</italic> contains two potential eIF2α kinases that are thought to respond to particular stresses and not to be activated in unstressed epithelial wing disc cells. When protein kinase R-like endoplasmic reticulum (ER) kinase (PERK), a kinase that phosphorylates eIF2α during the unfolded protein response (<xref ref-type="bibr" rid="bib94">Shi et al., 1998</xref>; <xref ref-type="bibr" rid="bib34">Harding et al., 1999</xref>; <xref ref-type="bibr" rid="bib35">Harding et al., 2000</xref>; <xref ref-type="bibr" rid="bib81">Pakos-Zebrucka et al., 2016</xref>), was depleted using RNAi, p-eIF2α levels were unaffected in wild type wing discs (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). By contrast, in the <italic>Rp<sup>+/-</sup></italic> genotypes the levels of p-eIF2α were reduced by PERK depletion (<xref ref-type="fig" rid="fig3">Figure 3H</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J, K</xref>). Thus, PERK activity was higher in <italic>Rp<sup>+/-</sup></italic> cells and responsible for eIF2α phosphorylation there. Consistently, PERK knock-down cell-autonomously restored normal translation levels in multiple <italic>Rp<sup>+/-</sup></italic> genotypes (<xref ref-type="fig" rid="fig3">Figure 3I</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L</xref>). Depletion of the other eIF2α kinase known in <italic>Drosophila</italic>, Gcn2, did not decrease p-eIF2α levels in <italic>Rp<sup>+/-</sup></italic> wing disc cells (<xref ref-type="fig" rid="fig3">Figure 3J</xref>).</p></sec><sec id="s2-4"><title>Xrp1 increases protein aggregation and modifies UPR gene expression in <italic>RpS<sup>+/-</sup></italic> cells</title><p>Recently, protein aggregates have been detected in the cytoplasm of wing disc cells heterozygous for <italic>RpS3</italic>, <italic>RpS23</italic>, and <italic>RpS26</italic> mutants, as foci of ubiquitin or p62 accumulation, reflecting decreased proteasome activity and autophagy (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>). We confirmed the greater accumulation of aggregates in <italic>RpS3<sup>+/-</sup></italic>and <italic>RpS18<sup>+/-</sup></italic>cells compared to wild type cells but did not see this for <italic>RpL27A<sup>+/-</sup></italic> cells (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>). Significantly, another study saw no general increase in autophagy in <italic>RpL14<sup>+/-</sup></italic> wing discs (<xref ref-type="bibr" rid="bib76">Nagata et al., 2019</xref>). It would be interesting to examine more mutants affecting the LSU, to see whether autophagy is generally unaffected by <italic>RpL</italic> mutations. Importantly, aggregates in <italic>RpS3<sup>+/-</sup></italic>and <italic>RpS18<sup>+/-</sup></italic> wing discs were Xrp1-dependent, placing them downstream of Xrp1 activation (<xref ref-type="fig" rid="fig4">Figure 4D–E</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Xrp1-dependent aggregates and gene expression changes in <italic>RpS</italic><sup>+/-</sup> cells.</title><p>Panels A-E show single confocal planes from third instar wing imaginal discs, mosaic for the genotypes indicated. In all cases, the plane passes through the central nuclei-containing disk portion for the genotypes shown. (<bold>A</bold>) p62 was higher in <italic>RpS18<sup>+/-</sup></italic> cells than <italic>RpS18<sup>+/+</sup></italic> cells. (<bold>B</bold>) p62 was higher in <italic>RpS3<sup>+/-</sup></italic> cells than <italic>RpS3<sup>+/-</sup></italic> cells. (<bold>C</bold>) p62 was comparable in <italic>RpL27A<sup>+/- </sup></italic>cells and <italic>RpL27A<sup>+/+</sup></italic> cells. (<bold>D</bold>) Clones of cells expressing Xrp1-RNAi in a <italic>RpS18</italic><sup>+/-</sup> wing disc in white. Levels of both p62 and ubiquitinylated proteins were reduced by Xrp1 knock-down. (<bold>E</bold>) Mosaic of <italic>RpS3</italic><sup>+/-</sup> and <italic>RpS3</italic><sup>+/+</sup> cells in <italic>Xrp1<sup>+/-</sup></italic> wing disc. No increase in p62 was seen in <italic>RpS3</italic><sup>+/-</sup> cells (compare panel B). (<bold>F</bold>) Clones of cells expressing PERK-RNAi in a <italic>RpS18</italic><sup>+/-</sup> wing disc in white. Levels of both p62 and ubiquitinylated proteins remained unaffected by PERK knock-down (<bold>G</bold>). PERK mRNA levels (fold changes in mRNA-seq replicates relative to the wild-type controls according to Deseq2) for the indicated genotypes. PERK mRNA was increased in both <italic>RpS17</italic><sup>+/-</sup> and <italic>RpS3</italic><sup>+/-</sup> wing discs but not <italic>RpS3</italic><sup>+/-</sup>, <italic>Xrp1</italic><sup>M2-73/+</sup> cells. (<bold>H</bold>) mRNA levels for 11 genes participating in the Unfolded Protein Response. All were significantly affected only in the <italic>RpS3<sup>+/-</sup> Xrp1 <sup>M2-73/+</sup></italic> genotype. Statistics: Asterisks indicate statistical significance determined by Deseq2 (*: p<sub>adj</sub> &lt;0.05, **: p<sub>adj</sub> &lt;0.005, ***: p<sub>adj</sub> &lt;0.0005) compared to wild type control (black asterisks) or to <italic>RpS3</italic><sup>+/-</sup> genotype (grey asterisks). Comparisons not indicated were not significant ie p<sub>adj</sub> ≥0.05 eg <italic>PERK</italic> mRNA in <italic>RpS3<sup>+/-</sup> Xrp1 <sup>M2-73/+</sup></italic> compared to wild type control. Further data relevant to this Figure are shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. Data are based on mRNA-sequencing of 3 biological replicates for each genotype. Genotypes: A: p{hs:FLP}/ p{hs:FLP}; FRT42 <italic>RpS18</italic> p{Ubi:GFP}/FRT42, B: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B, C: p{hs:FLP}/ p{hs:FLP}; <italic>RpL27A<sup>-</sup></italic> p{arm:LacZ} FRT40/FRT40, D: p{hs:FLP}/+; UAS- RNAi<sup>Xrp1</sup>/ GstD lacZ, <italic>RpS18</italic><sup>-</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, E: p{hs:FLP}/ p{hs:FLP}; FRT82 RpS3 p{arm:LacZ} /FRT82B Xrp1<sup>M2-73</sup>, F: p{hs:FLP}/+; UAS- RNAi<sup>PERK</sup> / GstD-lacZ, <italic>RpS18</italic><sup>-</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+,G-H: wt: w <sup>11-18</sup> /+; FRT82B/+, RpS17/+: w<sup>11-18</sup> /y w p{hs:FLP}; <italic>RpS17</italic> p{ubi:GFP} FRT80B/+, RpS3/+: w<sup>11-18</sup> /y w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ/+, <italic>RpS3</italic>/+, <italic>Xrp1</italic><sup>[M2-73]</sup>/+: w<sup>11-18</sup> /y w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ}/ FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Little UPR detected in <italic>Rp<sup>+/-</sup></italic> wing discs.</title><p>Panels show single confocal planes from third instar wing imaginal discs expressing the UPR reporter UAS-Xbp1-GFP in the wing pouch under <italic>nub-Gal4</italic> control. GFP expression indicates an unfolded protein response. (<bold>A</bold>) Little evidence for UPR in wild type wing discs. (<bold>B</bold>) Elevated UPR in <italic>RpS17<sup>+/-</sup></italic> wing discs. (<bold>C</bold>) Little evidence for UPR in <italic>RpS3<sup>+/-</sup></italic> wing discs. (<bold>D</bold>) No upregulation of Crc/ATF4 in <italic>RpS3<sup>+/-</sup></italic> cells. Genotypes: A: Xbp1-EGFP/nubGal4; +/+, B: Xbp1-EGFP/nubGal4; <italic>RpS17</italic> p{arm:LacZ} FRT80B /+, C: Xbp1-EGFP/nubGal4; FRT82 <italic>RpS3</italic> p{arm:LacZ} /+ D: p{hs:FLP}/ p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ} /FRT82B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig4-figsupp1-v3.tif"/></fig></fig-group><p>PERK is a transmembrane protein with a cytoplasmic kinase domain that is a sensor of unfolded proteins within the ER, not within the cytoplasm or nucleolus ( <xref ref-type="bibr" rid="bib9">Bertolotti et al., 2000</xref>; <xref ref-type="bibr" rid="bib35">Harding et al., 2000</xref>; <xref ref-type="bibr" rid="bib91">Ron and Walter, 2007</xref>; <xref ref-type="bibr" rid="bib110">Walter and Ron, 2011</xref>). Cytoplasmic aggregates can cause unfolded protein accumulation within the ER by competing for proteasomes, however. ER stress also activates Ire-1 and Atf6 in parallel to PERK (<xref ref-type="bibr" rid="bib9">Bertolotti et al., 2000</xref>; <xref ref-type="bibr" rid="bib91">Ron and Walter, 2007</xref>; <xref ref-type="bibr" rid="bib110">Walter and Ron, 2011</xref>; <xref ref-type="bibr" rid="bib40">Hetz, 2012</xref>; <xref ref-type="bibr" rid="bib72">Mitra and Ryoo, 2019</xref>). Xbp1-GFP (<xref ref-type="bibr" rid="bib98">Sone et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Mitra and Ryoo, 2019</xref>), a reporter for Ire-1 activity, was only inconsistently activated in <italic>Rp<sup>+/-</sup></italic> wing discs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, C</xref>), in agreement with the absence of any transcriptional signature of Atf6 or Xbp1 activation in <italic>Rp</italic><sup>+/-</sup> wing disc mRNA-seq data (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Crc/Atf4 protein was not upregulated in RpS3<sup>+/-</sup> cells, which would be expected in the classic PERK/ATF4 branch activation of UPR (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). PERK mRNA levels were elevated by 1.4 x in both <italic>RpS3<sup>+/-</sup></italic> and <italic>RpS17<sup>+/-</sup></italic> wing discs, however (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). This increase was statistically very significant, replicated in another group’s data, and entirely dependent on <italic>Xrp1</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). <italic>BiP</italic> and 10 other UPR genes were affected differently. Although none were significantly altered in <italic>RpS17<sup>+/-</sup></italic> or <italic>RpS3<sup>+/-</sup></italic> discs, all these genes were affected in <italic>RpS3<sup>+/-</sup> Xrp1<sup>+/- </sup></italic>wing discs, suggesting that Xrp1 prevents their elevation in <italic>RpS17<sup>+/-</sup></italic> or <italic>RpS3<sup>+/-</sup></italic> discs (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Since these genes help restore ER proteostasis (<xref ref-type="bibr" rid="bib110">Walter and Ron, 2011</xref>), we speculate that Xrp1 might sensitize <italic>Rp<sup>+/-</sup></italic> cells to PERK activation relative to Atf6 or Xbp1 branches of the UPR (<xref ref-type="bibr" rid="bib61">Lin et al., 2007</xref>), by elevating the expression of PERK while blunting the usual proteostatic response. Testing this notion would require manipulating multiple genes in vivo simultaneously.</p></sec><sec id="s2-5"><title>eIF2α phosphorylation is sufficient to induce competitive apoptosis, but through Xrp1</title><p>We determined whether manipulating p-eIF2α levels alone was sufficient to cause competition of otherwise wild-type cells. Consistent with this notion, clones of cells depleted for PPP1R15 were rapidly lost from wing imaginal discs and could rarely be recovered (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Under some conditions (longer heat shock) where clones of cells depleted for PPP1R15 survived temporarily, we verified that p-eIF2α was increased and translation reduced compared to nearby wild-type cells (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>). Such surviving clones were characterized by apoptosis of PPP1R15-depleted cells predominantly at the interface with wild-type cells, a sign of cell competition (<xref ref-type="fig" rid="fig5">Figure 5E</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>eIF2α phosphorylation can induce Xrp1 expression and cell competition.</title><p>All panels show single confocal planes from third instar wing imaginal discs, mosaic for the genotypes indicated. All the sections pass through the central region of the disc proper containing nuclei in all genotypes, as indicated by the DNA stain in blue in some panels. (<bold>A</bold>) Clones expressing <italic>white</italic> RNAi (green). Clones induced by 7 min heat shock. (<bold>B</bold>) Clones expressing <italic>PPP1R15</italic> RNAi (green)were fewer and smaller than the control (compare panel A). Clones induced by 7 min heat shock. (<bold>C</bold>) Clones expressing <italic>PPP1R15</italic> RNAi (white) contain phosphorylated eIF2α (see C’). (<bold>D</bold>) Clones induced by 25 ± 5 min heat shock, which results in larger clone areas (white). Labelled clones expressing <italic>PPP1R15</italic> RNAi reduced translation rate (see D’). (<bold>E</bold>) Labelled clones expressing <italic>PPP1R15</italic> RNAi (green) underwent competitive apoptosis at interfaces with wild type cells (activated caspase Dcp1 in magenta; see also E’). (<bold>F</bold>) <italic>Nub-Gal4</italic> drives gene expression in the wing pouch, shown in green for RFP, with little expression of Xrp1-HA (magenta; see also F’). (<bold>G</bold>) <italic>PPP1R15</italic> RNAi induces Xrp1-HA expression in the wing pouch (magenta; see also G’). (<bold>H</bold>) Clones co-expressing <italic>PPP1R15</italic> RNAi and <italic>Xrp1</italic> RNAi (green) lacked competitive apoptosis (activated caspase Dcp1 in magenta; see also H’). (<bold>I</bold>) Clones expressing <italic>PPP1R15</italic> RNAi (green). Experiment performed in parallel to panel H. Note competitive apoptosis at interfaces with wild type cells (activated caspase Dcp1 in magenta; see also I’), and smaller clone size. Cell death at the basal surface of the same disc shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>. (<bold>J</bold>) Clones co-expressing <italic>PPP1R15</italic> RNAi and <italic>Xrp1</italic> RNAi (white) showed less eIF2α phosphorylation than for <italic>PPP1R15</italic> RNAi alone (compare panel C). Sample prepared in parallel to panel C (in the same tube from fixation to staining). (<bold>K</bold>) <italic>Xrp1</italic> knock-down restored normal translation rate to cell clones expressing <italic>PPP1R15</italic> RNAi (green; see also K’). Sample prepared in parallel to panel D (in the same tube from fixation to staining). Additional data relevant to this Figure is shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Genotypes: A: {hs:FLP}/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>w</sup>, B: {hs:FLP}/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>PPP1R15</sup> (line: BL 33011) (samples were processed on the same day, not on the same tube), C: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /TRE-dsRed; act&gt; CD2&gt; Gal4, UAS-GFP /+(line: v107545) (processed in parallel with 5 J), D: {hs:FLP}/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>PPP1R15</sup> (line: BL 33011), E: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107545),F: nubGal4, UAS-RFP/+; Xrp1-HA/RNAi<sup>w</sup>, G: nubGal4, UAS-RFP/ UAS – RNAi<sup>PPP1R15</sup>; Xrp1-HA/+ (line: v107545), H, J, K: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> / UAS-RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107545) (5 H processed in parallel with 5I. Also, 5 K processed in parallel with <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>) (line RNAi<sup>PPP1R15</sup>: v107545 and line RNAi<sup>Xrp1</sup>: v107860), I: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /TRE-dsRed; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line RNAi<sup>PPP1R15</sup>: v107545).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>eIF2α phosphorylation induces Xrp1 expression and cell competition.</title><p>Single confocal planes from third instar wing imaginal discs. (<bold>A</bold>) Clones expressing PPP1R15-RNAi had increased p-eIF2α levels (<bold>A’</bold>). (<bold>B</bold>) Clones expressing PPP1R15-RNAi had reduced translation (OPP) (<bold>B’</bold>). (<bold>C</bold>) Basal section of the same disc shown in <xref ref-type="fig" rid="fig5">Figure 5E</xref>. More dying PPP1R15-RNAi cells labeled for active caspase (magenta, see also C’) accumulate basally at the boundaries with the wild-type cells. (<bold>D</bold>) <italic>nub-Gal4</italic> driving <italic>PPP1R15</italic> RNAi in the wing pouch (green) led to Xrp1-HA expression (magenta; see also D’). (<bold>E</bold>) Basal confocal section of the wing disc also shown in <xref ref-type="fig" rid="fig5">Figure 5H</xref>, mosaic for cells expressing <italic>PPP1R15</italic> RNAi and Xrp1 RNAi (green). Even at these basal levels, apoptosis was almost completely rescued by Xrp1 knockdown (magenta, see also E’). (<bold>F</bold>) Basal confocal section of wing disc mosaic for wild-type cells and cells expressing <italic>PPP1R15</italic> RNAi also shown in <xref ref-type="fig" rid="fig5">Figure 5I and a</xref> parallel control to panel E. Note extensive cell death basally (magenta, see also F’), as well as smaller clone size (green). Genotypes: A: {hs:FLP}/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>PPP1R15</sup> (line: BL 33011), B: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107545) (processed in parallel with <xref ref-type="fig" rid="fig5">Figure 5K</xref>), C: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107545) (basal side of the same disc in <xref ref-type="fig" rid="fig5">Figure 5E</xref>), D: nubGal4, UAS-RFP/ UAS – RNAi<sup>PPP1R15</sup>; Xrp1-HA/+ (line: Bl 33011), E: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107545) (basal side of the same disc in <xref ref-type="fig" rid="fig5">Figure 5H</xref>), F: {hs:FLP}/+; UAS – RNAi<sup>PPP1R15</sup> /UAS-RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line RNAi<sup>PPP1R15</sup>: v107545 and line RNAi<sup>Xrp1</sup>: v107860) (basal side of the same disc in <xref ref-type="fig" rid="fig5">Figure 5I</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig5-figsupp1-v3.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>eIF2α phosphorylation reduces bristle size.</title><p>Minute-like short, thin bristles occur on adults containing clones depleted for PPP1R15, for example compare highlighted posterior scutellar bristle (black arrow) with normal contralateral bristle (white arrow). Genotype: p{hs:FLP}/+; UAS- RNAi <sup>PPP1R15</sup>/+;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 33011).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig5-figsupp2-v3.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>eIF2α phosphorylation is not required for cell competition.</title><p>All panels show single confocal planes from third instar wing imaginal discs, mosaic for the genotypes indicated. (<bold>A</bold>) When mitotic recombination generated twin clones of <italic>RpL19<sup>+/+/+</sup></italic> cells (brightly labeled) and <italic>RpL19<sup>+/-</sup></italic> ± (black) in the <italic>RpL19<sup>+/+</sup></italic> background (gray), the <italic>RpL19<sup>+/-</sup></italic> ± did not survive. This was also shown by the absence of mCherry expression, which would have been labelled white in panel A’. (<bold>B</bold>) Clones of <italic>perk<sup>-/-</sup> RpL19<sup>+/-</sup></italic> ± (black) were also not seen after recombination in the <italic>perk<sup>+/-</sup> RpL19<sup>+/+</sup></italic> background (gray) led to twin clones of <italic>perk<sup>+/+</sup> RpL19<sup>+/+/+</sup></italic> cells (brightly labeled). Any clones of <italic>perk<sup>-/-</sup> RpL19<sup>+/-</sup></italic> ± would also have been detected through mCherry expression, which would have been labelled white in panel B’. (<bold>C</bold>) Clones of both <italic>RpL36<sup>+/+/+/+</sup></italic> cells (brightly labeled) and <italic>RpL36<sup>+/+</sup></italic> cells (black) survived in the <italic>RpL36<sup>+/+/+</sup></italic> background (gray). (<bold>D</bold>) No clones of <italic>RpL36<sup>+/-</sup></italic> ± (black) were seen after recombination in the <italic>RpL36<sup>+/+</sup></italic> background (gray) generated twin clones of <italic>RpL36<sup>+/+/+</sup></italic> cells (brightly labeled). (<bold>E</bold>) No clones of <italic>perk<sup>-/-</sup> RpL36<sup>+/-</sup></italic> ± (black) were seen after recombination in the <italic>perk<sup>+-/-</sup> RpL36<sup>+/+</sup></italic> background (gray) generated twin clones of <italic>perk<sup>+/+</sup> RpL36<sup>+/+/+</sup></italic> cells (brightly labeled). (<bold>F</bold>) Clones of <italic>perk<sup>-/-</sup> RpL36<sup>+/+</sup></italic> cells (black) were readily obtained after recombination in the <italic>perk<sup>+-/-</sup> RpL36<sup>+/+/+</sup></italic> background (gray) generated twin clones of <italic>perk<sup>+/+</sup> RpL36<sup>+/+/+/+</sup></italic> cells (brightly labeled). Genotypes: A,A’: y w, hs-FLP; Act5C &gt; GAL4 w, UAS-mCherry-CAAX, Df(2 R)M60E; FRT82B, ubi-GFP-nls, tubP-GAL80, M{RpL19 genomic}ZH-86Fb/FRT82B. B,B’: y w, hs-FLP; Act5C &gt; GAL4 w, UAS-mCherry-CAAX, Df(2 R)M60E; FRT82B, ubi-GFP-nls, tubP-GAL80, M{RpL19 genomic}ZH-86Fb/FRT82B Perk<sup>null</sup> C: FM7/hs-FLP; FRT82B p{RpL36<sup>+</sup>} p{arm:LacZ}/FRT82B. D: Df(1)R194/hs-FLP; FRT82B p{RpL36<sup>+</sup>} p{arm:LacZ}/FRT82B. E: Df(1)R194/hs-FLP; FRT82B p{RpL36<sup>+</sup>} p{arm:LacZ}/FRT82B PERK<sup>null</sup> F: FM7/hs-FLP; FRT82B p{RpL36<sup>+</sup>} p{arm:LacZ}/FRT82B PERK<sup>null</sup> The FM7 and Df(1)R194 genotypes used in panels C-F were unmarked in wing discs. The experiment with FRT82B led to the two classes of discs with and without clones shown in panels C and D, and the experiment with FRT82B <italic>perk<sup>-</sup></italic> led to the two classes of discs with and without clones shown in panels E and F. A parallel experiment with FRT82B <italic>Xrp1<sup>-</sup></italic>, which rescues <italic>RpL36<sup>+/-</sup></italic> ± (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>) led only to wing discs with clones equal in size and frequency to reciprocal twin clones.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig5-figsupp3-v3.tif"/></fig></fig-group><p>If eIF2α phosphorylation was the downstream effector of Xrp1 that triggers cell competition in <italic>Rp</italic><sup>+/-</sup> cells then PPP1R15 depletion should eliminate cells independently of Xrp1. Like <italic>Rp<sup>+/-</sup></italic> cells; however, PPP1R15-depleted cells showed strong upregulation of Xrp1 protein (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). When Xrp1 was knocked-down in PPP1R15-depleted cells, competitive cell death was completely blocked, and clone survival improved (Figure H-I; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E-F</xref>). Even the p-eIF2α levels in the PPP1R15 depleted clones partially depended on Xrp1 (compare <xref ref-type="fig" rid="fig5">Figure 5C</xref> with <xref ref-type="fig" rid="fig5">Figure 5J</xref>), and translation rates were similar to wild-type levels in PPP1R15 clones lacking Xrp1 (<xref ref-type="fig" rid="fig5">Figure 5K</xref>). Interestingly, PPP1R15 knock-down reduced bristle size, another similarity with <italic>Rp</italic> mutants (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>).</p><p>These data raised the possibility of positive feedback between Xrp1 expression and eIF2α phosphorylation. To assess this, we compared Xrp1 expression in <italic>RpS18<sup>+/-</sup></italic> cells with or without PERK RNAi or PPP1R15 over-expression (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>), each of which reduces eIF2α phosphorylation to or below baseline levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H-K</xref>). Because Xrp1 protein levels were unaffected, we concluded that while eIF2α phosphorylation was sufficient to promote Xrp1 expression in otherwise wild-type cells, it was not necessary for the Xrp1 protein expression seen in <italic>RpS18<sup>+/-</sup></italic> cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>). This continued Xrp1 expression was functional, because none of Xrp1-dependent JnK activity in <italic>RpS17<sup>+/-</sup></italic> cells, Xrp1-dependent GstD-LacZ reporter activity in <italic>RpS18<sup>+/-</sup></italic> cells, or Xrp1-dependent ubiquitin and p62 foci in <italic>RpS18<sup>+/-</sup></italic> cells were affected by Perk knock-down (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref> and <xref ref-type="fig" rid="fig6s2">2</xref>). Xrp1 protein levels were reduced by knockdown of its heterodimer partner, Irbp18, in <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), however. These findings indicate that <italic>Rp<sup>+/-</sup></italic> cells activate Xrp1 expression independently of eIF2α phosphorylation. Positive feedback between Xrp1 expression and eIF2α phosphorylation might still be important under some circumstances, for example when PPP1R15 is knocked-down, where the effects on global translation and on cell competition depended on Xrp1 (<xref ref-type="fig" rid="fig5">Figure 5C–E and H–K</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>eIF2α phosphorylation is dispensable for Xrp1 expression in Minutes.</title><p>All panels show single confocal planes from <italic>RpS18<sup>+/-</sup></italic> third instar wing imaginal discs, co-expressing GFP and the indicated constructs in the posterior compartments. All the sections pass through the central region of the disc proper containing nuclei, as indicated by the DNA stain in blue. (<bold>A</bold>) Perk knock-down had no effect on Xrp1 expression in <italic>RpS18<sup>+/-</sup></italic>. (<bold>B</bold>) PPP1R15 over-expression had no effect on Xrp1 expression in <italic>RpS18<sup>+/-</sup></italic>. (<bold>C</bold>) Irbp18 knock-down strongly reduced Xrp1 expression in <italic>RpS18<sup>+/-</sup></italic>. (<bold>D</bold>) Knock-down for the <italic>w</italic> gene had no effect on Xrp1 expression in <italic>RpS18<sup>+/-</sup></italic>. Genotypes: A: <italic>RpS18</italic><sup>-</sup>, en-GAL4, UAS-GFP / UAS- RNAi<sup>PERK</sup>; Xrp1-HA /+, B: <italic>RpS18</italic><sup>-</sup>,en-GAL4, UAS-GFP / UAS-PPP1R15; Xrp1-HA /+, C: <italic>RpS18</italic><sup>-</sup>,en-GAL4, UAS-GFP /+; Xrp1-HA /UAS- RNAi<italic><sup>Irbp18</sup></italic>, D:<italic>RpS18</italic><sup>-</sup>,en-GAL4, UAS-GFP /+; Xrp1-HA /UAS- RNAi<italic><sup>w</sup></italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>PERK is dispensable for Xrp1-dependent JnK activity in Minute cells.</title><p>All panels show single confocal planes from <italic>RpS17<sup>+/-</sup></italic> third instar wing imaginal discs, co-expressing GFP and the indicated constructs in the green-labeled clones. All the sections pass through the central region of the disc proper containing nuclei, as indicated by the DNA stain. (<bold>A</bold>) Clonal knockdown of the <italic>w</italic> gene did not affect TRE-dsRed, a reporter for JNK activity; (<bold>B</bold>) Bsk<sup>DN</sup> expression extinguished TRE-dsRed from cell clones, confirming JNK-dependence of this reporter; (<bold>C</bold>) Irbp18 knock-down extinguished TRE-dsRed from cell clones, confirming Xrp1/Irbp18-dependence of this reporter, as previously concluded from non-clonal experiments (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>); (<bold>D</bold>) PERK knock-down had little effect on TRE-dsRed, suggested that JNK is activated by Xrp1/Irbp18 independently of eIF2α phosphorylation. Genotypes: A: p{hs:FLP}/+; TRE-dsRed/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /UAS- RNAi<italic><sup>w</sup>,</italic> B: p{hs:FLP}/+; TRE-dsRed/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /UAS- Bsk<sup>DN</sup>, C: p{hs:FLP}/+; TRE-dsRed/+; <italic>RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /UAS- RNAi<italic><sup>Irbp18</sup>,</italic> D: p{hs:FLP}/+; TRE-dsRed/ UAS- RNAi<italic><sup>PERK</sup>; RpS17</italic>, act&gt; CD2&gt; Gal4, UAS-GFP /+<italic>.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>PERK is dispensable for Xrp1-dependent GstD1 activity in Minute cells.</title><p>All panels show single confocal planes from <italic>RpS18<sup>+/-</sup></italic> third instar wing imaginal discs, co-expressing GFP and the indicated constructs in the green-labeled clones. (<bold>A</bold>) Clonal knockdown of the <italic>w</italic> gene did not affect GstD1-LacZ, a reporter for oxidative stress response; (<bold>B</bold>) Xrp1 knock-down extinguished GstD1-LacZ from cell clones, confirming Xrp1-dependence of this reporter, as seen in non-clonal experiments (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>); (<bold>C</bold>) PERK knock-down had no effect on GstD1-LacZ, suggested that Xrp1 regulates GstD1-LacZ independently of eIF2α phosphorylation. Genotypes: A: p{hs:FLP}/+;GstD1-lacZ, <italic>RpS18</italic><sup>-</sup>/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS-RNAi<sup>w</sup>, B: p{hs:FLP}/+; UAS- RNAi<sup>Xrp1</sup>/ GstD1 lacZ, <italic>RpS18</italic><sup>-</sup>; act&gt; CD2&gt; Gal4, UAS-GFP/+, C: p{hs:FLP}/+; UAS- RNAi<sup>PERK</sup> / GstD1-lacZ, <italic>RpS18</italic><sup>-</sup>; act&gt; CD2&gt; Gal4, UAS-GFP/+.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig6-figsupp2-v3.tif"/></fig></fig-group><p>We also tested whether increased eIF2α phosphorylation was necessary for cell competition (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). We used assays where mitotic recombination generates clones of <italic>RpL19<sup>+/-</sup></italic> cells or clones of <italic>RpL36<sup>+/-</sup></italic>, both subject to competition by surrounding cells (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A, D</xref>; <xref ref-type="bibr" rid="bib107">Tyler et al., 2007</xref>; <xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref>). Since PERK was responsible for increasing eIF2α phosphorylation, we expected that if this was required for cell competition, then a <italic>perk</italic> null mutation should rescue the elimination <italic>RpL19<sup>+/-</sup></italic> or <italic>RpL36<sup>+/-</sup></italic> clones. Since no <italic>RpL19<sup>+/-</sup> perk<sup>-/-</sup></italic> or <italic>RpL36<sup>+/-</sup> Perk<sup>-/-</sup></italic> clones were recovered (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B, E</xref>), although <italic>RpL36<sup>+/+</sup> perk<sup>-/-</sup></italic>clones survived normally (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3C, F</xref>), we concluded that PERK-dependent eIF2α phosphorylation was not required for cell competition.</p><p>These data show that eIF2α phosphorylation was sufficient to reduce cell competitiveness in otherwise wild type cells, but only in the presence of Xrp1. It was the mechanism whereby Xrp1 reduced global translation rate in <italic>Rp<sup>+/-</sup></italic> mutant cells, but apparently not the downstream effector of Xrp1 for cell competition.</p></sec><sec id="s2-6"><title>Interrupting the translation cycle activates Xrp1-dependent cell competition, independently of diminished translation</title><p>Phosphorylation of eIF2α inhibits CAP-dependent initiation. To explore further whether reduced translation was sufficient to cause cell competition, we also reduced translation by clonal depletion of translation factors acting at a variety of steps in the translation cycle, not only at initiation but also the 40 S-60S subunit joining and elongation steps (<xref ref-type="bibr" rid="bib44">Jackson et al., 2010</xref>). Specifically, we depleted eIF4G, eIF5A, eIF6, eEF1α1, and eEF2, none of which is encoded by a haploinsufficient gene (<xref ref-type="bibr" rid="bib66">Marygold et al., 2007</xref>). eIF4G is part of the eIF4 complex which binds the mRNA 5’cap and recruits SSU to enable translation initiation (<xref ref-type="bibr" rid="bib44">Jackson et al., 2010</xref>). It is now accepted that eIF5A functions in translation elongation and termination (<xref ref-type="bibr" rid="bib92">Saini et al., 2009</xref>; <xref ref-type="bibr" rid="bib93">Schuller et al., 2017</xref>). eEF1α1 delivers aminoacyl-tRNAs to the ribosome and eEF2 also promotes ribosome translocation (<xref ref-type="bibr" rid="bib25">Dever and Green, 2012</xref>). eIF6 has a role during LSU biogenesis and also in translation initiation (<xref ref-type="bibr" rid="bib16">Brina et al., 2015</xref>).</p><p>All these depletions exhibited severe reduction in translation rate in the third instar larvae, as did TAF1B depletion (<xref ref-type="fig" rid="fig7">Figure 7A, E, I and M</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, E</xref>; the fact that clones of cells expressing these dsRNAs could be recovered with such low translation suggests that translation factor depletion probably exacerbates over time, initially being insufficient to prevent translation and growth, but eventually becoming severe). Importantly, all these translation factor depletions resulted in more dramatic induction of apoptosis in depleted cells that were close to wild-type cells than within the clones, suggesting that differences in translation rate might be sufficient to initiate cell competition (<xref ref-type="fig" rid="fig7">Figure 7B, F and J</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B, F</xref>; <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Interestingly, in all these cases translation increased in wild-type cells near to the affected clones, something that was rare adjacent to <italic>Rp</italic><sup>+/-</sup> cells and not seen adjacent to cells depleted for PPP1R15, although it was observed near to TAF1B depleted cells (<xref ref-type="fig" rid="fig7">Figure 7A, E, I and M</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, E</xref>). Phosphorylated RpS6 accumulated in wild-type cells adjacent to TAF1B depleted cells, suggesting that a non-autonomous activation of Tor accounts for the increased translation in cells nearby those with translation deficits (<xref ref-type="fig" rid="fig7">Figure 7N</xref>; <xref ref-type="bibr" rid="bib57">Laplante and Sabatini, 2012</xref>; <xref ref-type="bibr" rid="bib90">Romero-Pozuelo et al., 2017</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Depletion of translation factors induces Xrp1 expression, eIF2α phosphorylation, reduced translation, and cell competition.</title><p>Clones of cells depleted for translation factors are labelled in green. In each case, translation factor depletion reduced translation rate, resulted in competitive cell death at interfaces with wild type cells, induced Xrp1-HA expression, and led to eIF2α phosphorylation. Translation rate, dying cells (activated caspase Dcp1), Xrp1-HA and p-eIF2α are indicated in magenta and in separate channels as labelled. To clarify cell-autonomy, cell death is also shown in higher magnification in <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>. (<bold>A–D</bold>) Clones expressing RNAi for eIF4G. (<bold>E–H</bold>) Clones expressing RNAi for eEF2. (<bold>I–L</bold>) Clones expressing RNAi for eIF6. In all cases (panels A,E,I), wild-type cells near to cells depleted for translation factors show higher translation rate than other wild type cells. (<bold>M</bold>) Clones of cells depleted for TAF1B (green) also showed a cell-autonomous reduction in translation rate and non-autonomous increase in nearby wild-type cells (translation rate in magenta, see also M’). (<bold>N</bold>) Clones of cells depleted for TAF1B (green) showed a non-autonomous increase in RpS6 phosphorylation in nearby cells (magenta, see also N’). Additional data relevant to this Figure is shown in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref> and <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>. Genotypes: A, B, D: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v17002), C:{hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /Xrp1-HA (line: v17002), E, F, H: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v107268), G: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA (line: v107268), I, J, L:{hs:FLP}/+; UAS – RNAi <sup>eIF6</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / + (line: v108094), K: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA(line: v108094), M, N: p{hs:FLP}/+; UAS-RNAi<sup>TAF1B</sup>/+;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 61957).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig7-v3.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Xrp1 expression, eIF2α phosphorylation, reduced translation, and cell competition after depletion of additional translation factors.</title><p>Clones of cells depleted for translation factors are shown in green. In each case, translation factor depletion reduced translation rate, resulted in competitive cell death at interfaces with wild-type cells, induced Xrp1-HA expression, and led to eIF2α phosphorylation. Translation rate, dying cells (activated caspase Dcp1), Xrp1-HA and p-eIF2α are indicated in magenta and in separate channels as labelled. To clarify cell-autonomy, cell death is also shown in higher magnification in <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>. (<bold>A–D</bold>) Clones expressing RNAi for eIF5A. (<bold>E–H</bold>) Clones expressing RNAi for eEF1α. (<bold>I,J</bold>) Clones expressing RNAi for TAF1B. (<bold>I,J</bold>) Clones expressing RNAi for TAF1B. Genotypes: A, B, D: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / + (line: v101513), C: {hs:FLP}/+; UAS – RNAi <sup>eIF5A</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA (line: v101513), E, F, H: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v104502), G: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> /+; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA (line: v104502), I: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /+;act&gt; CD2&gt; Gal4, UAS- GFP / Xrp1-HA (line: v105873), J: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /+;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: Bl 61957).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig7-figsupp1-v3.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Cell-autonomy of cell death after translation factor depletion.</title><p>All panels show cell death, indicated by Dcp1 labeling in magenta in panels A-E and in white in panels A”-E”, associated with clones of cells depleted for the indicated translation factors (green in panels A-E and white in panels A’-E’). The images shown are enlargements of portions of <xref ref-type="fig" rid="fig7">Figure 7B, F and J</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref> panels B, F. In all cases, the large majority of the dying cells are cells depleted for translation factors close to the wild-type cells (black in panels A-E and A’-E’), with only a few depleted cells dying away from the clone boundary, and only a few dying wild-type cells. (<bold>A-A”</bold>) RNAi for eIF4G; (<bold>B</bold>) RNAi for eEF2; (<bold>C</bold>) RNAi for eEF1α(<bold>D</bold>) RNAi for eIF5A; (<bold>E</bold>) RNAi for eIF6.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig7-figsupp2-v3.tif"/></fig><fig id="fig7s3" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 3.</label><caption><title>Translation factor knock-down induces Xrp1 expression.</title><p>Knock down of translation factors using nub-Gal4 to drive RNAi in the wing pouch (green) induced Xrp1-HA expression (magenta, and separate channels as indicated). (<bold>A</bold>) In the control of nub-Gal4 expressing RFP along with w-RNAi, negligible Xrp1-HA was detected (see A’). (<bold>B</bold>) eIF4G-RNAi. (<bold>C</bold>) eEF2- RNAi. (<bold>D</bold>) eEF1α1-RNAi. (<bold>E</bold>) eIF5A-RNAi. (<bold>F</bold>) eIF6-RNAi. (<bold>G</bold>) TAF1B-RNAi (<bold>H</bold>) TAF1B-RNAi. Genotypes: A: nubGal4, UAS-RFP/+; Xrp1-HA/RNAi<sup>w</sup>, B: nubGal4, UAS-RFP/ UAS – RNAi<sup>eIF4G</sup>; Xrp1-HA/+, C: nubGal4, UAS-RFP/ UAS –RNAi<sup>eEF2</sup>; Xrp1-HA/+, D: nubGal4, UAS-RFP/ UAS – RNAi<sup>eEF1α1</sup>; Xrp1-HA/+, E: nubGal4, UAS-RFP/ UAS – RNAi <sup>eIF5A</sup>; Xrp1-HA/+, F: nubGal4, UAS-RFP/ UAS – RNAi <sup>eIF6</sup>; Xrp1-HA/+, G: nubGal4, UAS-RFP/ RNAi<sup>TAF1B</sup>; Xrp1-HA/+ (v105873), H: nubGal4, UAS-RFP/ RNAi<sup>TAF1B</sup>; Xrp1-HA/+ (line: BL 61957).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig7-figsupp3-v3.tif"/></fig></fig-group><p>To confirm that translation factor depletion affected translation directly, and downstream of Xrp1 and PERK, Xrp1 expression and eIF2α phosphorylation were examined. Unexpectedly, depletion for translation factors was associated with both cell-autonomous induction of Xrp1 expression and eIF2α phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7C, D, G, H, K and L</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>,D,G,H; <xref ref-type="fig" rid="fig7s3">Figure 7—figure supplement 3</xref>). The levels were at least comparable to those of TAF1B-depleted cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1I, J</xref>). When Xrp1 was knocked-down, PPP1R15 overexpressed, or PERK depleted simultaneously with translation factor depletion, the translation factor depletions behaved similarly to one another, and also similarly to TAF1B knock-down. PPP1R15 overexpression reduces eIF2α phosphorylation even in wild type cells, without increasing their global translation rate or affecting survival (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A-F</xref>). In translation-factor-depleted cells, PPP1R15 overexpression also reduced eIF2α phosphorylation to or even below control levels (<xref ref-type="fig" rid="fig8">Figure 8A, D and G</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1G, J and M</xref>, <xref ref-type="fig" rid="fig8s4">Figure 8—figure supplement 4</xref>), but this did not restore normal translation rates (<xref ref-type="fig" rid="fig8">Figure 8B, E and H</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1H, K and N</xref>). There was no rescue of competitive cell death (<xref ref-type="fig" rid="fig8">Figure 8C, F and I</xref>; <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1I, L and O</xref>) or Xrp1 expression (<xref ref-type="fig" rid="fig8">Figure 8J–L</xref>; <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1P, Q and R</xref>). PERK knock-down similarly did not affect Xrp1 expression or rescue competitive cell death in translation-factor knock-downs or TAF1B knock-down (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). Knockdown of Xrp1 reduced levels of eIF2α phosphorylation in some cases (<xref ref-type="fig" rid="fig8">Figure 8M, P and S</xref> <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3J</xref>), although for eIF5A and eEF1α1 the reduction was only partial so that both the eIF5A Xrp1 depleted and eEF1α1 Xrp1-depleted cells retained more eIF2α phosphorylation than wild-type cells (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3D, G</xref>). For all the translation factors, however, Xrp1 depletion eliminated or strongly reduced cell death at the competing cell boundaries, irrespective of whether eIF2α phosphorylation remained (<xref ref-type="fig" rid="fig8">Figure 8O, R and U</xref>; <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3F, I</xref>). We also found that overall translation rate, as estimated by OPP incorporation, was only partially restored by simultaneous Xrp1 depletion from most translation factor knock-down cells, and remained lower than wild type cells (<xref ref-type="fig" rid="fig8">Figure 8N and Q</xref>; <xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3H</xref>). Remarkably, simultaneous knock-down of Xrp1 along with eIF6 resulted in translation rates similar to or higher than in wild type cells (<xref ref-type="fig" rid="fig8">Figure 8T</xref>). We have also seen this with eEF1α Xrp1 double knockdown (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3E</xref>), but interpretation is difficult because some clones depleted only for eEF1α also had higher OPP labeling. Reduced translation upon TAF1B knock-down was also Xrp1-dependent (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3K, L</xref>), although Xrp1 depletion had no effect on eIF2α phosphorylation, global translation, or cell survival of otherwise wild-type cells (<xref ref-type="fig" rid="fig8s3">Figure 8—figure supplement 3A-C</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Interrupting the translation cycle activates Xrp1-dependent cell competition, independently of diminished translation.</title><p>Single confocal planes from third instar wing imaginal discs. p-eIF2α levels, translation rate (ortho-propargyl puromycin), dying cells (activated caspase Dcp1) and Xrp1-HA are indicated in magenta and in separate channels as labelled. (<bold>A–L</bold>) Clones of cells depleted for translation factors which also overexpress PPP1R15 are shown in green. In each case, PPP1R15 overexpression was sufficient to reduce eIF2α phosphorylation to near control levels (or even lower), but it did not restore normal translation rates, did not affect Xrp1-HA levels and did not reduce competitive cell death. (<bold>A–C</bold>) Clones co-expressing PPP1R15 and RNAi for eEF2. (<bold>D–F</bold>) Clones co-expressing PPP1R15 and RNAi eIF4G. (<bold>G-I</bold>) Clones co-expressing PPP1R15 and RNAi for eIF6. (<bold>J–K</bold>) Xrp1-HA expression (magenta) in clones co-expressing PPP1R15 and RNAi for eEF2 (<bold>J</bold>), eIF4G (<bold>K</bold>), or eIF6 (<bold>L</bold>). (<bold>M–U</bold>) Clones of cells depleted for translation factors which also express Xrp1-RNAi are shown in green. (<bold>M–O</bold>) Clones depleted for Xrp1 as well as eEF2 expressed phospho-eIF2α at near to control levels, only partially restored overall translation rate, but lacked competitive cell death. (<bold>P–R</bold>) Clones depleted for Xrp1 as well as eIF4G expressed phospho-eIF2α at near to control levels, only partially restored overall translation rate, but lacked competitive cell death. (<bold>S–U</bold>) Clones depleted for Xrp1 as well as eIF6 expressed phospho-eIF2α at near to control levels, restored overall translation rate and lacked competitive cell death. Genotypes: A-C: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup>/ UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / +, D-F: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / +, G-I: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup>/ UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / +, J: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup>/ UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, K: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, L: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup>/ UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, M-O: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup>/ UAS- RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, P-R: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /UAS- RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / +, S-U: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup>/ UAS- RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / +.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig8-v3.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Translation and transcription factor knock down affect global translation, cell competition, and Xrp1 expression, independently of PPP1R15 over-expression.</title><p>Single confocal planes from third instar wing imaginal discs. p-eIF2α levels, translation rate (ortho-propargyl puromycin), dying cells (activated caspase Dcp1) and Xrp1-HA are indicated in magenta and in separate channels as labelled. (<bold>A–C</bold>) Control clones overexpressing RNAi against white showed no effect in p-eIF2a levels(A), translational rates (<bold>B</bold>) or cell death (<bold>C</bold>). (<bold>D–F</bold>) Clones of cells depleted for white gene which also overexpress PPP1R15 (shown in green) present lower levels of eIF2α phosphorylation, but had no effect on translational levels or cell death. (<bold>G–R</bold>) Clones of cells depleted for translation factors which also overexpress PPP1R15 are shown in green. PPP1R15 overexpression reduced eIF2α phosphorylation in the cells depleted for eEF1α (<bold>G</bold>), eIF5A (<bold>J</bold>) or TAF1B (<bold>M</bold>), but did not restore translation levels back to normal (<bold>H, K,N</bold>). PPP1R15 overexpression did not reduce Xrp1-HA levels or rescue competitive cell death in the cells depleted for eEF1α (<bold>I, P</bold>), eIF5A (<bold>L, Q</bold>) or TAF1B (<bold>O, R</bold>). Genotypes: A-C: {hs:FLP}/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>w</sup>, D-F: {hs:FLP}/+; UAS-PPP1R15/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>w</sup>,G-I: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> /UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v104502), J-L: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup> /UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / + (line: v101513), M-O: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> /UAS-PPP1R15;act&gt; CD2&gt; Gal4, UAS- GFP /+ (line: v105873), P: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> /UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA (line: v104502), Q: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup> / UAS-PPP1R15; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA (line: v101513), R: p{hs:FLP}/+; UAS- RNAi<sup>TAF1B</sup> / UAS-PPP1R15;act&gt; CD2&gt; Gal4, UAS- GFP / Xrp1-HA (line: v105873).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig8-figsupp1-v3.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Translation and transcription factor knock down affect Xrp1 expression, and cell survival, independently of PERK knock-down.</title><p>Single confocal planes from third instar wing imaginal discs. Dying cells (activated caspase Dcp1) and Xrp1-HA are indicated in magenta and in separate channels as labelled. Clones of cells depleted for translation factors which also overexpress PERK-RNAi (v110278)are shown in green. In no case did PERK depletion affect Xrp1-HA induction or suppress competitive cell death. (<bold>A,B</bold>) Clones expressing RNAi for both eEF2 and PERK. (<bold>C,D</bold>) Clones expressing RNAi for both eIF4G and PERK. (<bold>E,F</bold>) Clones expressing RNAi for both eIF6 and PERK. (<bold>G,H</bold>) Clones expressing RNAi for both eEF1α1 and PERK. (<bold>I,J</bold>). Clones expressing RNAi for both eIF5A and PERK. (<bold>K,L</bold>). Clones expressing RNAi for both TAF1B and PERK. Genotypes: A: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup>/ UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, B: {hs:FLP}/+; UAS – RNAi<sup>eEF2</sup>/ UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, C: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, D: {hs:FLP}/+; UAS – RNAi<sup>eIF4G</sup> /UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, E: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup>/UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, F: {hs:FLP}/+; UAS – RNAi<sup>eIF6</sup>/ UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, G: {hs:FLP}/+; UAS – RNAi <sup>eEF1α1</sup>/UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, H: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> /UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, I: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup>/UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, J: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup> /UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+, K: {hs:FLP}/+; UAS – RNAi<sup>TAF1B</sup>/UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP / Xrp1-HA, L: {hs:FLP}/+; UAS – RNAi<sup>TAF1B</sup> /UAS-RNAi<sup>PERK</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig8-figsupp2-v3.tif"/></fig><fig id="fig8s3" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 3.</label><caption><title>Role of Xrp1 in eIF2α phosphorylation and global translation after knockdown of translation or transcription factors.</title><p>Single confocal planes from third instar wing imaginal discs. p-eIF2α levels, translation rate (ortho-propargyl puromycin), dying cells (activated caspase Dcp1) and Xrp1-HA are indicated in magenta and in separate channels as labelled. (<bold>A–C</bold>) Control clones overexpressing RNAis against both white and Xrp1 showed no effect in p-eIF2a levels(A), translational rates (<bold>B</bold>) or cell death (<bold>C</bold>). (<bold>D–F</bold>) Clones depleted for Xrp1 as well as eEF1α retained high levels of eIF2α phosphorylation but actually showed a global translation rate higher than wild type cells. They lacked competitive cell death. (<bold>G–I</bold>) Clones of cells depleted eIF5A that also express RNAi for Xrp1 are shown in green. Xrp1-depletion did not reduce eIF2α phosphorylation or restore translation levels, but it reduced levels of competitive cell death (compare panel I and panel B in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). (<bold>J–L</bold>) Clones depleted for Xrp1 as well as TAF1B expressed phospho-eIF2α at near to control levels and completely restored overall translation rate. Genotypes: A-C: {hs:FLP}/+; UAS- RNAi<sup>Xrp1</sup>/+; act&gt; CD2&gt; Gal4, UAS-GFP / UAS – RNAi<sup>w</sup>, D-F: {hs:FLP}/+; UAS – RNAi<sup>eEF1α1</sup> / UAS-RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v104502), G-I: {hs:FLP}/+; UAS – RNAi<sup>eIF5A</sup> / UAS- RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v101513), J-K: {hs:FLP}/+; UAS – RNAi<sup>TAF1B</sup> / UAS- RNAi<sup>Xrp1</sup>; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v105873), L: {hs:FLP}/+; UAS – RNAi<sup>TAF1B</sup> / +; act&gt; CD2&gt; Gal4, UAS-GFP /+ (line: v105873).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig8-figsupp3-v3.tif"/></fig><fig id="fig8s4" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 4.</label><caption><title>Quantification of p-eIF2α levels.</title><p>Relative p-eIF2α levels within RNAi-expressing clones from <xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig7">7</xref> (and supplements) were measured as average pixel intensities of single confocal planes using Fiji. Results for clones in each wing disc were pooled and normalized to the p-eIF2α level of wild type regions of the same disc. Mean and standard deviation from multiple discs are shown. Statistical significance is shown for each genotype compared to the w RNAi control or w RNAi+ PPP1 R15 over-expression control, respectively (** - p &lt; 0.01; * - p &lt; 0.05; ns – p ≥ 0.05). In addition, every genotype differed significantly when PPP1R15 was over-expressed. Exact p values, compared to wRNAi: eEF2, p = 3.19 × 10<sup>–6</sup>; eEF1α, p = 0.00263; eIF5A, p = 0.00588; eIF6, p = 0.00204; eIF4G, p = 0.00104. Exact p values, compared to wRNAi+ PPP1 R15 over-expression: eEF2+ PPP1 R15, p = 0.175; eEF1α, p = 0.068; eIF5A, p = 0.071; eIF6, p = 0.0954; eIF4G, p = 0.0227. Exact p values, comparing the same genotypes with and without PPP1R15 over-expression: w, p = 0.00231; eEF2, p = 1.95 × 10<sup>–5</sup>;eEF1α, p = 0.00255; eIF5A, p = 0.00584; eIF6, p = 0.00104; eIF4G, p = 1.32 × 10<sup>–7</sup>. Statistics: pairs of genotypes were compared by t test and the Benjamini-Hochberg procedure for multiple testing used to adjust FDR to 0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig8-figsupp4-v3.tif"/></fig></fig-group><p>These results unexpectedly show that translation factor or polI depletion triggers similar effects to depletion of ribosome components in <italic>Rp</italic> mutants, in which Xrp1 expression leads to eIF2α phosphorylation and to cell competition. The results separate eIF2α phosphorylation from cell competition, however, because Xrp1-dependent competitive cell death continued even when eIF2α phosphorylation levels was restored to normal by PPP1R15 overexpression, and because remaining eIF2α phosphorylation in eIF5A Xrp1-depleted and eEF1α1 Xrp1-depleted cells did not lead to cell competition. The results also separate cell competition from differences in translation levels, because no competitive cell death was observed in eIF4G Xrp1-depleted, eIF5A Xrp1-depleted, and eEF2 Xrp1-depleted cells, even though their translation was lower than the nearby wild type cells. Indeed, depletion for eIF6 or TAF1B induced Xrp1 and cell competition, even though without Xrp1 these cells seemed to translate at similar or higher rates to their neighbors. These results focus attention on Xrp1 as the key effector of cell competition, irrespective of eIF2α phosphorylation and overall translation rate.</p><p>These results also raise the question of whether <italic>Rp</italic> haploinsufficiency, rRNA depletion, eIF2α phosphorylation, and translation factor depletion all activate Xrp1 through a common pathway. In <italic>Rp</italic><sup>+/-</sup> genotypes, Xrp1 expression depends on a specific ribosomal protein, RpS12, and is almost completely prevented by <italic>rpS12<sup>G97D</sup></italic>, a mis-sense allele that specifically affects this aspect of RpS12 function (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>). We found that <italic>rpS12<sup>G97D</sup></italic> homozygosity also reduced Xrp1 induction when TAF1B was depleted (<xref ref-type="fig" rid="fig9">Figure 9A–C</xref>), but had much less effect when eEF2 was depleted (<xref ref-type="fig" rid="fig9">Figure 9D–E</xref>). Thus, the mechanism of Xrp1 activation may resemble that in <italic>Rp</italic><sup>+/-</sup> cells when rRNA synthesis is affected, but appears distinct when translation factors are inhibited.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>RpS12-dependence of Xrp1 expression.</title><p>Figures show projections of Xrp1-HA expression from the wing discs of indicated genotypes. (<bold>A</bold>) Neglegible Xrp1-HA (magenta in A’) was expressed in control discs where <italic>nub-Gal4</italic> drove only reporter RFP expression in the wing pouch (green in A’-E’). (<bold>B</bold>) TAF1B knockdown resulted in Xrp1-HA expression (magenta in B’). (<bold>C</bold>) Xrp1-HA expression was greatly reduced when TAF-1B was knocked-down in the <italic>rpS12<sup>G97D</sup></italic> background (see also magenta in C’). (<bold>D</bold>) eEF2 knockdown resulted in strong Xrp1-HA expression (magenta in D’). (<bold>E</bold>) Xrp1-HA expression was only moderately reduced when eEF2 was knocked-down in the <italic>rpS12<sup>G97D</sup></italic> background (see also magenta in E’). Genotypes: A: nubGal4, UAS-RFP/+; Xrp1-HA/Xrp1-HA,B: nubGal4, UAS-RFP/ UAS – RNAi<sup>TAF1B</sup>;Xrp1-HA/ Xrp1-HA (line: v105873), C: nubGal4, UAS-RFP/ UAS –RNAi<sup>TAF1B</sup>; <italic>Rps12<sup>G97D</sup></italic>, Xrp1-HA/ <italic>Rps12<sup>G97D</sup></italic>, Xrp1-HA, D: nubGal4, UAS-RFP/ UAS – RNAi<sup>eEF2</sup>;Xrp1-HA/ Xrp1-HA, E: nubGal4, UAS-RFP/ UAS –RNAi<sup>eEF2</sup>; <italic>Rps12<sup>G97D</sup></italic>, Xrp1-HA/ <italic>Rps12<sup>G97D</sup>,</italic> Xrp1-HA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig9-v3.tif"/></fig></sec><sec id="s2-7"><title>Xrp1 is a transcription factor that regulates cell competition</title><p>Xrp1 is a key mediator of multiple defects in ribosome biogenesis or function. Xrp1 is a sequence-specific DNA-binding protein implicated in genome maintenance, and binds directly to sequences of the P element whose transposition it promotes (<xref ref-type="bibr" rid="bib1">Akdemir et al., 2007</xref>; <xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>). Xrp1 also controls expression of many genes at the mRNA level (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>), and other similar bZip proteins are transcription factors (<xref ref-type="bibr" rid="bib105">Tsukada et al., 2011</xref>).</p><p>To test whether Xrp1 is a transcription factor, we used a dual-luciferase reporter system in transfected S2 cells (<xref ref-type="fig" rid="fig10">Figure 10A–D</xref>; <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>). Luciferase reporter plasmids were either based on the widely-used core promoter of the <italic>Drosophila</italic> hsp70 gene, or on a 400 bp genomic sequence spanning the transcription start site of the <italic>Xrp1</italic> gene itself (<xref ref-type="fig" rid="fig10s2">Figure 10—figure supplement 2</xref>). We cloned 8 x repeats of either of two different matches to the 10 bp Xrp1/Irbp18 consensus binding site in vitro (<xref ref-type="bibr" rid="bib117">Zhu et al., 2011</xref>), which is similar to that recently deduced from ChIP-Seq following Xrp1 overexpression in vivo (<xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref>) (Target 1 and Target 3) or of the sequence footprinted by Xrp1/Irbp18 on the P element terminal repeat (<xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>) (target 2), which also contains a consensus match (<xref ref-type="fig" rid="fig10">Figure 10A and B</xref>). When Xrp1 expression was induced in transfected S2 cells, each of these Xrp1-binding sequences conferred 3x-8x activation of luciferase expression, whereas scrambled sequences were inactive (<xref ref-type="fig" rid="fig10">Figure 10C, D</xref>, <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1A, B</xref>). In the case of target 1, several-fold further induction was achieved by co-transfection and induction of Irbp18 expression, culminating in 23 x stimulation of luciferase expression by repeats of the Target 1 sequence in conjunction with the hsp70 basal promoter (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1A</xref>). Irbp18 alone was inactive in the absence of transfected Xrp1 (<xref ref-type="fig" rid="fig10">Figure 10C and D</xref>; <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1A, B</xref>). Thus, the Xrp1/Irbp18 heterodimer stimulated transcription through its cognate binding sequences.</p><fig-group><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Transcriptional regulation by Xrp1.</title><p>(<bold>A</bold>) Xrp1/Irbp18 binding consensus defined by bacterial 1-hybrid studies (<xref ref-type="bibr" rid="bib117">Zhu et al., 2011</xref>) and by Xrp1 ChIP from <italic>Drosophila</italic> eye imaginal discs overexpressing an Xrp1-HA protein (<xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref>). (<bold>B</bold>) Xrp1 binding motif sequences multimerized in luciferase reporter plasmids upstream of transcription start sites from the <italic>Xrp1</italic> gene or from the <italic>hsp70</italic> gene. Targets 1 and 3 were based on the 1-hybrid consensus, target 2 is the P element sequence footprinted by Xrp1-Irbp18 (<xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>). The match to the consensus sites is shown in bold type. (<bold>C</bold>) Luciferase assays following transfection of reporters and protein expression plasmids into S2 cells. The target 1-TATA<sup>Xrp1</sup> reporter showed sequence-specific activation by transfected Xrp1. Transfected Irbp18 alone had no effect, but synergized with Xrp1. p-Values for comparisons between target one reporters and scrambled reporters were: Padj = 1, Padj = 0.00827, Padj = 3.47 × 10<sup>–7</sup>, respectively. (<bold>D</bold>) Luciferase assays following transfection of reporters and protein expression plasmids into S2 cells. The target 2-TATA<sup>Xrp1</sup> reporter showed sequence-specific activation by transfected Xrp1. Transfected Irbp18 alone had no effect. p-Values for comparisons between target two reporters and scrambled reporters were: Padj = 1, Padj = 2.00 × 10<sup>–8</sup>, Padj = 1.96 × 10<sup>–7</sup> respectively. (<bold>E</bold>) Potential regulatory sequences in the 2.7 kb upstream intergenic fragment used in the GstD1-GFP reporter (<xref ref-type="bibr" rid="bib101">Sykiotis and Bohmann, 2008</xref>; <xref ref-type="bibr" rid="bib17">Brown et al., 2021</xref>).3 Xrp1-binding motifs and the antioxidant response element (ARE) are indicated. (<bold>F–I</bold>) and (<bold>K-N</bold>) show projections from the central disc-proper regions of wing discs expressing reporter transgenes in the indicated genetic backgrounds. (<bold>F</bold>) Baseline GstD1-GFP expression in the wild-type wing disc. (<bold>G</bold>) Elevated GstD1-GFP expression in the <italic>RpS3<sup>+/-</sup></italic> wing disc. (<bold>H</bold>) Baseline GstD1ΔARE-GFP expression in the wild-type wing disc. (<bold>I</bold>) Elevated GstD1ΔARE-GFP expression in the <italic>RpS3<sup>+/-</sup></italic> wing disc. (<bold>J</bold>) Quantification of these results. Average pixel intensity from wing pouch regions was measured. Mean± SEM from multiple samples is shown. N = 5 for each genotype. Exact p values were: for GstD1-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to <italic>RpS3<sup>+/+</sup></italic>, Padj = 0.00257; for GstD1ΔARE-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to <italic>RpS3<sup>+/+</sup></italic>, Padj = 2.55 × 10<sup>–5</sup>; for GstD1-GFP in <italic>RpS3<sup>+/+</sup></italic> compared to GstD1ΔARE-GFP in <italic>RpS3<sup>+/+</sup></italic>, Padj = 0.993; for GstD1-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to GstD1ΔARE-GFP in <italic>RpS3<sup>+/-</sup></italic>, Padj = 0.0313. (<bold>K</bold>) baseline GstD1-GFP expression in the wild type wing disc. (<bold>L</bold>) Elevated GstD1-GFP expression in the <italic>RpS17<sup>+/-</sup></italic> wing disc. (M) baseline expression of GstD1-GFP with all 3 Xrp1-binding motifs mutated in the wild type wing disc. (<bold>N</bold>) Expression of GstD1-GFP with all 3 Xrp1-binding motifs mutated was similar in the <italic>RpS17<sup>+/-</sup></italic> wing disc to the wild type control. (<bold>O</bold>) Quantification of these results. Average pixel intensity from wing pouch regions was measured. Mean± SEM from multiple samples is shown. N = 5,6,5,6 for respective samples. Exact p values were: for GstD1-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to <italic>RpS3<sup>+/+</sup></italic>, Padj = 2.34 × 10<sup>–6</sup>; for GstD1mXrp1-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to <italic>RpS3<sup>+/+</sup></italic>, Padj = 0.116; for GstD1-GFP in <italic>RpS3<sup>+/+</sup></italic> compared to GstD1mXrp1-GFP in <italic>RpS3<sup>+/+</sup></italic>, Padj = 0.112; for GstD1-GFP in <italic>RpS3<sup>+/-</sup></italic> compared to GstD1mXrp1-GFP in <italic>RpS3<sup>+/-</sup></italic>, Padj = 1.19 × 10<sup>–6</sup>. (<bold>P</bold>) Pooled copia transcript levels for indicated genotypes determined from mRNA-seq data. Mean± standard deviation is shown. Values for individual copia insertions are shown in <xref ref-type="fig" rid="fig10s2">Figure 10—figure supplement 2</xref>. Asterisks indicate statistical significance of the difference from the wild type control: **, p &lt; 0.01; *, p &lt; 0.05; ns, p ≥ 0.05. Exact p values were: for RpS17<sup>+/-</sup> compared to wild type, p = 4 × 10<sup>–14</sup>; for RpS3<sup>+/-</sup> compared to wild type, p = 2.33 × 10<sup>–14</sup>; for RpS3<sup>+/-</sup> Xrp1<sup>+/-</sup> compared to wild type, p = 0.262; for RpS3<sup>+/-</sup> Xrp1<sup>+/-</sup> compared to wild type, p = 0.262;for Xrp1<sup>+/-</sup> compared to wild type, p = 0.494; for RpS3<sup>+/-</sup> Xrp1<sup>+/-</sup> compared to wild type, p = 0.262; for rpS12<sup>D97/D97</sup> compared to wild type, p = 0.858; for RpS3<sup>+/-</sup> rpS12<sup>D97/D97</sup> compared to wild type, p = 0.0201; for RpS3<sup>+/-</sup> rpS12<sup>D97/D97</sup> compared to wild type, p = 0.0201; for RpS3<sup>+/-</sup> Xrp1<sup>+/-</sup> compared to RpS3<sup>+/-</sup>, p = 4.91 × 10<sup>–14</sup>; for RpS3<sup>+/-</sup> Xrp1<sup>+/-</sup> compared to Xrp1<sup>+/-</sup>, p = 0.635; for RpS3<sup>+/-</sup> rpS12<sup>D97/D97</sup> compared to rpS12<sup>D97/D97</sup>, p = 0.251. Statistics:1-way ANOVA with Bonferroni-Holm correction for multiple testing was performed for the data shown in panels C,D,J,O,P. Data in panels C,D were based on triplicate measurements from each of three biological replicates for each transfection. Data in panel P were based on three biological replicates for each genotype. Genotypes: F: GstD1-GFP/+, G: GstD1-GFP/+; FRT82 <italic>RpS3</italic> p{arm:LacZ}/+, H: GstD1ΔARE-GFP/+, I: GstD1ΔARE-GFP/+; FRT82 <italic>RpS3</italic> p{arm:LacZ}/+, K: GstD1-GFP/+, L: GstD1-GFP; <italic>RpS17</italic> p{arm:LacZ} FRT80B/+, M: GstD1 Xrp1m –GFP, N: GstD1Xrp1m-GFP; <italic>RpS17</italic> p{arm:LacZ} FRT80B/+. Genotypes of P graph per column: 1<sup>st</sup>: w<sup>11-18</sup>; FRT82B/+, 2<sup>nd</sup>: w<sup>11-18</sup>; w p{hs:FLP}; <italic>RpS17</italic> p{ubi:GFP} FRT80B/+,3<sup>rd</sup>: w<sup>11-18</sup>;w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ/+, 4<sup>th</sup>: w<sup>11-18</sup>;w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ/FRT82B FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, 5<sup>th</sup>: w<sup>11-18</sup>; FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup> / +, 6<sup>th</sup>: w<sup>11-18</sup>; <italic>rpS12<sup>D97</sup></italic> FRT80B / <italic>rpS12<sup>D97</sup></italic> FRT80B, 7<sup>th</sup>: w<sup>11-18</sup>; <italic>rpS12<sup>D97</sup></italic> FRT80B / <italic>rpS12<sup>D97</sup></italic> FRT80B <italic>RpS3</italic>.</p><p><supplementary-material id="fig10sdata1"><label>Figure 10—source data 1.</label><caption><title>Luciferase data relevant to panels C,D.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig10-data1-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig10sdata2"><label>Figure 10—source data 2.</label><caption><title>GFP data relevant to panel J.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig10-data2-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig10sdata3"><label>Figure 10—source data 3.</label><caption><title>GFP data relevant to panel O.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig10-data3-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig10sdata4"><label>Figure 10—source data 4.</label><caption><title>mRNA-Seq data relevant to panel P, and also to <xref ref-type="fig" rid="fig10s3">Figure 10—figure supplement 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig10-data4-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig10-v3.tif"/></fig><fig id="fig10s1" position="float" specific-use="child-fig"><label>Figure 10—figure supplement 1.</label><caption><title>Luciferase assays with <italic>hsp70</italic>-based reporter plasmids.</title><p>Fold change in the luciferase/renilla signal is shown for the remaining reporter constructs shown in <xref ref-type="fig" rid="fig10">Figure 10B</xref>. (<bold>A</bold>) Target one conferred sequence-specific activation by transfected Xrp1 protein. Transfected Irbp18 alone had no effect, but synergized with Xrp1. Lesser activation by Target three was rendered not significant by correction for multiple testing, but the increase in both Xrp1 and Xrp1+ Irbp18 samples suggests that it may nevertheless be real. (<bold>B</bold>) Target two conferred sequence-specific activation by transfected Xrp1 protein. Transfected Irbp18 alone had no effect. It may be significant that Targets 1 and 3 are better matches to the in vivo-derived ChIP-Seq consensus than Target 2 (see <xref ref-type="fig" rid="fig10">Figure 10A</xref>). Statistics:1-way ANOVA with Bonferroni-Holm correction for multiple testing was performed for the data shown in each of panels A,B. ns, p &gt; 0.05.**, p &lt; 0.01. Data were based on triplicate measurements from each of three biological replicates for each transfection. Exact p-values for comparisons between target one reporters and scrambled reporters (panel A) were: Padj = 1, Padj = 1.80 × 10<sup>–6</sup>, Padj = 0 for Irbp18, Xrp1, and Irpb18+ Xrp1 transfected cells respectively. Exact p-values for comparisons between target two reporters and scrambled reporters (panel A) were: Padj = 1, Padj = 1, Padj = 0.225 for Irbp18, Xrp1, and Irpb18+ Xrp1 transfected cells respectively. Exact p-values for comparisons between target three reporters and scrambled reporters (panel B) were: Padj = 0.983, Padj = 6.70 × 10<sup>–6</sup>, Padj = 8.03 × 10<sup>–6</sup>,for Irbp18, Xrp1, and Irpb18+ Xrp1 transfected cells, respectively.</p><p><supplementary-material id="fig10s1sdata1"><label>Figure 10—figure supplement 1—source data 1.</label><caption><title>Luciferase measurements relevant to <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-fig10-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig10-figsupp1-v3.tif"/></fig><fig id="fig10s2" position="float" specific-use="child-fig"><label>Figure 10—figure supplement 2.</label><caption><title><italic>Xrp1</italic> promoter proximal sequences.</title><p>The 400 bp <italic>Xrp1</italic> core promoter sequence is shown. Transcription start site indicated by arrow. A variety of conserved promoter element sequences are indicated (<xref ref-type="bibr" rid="bib79">Ohler et al., 2002</xref>; <xref ref-type="bibr" rid="bib48">Juven-Gershon and Kadonaga, 2010</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig10-figsupp2-v3.tif"/></fig><fig id="fig10s3" position="float" specific-use="child-fig"><label>Figure 10—figure supplement 3.</label><caption><title>Transcription of individual Copia elements.</title><p>mRNA abundances for 24 distinct copia insertions reveal generally similar regulation by RpS12 and Xrp1 in RpS17<sup>+/-</sup> and RpS3<sup>+/-</sup> genotypes. Genotypes of graph per column: 1<sup>st</sup>: w<sup>11-18</sup>; FRT82B/+, 2<sup>nd</sup>: w<sup>11-18</sup>; w p{hs:FLP}; <italic>RpS17</italic> p{ubi:GFP} FRT80B/+,3<sup>rd</sup>: w<sup>11-18</sup>;w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ/+, 4<sup>th</sup>: w<sup>11-18</sup>;w p{hs:FLP}; FRT82 <italic>RpS3</italic> p{arm:LacZ/FRT82B FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup>, 5<sup>th</sup>: w<sup>11-18</sup>; FRT82B <italic>Xrp1<sup>M2</sup></italic><sup>–73</sup> / +, 6<sup>th</sup>: w<sup>11-18</sup>; <italic>rpS12<sup>D97</sup></italic> FRT80B / <italic>rpS12<sup>D97</sup></italic> FRT80B, 7<sup>th</sup>: w<sup>11-18</sup>; <italic>rpS12<sup>D97</sup></italic> FRT80B / <italic>rpS12<sup>D97</sup></italic> FRT80B <italic>Rp.</italic></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig10-figsupp3-v3.tif"/></fig></fig-group><p>It has been suggested that an oxidative stress response in <italic>Rp</italic><sup>+/-</sup> cells leads to competition with wild type cells (<xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>). <italic>Rp</italic><sup>+/-</sup> cells express GstD1 reporters, whose transcription is activated by Nrf2, the master regulator of oxidative stress responses (<xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>). Because the genes expressed in <italic>Rp</italic><sup>+/-</sup> cells are also enriched for Xrp1 binding motifs, some of these genes might be activated directly by Xrp1, including GstD1 (<xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref> <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). The GstD1-GFP reporter used to report oxidative stress in <italic>Rp</italic><sup>+/-</sup> cells contains a 2.7 kb genomic fragment that contains an Antioxidant Response Element (ARE) bound by the Nrf2/MafS dimer at position 1450–1460 (<xref ref-type="fig" rid="fig10">Figure 10E</xref>). Deletion of this motif abolishes GstD1-GFP induction in response to oxidative stress (<xref ref-type="bibr" rid="bib101">Sykiotis and Bohmann, 2008</xref>). Recently, Brown et al identified Xrp1 binding motifs within the same GstD1-GFP reporter, and showed that these sequences are required for Xrp1-dependent induction in response to ER stress (<xref ref-type="bibr" rid="bib17">Brown et al., 2021</xref>). We therefore compared induction of GstD1-GFP reporters in <italic>Rp</italic><sup>+/-</sup> wing discs where the reporter sequences were either wild type, deleted for the Nrf2 binding motif, or mutated at the Xrp1-binding motifs (<xref ref-type="fig" rid="fig10">Figure 10E</xref>). We found that the Nrf2 binding motif was dispensable for GstD1-GFP induction in <italic>Rp</italic><sup>+/-</sup> wing discs, whereas the Xrp1 sites were required, consistent with induction of GstD1-GFP and perhaps other genes as direct transcriptional targets of Xrp1, not Nrf2 (<xref ref-type="fig" rid="fig10">Figure 10F–O</xref>).</p><p>In addition to single copy genes, repetitive elements can also be regulated by Xrp1, as is revealed by re-analysis of previously published mRNA-seq data (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Transcription of the retrotransposon copia, for example, was elevated in RpS17 and RpS3 in an Xrp1-dependent (and RpS12-dependent) manner (<xref ref-type="fig" rid="fig10">Figure 10P</xref>, <xref ref-type="fig" rid="fig10s3">Figure 10—figure supplement 3</xref>). Accordingly, the regulatory, untranslated leader region of copia contains 7 copies of a motif closely matching the Xrp1 binding consensus, including 2 in a 28 bp region of dyad symmetry that is deleted from variants with reduced expression (<xref ref-type="fig" rid="fig10">Figure 10Q</xref>; <xref ref-type="bibr" rid="bib75">Mount and Rubin, 1985</xref>; <xref ref-type="bibr" rid="bib96">Sneddon and Flavell, 1989</xref>; <xref ref-type="bibr" rid="bib67">Matyunina et al., 1996</xref>; <xref ref-type="bibr" rid="bib69">McDonald et al., 1997</xref>; <xref ref-type="bibr" rid="bib113">Wilson et al., 1998</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We explored the mechanisms by which <italic>Rp</italic> mutations affect <italic>Drosophila</italic> imaginal disc cells, causing reduced translation and elimination by competition with wild-type cells in mosaics. Our findings reinforced the key role played by the AT-hook bZip protein Xrp1, which we showed is a sequence-specific transcription factor responsible for multiple aspects of not only the <italic>Rp</italic> phenotype, but also other ribosomal stresses (<xref ref-type="fig" rid="fig11">Figure 11</xref>). It was Xrp1, rather than the reduced levels of ribosomal subunits, that affected overall translation rate, primarily through PERK-dependent phosphorylation of eIF2α. Phosphorylation of eIF2α, as well as other disruptions to ribosome biogenesis and function such as reduction in rRNA synthesis or depletion of translation factors, were all sufficient to cause cell competition with nearby wild type cells, but this occurred because all these perturbations activated Xrp1, not because differences in translation levels between cells were sufficient to cause cell competition directly. In fact, our data show that differences in translation are neither sufficient nor necessary to trigger cell competition, which therefore depends on other Xrp1-dependent processes. Protein aggregation and activation of ‘oxidative stress response’ genes were also downstream effects of Xrp1 activity. While this paper was in preparation, other groups have also reported relationships between eIF2α phosphorylation, cell competition, and Xrp1 (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib17">Brown et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Ochi et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>),but none have reached the same overall conclusions as this study.</p><fig id="fig11" position="float"><label>Figure 11.</label><caption><title>Transcriptional responses to Ribosome defects.</title><p>Multiple consequences of defects in ribosome biogenesis, translation initiation, and translation elongation, depend on the transcription factor Xrp1 in the epithelial imaginal disc cells. Xrp1 is responsible for, or contributes to, reduced translation in response to these defects, through the PERK-dependent phosphorylation of eIF2α, a global regulator of CAP-dependent translation initiation. There is also evidence for some PERK-independent regulation of translation in genotypes such as TAF1B knock-down. Translation inhibition independently of Xrp1, which occurs after depletion of some translation factors, is not shown for simplicity. Xrp1 protein expression marks imaginal disc cells for elimination in competition with wild type cells. Differences in translation rate, including those caused by eIF2α phosphorylation or eIF2γ haploinsufficiency, are not sufficient to trigger cell competition without Xrp1. We speculate that other cellular stresses that phosphorylate eIF2α, including ER stress, nutrient deprivation, or (in mammals) infection with certain viruses might mark cells for competition, or interfere with cell competition that recognizes aneuploid cells on the basis of <italic>Rp</italic> or eIF2γ gene haploinsufficiency. It is notable that defective Tor signaling, which also reduces global translation rate, does not cause cell competition, (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>). Several pathways have been shown to induce Xrp1, including RpS12-dependent induction in <italic>Rp<sup>+/- </sup></italic>cells and TAF1B-depleted cells (<xref ref-type="bibr" rid="bib1">Akdemir et al., 2007</xref>; <xref ref-type="bibr" rid="bib19">Chapin et al., 2014</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-71705-fig11-v3.tif"/></fig><p>Our findings lead to a picture of Xrp1 as the key instigator of cell competition in response to multiple genetic triggers. Failure to appreciate the role of Xrp1 may have led to questionable conclusions in some previous studies. Our findings confirm the central importance of the transcriptional response to <italic>Rp</italic> mutations, and to other disruptions of ribosome biogenesis and function. They suggest therapeutic approaches to ribosomopathies, and have implications for the surveillance of aneuploid cells.</p><sec id="s3-1"><title>Xrp1 activation by <italic>Rp</italic> gene haploinsufficiency</title><p>Rp gene haploinsufficiency has been proposed to affect ribosome concentrations, and hence translation, lead to the accumulation of ribosome components and assembly intermediates, and cause proteotoxic stress. Any of these could have been responsible for activating Xrp1 in <italic>Rp<sup>+/-</sup></italic> cells.</p><p>Our data show that in fact ribosome subunit concentration is only moderately affected by <italic>Rp</italic> haploinsufficiency. We have seen 15–20% reduction in LSU concentrations in several <italic>RpL</italic> mutants, and 20–25% reduction in SSU concentrations in several <italic>RpS</italic> mutants. <italic>RpL14<sup>+/-</sup></italic> also reduced SSU ~ 25%. Ribosomal subunit levels were unaffected by <italic>Xrp1</italic>. Broadly similar results have been reported in yeast (<xref ref-type="bibr" rid="bib20">Cheng et al., 2019</xref>), and by mass spec quantification of ribosomal proteins in <italic>RpS3<sup>+/-</sup></italic> and <italic>RpS23<sup>+/-</sup> Drosophila</italic> wing discs (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>).</p><p>Multiple explanations for the modest effects on ribosome subunit number are possible. We particularly point out that, even if expression of a particular Rp is reduced in proportion to a 50% reduction in mRNA level, the respective protein concentration (i.e. number of molecules/cell volume) is unlikely to fall to 50%, because ribosomes are required for cellular growth, so that an <italic>Rp</italic> mutation affects the denominator in the concentration equation, as well as the numerator. It is even possible that a 50% reduction in its rate of Rp synthesis could leave steady state ribosome subunit concentration unaffected, if cellular growth rate was slowed by the same amount.</p><p>Modest changes in SSU and LSU levels could still affect ribosome function, which may depend more on the concentrations of free subunits than on total subunits. The data suggests, however, that cellular and animal models of DBA that have generally sought to achieve a 50% reduction in Rp protein expression (<xref ref-type="bibr" rid="bib37">Heijnen et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Khajuria et al., 2018</xref>) could be significantly more severe than occurs in DBA patients, and that actual ribosome subunit concentrations should be measured in DBA patient cells to guide future models.</p><p>We confirmed that ribosome assembly intermediates accumulate in <italic>Drosophila</italic> wing discs following <italic>Rp</italic> haploinsufficiency. In yeast, aggregates of unused Rp rapidly trigger transcriptional changes (<xref ref-type="bibr" rid="bib2">Albert et al., 2019</xref>; <xref ref-type="bibr" rid="bib106">Tye et al., 2019</xref>). It has been suggested proteotoxic stress might lead to eIF2α phosphorylation in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>), with Xrp1 amplifying this effect (<xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>), but we found that while Perk was responsible for eIf2α phosphorylation, it was not required for Xrp1 expression in <italic>Rp</italic> mutants, placing Perk and eIF2α phosphorylation downstream. Consistent with this, we show that the protein aggregates reported in <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>) were only seen in some Rp mutants, all affecting the SSU, and were also a downstream consequence of Xrp1 activity, as also now seen by others (<xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>). It remains plausible that unused ribosomal components are the initial trigger for cellular responses in <italic>Drosophila</italic> as in yeast, but in <italic>Drosophila</italic> the species involved have not yet been identified. Because Xrp1 expression depends particularly on RpS12, an RpS12-containing signaling species is one possibility (<xref ref-type="bibr" rid="bib50">Kale et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Boulan et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>).</p></sec><sec id="s3-2"><title><italic>Rp</italic> mutants affect global translation rate through eIF2α</title><p>PERK-dependent phosphorylation of eIF2α was the mechanism by which Xrp1 suppresses global translation in <italic>Rp<sup>+/-</sup></italic> mutants.</p><p>It is interesting that Xrp1 protein levels increase under conditions of reduced global translation. Perhaps Xrp1 is one of the few genes whose translation is enhanced when eIF2α is phosphorylated (<xref ref-type="bibr" rid="bib112">Wek, 2018</xref>; <xref ref-type="bibr" rid="bib17">Brown et al., 2021</xref>). Although PERK is known to be activated by ER stress, the IRE/Xbp1 branch of the UPR was not unequivocally detected in <italic>Rp<sup>+/-</sup></italic> mutants. We suspect that the UPR might be suppressed in <italic>Rp<sup>+/-</sup></italic> mutants by Xrp1-dependent changes in transcription of Perk, BiP, and other UPR genes (<xref ref-type="fig" rid="fig11">Figure 11</xref>). Perhaps in proliferative tissues it is preferable to replace stressed cells than to repair them.</p><p>It will be interesting to determine whether eIF2α phosphorylation occurs in human ribosomopathies. Notably, knock-out of CReP, one of the two mouse PPP1R15 homologs, causes anemia, similar to DBA (<xref ref-type="bibr" rid="bib36">Harding et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Da Costa et al., 2018</xref>), and PERK-dependent eIF2α phosphorylation occurs in RpL22-deficient mouse αβ T-cells and activates p53 there (<xref ref-type="bibr" rid="bib97">Solanki et al., 2016</xref>). Thus, inhibitors of eIF2α phosphorylation could be explored as potential DBA drugs. TAF1B depletion, which also acted through Xrp1 and eIF2α phosphorylation in <italic>Drosophila</italic>, is a model of Treacher Collins Syndrome (<xref ref-type="bibr" rid="bib104">Trainor et al., 2008</xref>), and failure to release eIF6, leading to defective LSU maturation and 80 S ribosome formation, causes Schwachman Diamond syndrome (<xref ref-type="bibr" rid="bib111">Warren, 2018</xref>), two other ribosomopathies where potential contributions of eIF2α phosphorylation are possible.</p></sec><sec id="s3-3"><title>Xrp1, not differential translation, causes competition between cells</title><p>Because eIF2α phosphorylation alone was sufficient to target cells for competitive elimination, at first it seemed that eIF2α phosphorylation was the mechanism by which Xrp1 caused cell competition, which often correlates with differences in cellular translation levels (<xref ref-type="bibr" rid="bib76">Nagata et al., 2019</xref>). One group has suggested this (<xref ref-type="bibr" rid="bib78">Ochi et al., 2021</xref>). Another group concluded that eIF2α phosphorylation in <italic>Rp<sup>+/-</sup></italic> cells did not lead to cell competition (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>), but the opposite conclusion is corroborated by the independent finding that haploinsufficiency for the γ subunit of eIF2 also causes cell competition (<xref ref-type="bibr" rid="bib46">Ji et al., 2021</xref>). Our conclusion is that eIF2α phosphorylation can cause cell competition but not directly. Instead, phosphorylation of eIF2α is itself sufficient to activate Xrp1 expression, as found by us and by several other groups (<xref ref-type="bibr" rid="bib17">Brown et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Ochi et al., 2021</xref>). Crucially, <italic>Perk</italic> inactivation restored eIF2α phosphorylation and global translation to normal in <italic>Rp<sup>+/-</sup></italic> cells (<xref ref-type="fig" rid="fig3">Figure 3H, I</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G-L</xref>), without preventing cell competition, which must therefore depend on other Xrp1 targets (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Elimination of <italic>eIF2γ</italic> haploinsufficient cells is also Xrp1-dependent, as expected if Xrp1 is downstream of eIF2 activity in cell competition (<xref ref-type="bibr" rid="bib46">Ji et al., 2021</xref>).</p><p>Knock-down of factors directly involved in the translation mechanism further distinguished cell competition from differential translation levels. Different factors affected translation in diverse ways. In <italic>Rp<sup>+/-</sup></italic> mutants, PERK-dependent phosphorylation of eIF2α suppressed global translation, which was normalized by Perk or Xrp1 depletion. PERK-dependent phosphorylation of eIF2α also contributed to the translation deficits of cells depleted for TAF1B, eIF6, and possibly eEF1α1, which were all partially restored by eIF2α dephosphorylation and fully by Xrp1 depletion, suggesting that Xrp1 can also affect translation by additional mechanisms. By contrast, translation deficits caused by eIF4G, eIF5A, or eEF2 depletion were restored little by eIF2α dephosphorylation or Xrp1 depletion, indicating Xrp1-independent effects of these factors on translation.</p><p>Several conclusions follow from studies of these factors. As noted above, reduced translation cannot be required for cell competition, because <italic>perk<sup>-/-</sup> Rp<sup>+/-</sup></italic> mutant cells are eliminated by <italic>perk<sup>+/-</sup> Rp<sup>+/+</sup></italic> cells (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Secondly, lower translation is not sufficient for competitive elimination, because no competitive cell death was observed in eIF4G Xrp1-depleted, eIF5A Xrp1-depleted, and eEF2 Xrp1-depleted cells, even though their translation was lower than the nearby wild type cells. Another group also concluded that lower translation alone was not sufficient for cell competition, based on different data (<xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>).</p><p>Our findings focus attention on Xrp1 activity as the key factor marking cells for competition, distinct from its effects on global translation, which only trigger cell competition when Xrp1 is induced (<xref ref-type="fig" rid="fig11">Figure 11</xref>).</p></sec><sec id="s3-4"><title>Transcriptional regulation of cell competition</title><p>We confirm that Xrp1 is a sequence-specific transcriptional activator, and propose that direct transcriptional targets of Xrp1 predispose <italic>Rp<sup>+/-</sup></italic> cells, and other genotypes, to elimination by wild-type cells (<xref ref-type="fig" rid="fig11">Figure 11</xref>). Expression of several hundred single copy genes is regulated by Xrp1 in Rp mutant cells, and we report here that expression of some transposable elements is affected in addition, whose potential contribution to cell competition might also be interesting (<xref ref-type="fig" rid="fig10">Figure 10P</xref>, <xref ref-type="fig" rid="fig10s3">Figure 10—figure supplement 3</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). One or more of these transcriptional targets may lead to competitive interactions with wild-type cells.</p><p>These Xrp1 targets include genes that also contribute to oxidative stress responses, such as GstD genes, which has previously led to the suggestion that an oxidative stress response is responsible for cell competition (<xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Baumgartner et al., 2021</xref>; <xref ref-type="bibr" rid="bib89">Recasens-Alvarez et al., 2021</xref>). Because the oxidative stress reporter used in previous studies is probably activated in <italic>Rp<sup>+/-</sup></italic> cells by direct Xrp1-binding, and not by the Nrf2-dependent ARE site, it is not now certain whether <italic>Rp<sup>+/-</sup></italic> cells experience oxidative stress or Nrf2 activity (<xref ref-type="fig" rid="fig10">Figure 10</xref>). An alternative explanation of cell competition in response to Nrf2 over-expression (<xref ref-type="bibr" rid="bib54">Kucinski et al., 2017</xref>) could be induction of Xrp1 expression by Nrf2 (<xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>).</p></sec><sec id="s3-5"><title>Xrp1 as a central orchestrator of cell competition</title><p>Our results reveal the central importance of Xrp1 as the driver of cell competition (<xref ref-type="fig" rid="fig11">Figure 11</xref>). Far from being expressed specifically in <italic>Rp</italic> mutants, we now find that Xrp1 is induced by multiple challenges, not only to ribosome biogenesis, such as by depletion of the polI cofactor TAF1B or LSU maturation factor eIF6, but also challenges to ribosome function, both at the levels of initiation or elongation, all leading to cell competition and to Xrp1-dependent eIF2α phosphorylation (<xref ref-type="fig" rid="fig11">Figure 11</xref>).</p><p>Had we not evaluated Xrp1 expression and function in PPP1R15-depleted cells, we would have concluded that eIF2α phosphorylation was the likely downstream effector of competition in <italic>Rp</italic> mutant cells, rather than an example of another upstream stress that induces Xrp1 (<xref ref-type="fig" rid="fig11">Figure 11</xref>). It is becoming apparent that other triggers of cell competition, including depletion for Helicase at 25E (Hel25E), a helicase that plays roles in mRNA splicing and in mRNA nuclear export, over-expression of Nrf2, the transcriptional master regulator of the oxidative stress response, and loss of mahjong, a ubiquitin ligase implicated in planar cell polarity, all lead to Xrp1 expression (<xref ref-type="bibr" rid="bib56">Langton et al., 2021</xref>; <xref ref-type="bibr" rid="bib78">Ochi et al., 2021</xref>; Kumar and Baker,unpublished). Earlier models regarding these cell competition mechanisms, in which the role of Xrp1 was not recognized, may be questionable. It would be important now to check for possible activation of Xrp1 in cells with other defects affecting translation, including mutations of an eIF5A-modifying enzyme (<xref ref-type="bibr" rid="bib82">Patel et al., 2009</xref>) and mutations of a pre-rRNA processing enzyme (<xref ref-type="bibr" rid="bib118">Zielke et al., 2020</xref>). It would not be surprising if other conditions that lead to eIF2α phosphorylation, such as ER stress, nutrient deprivation, or viral infection (<xref ref-type="bibr" rid="bib91">Ron and Walter, 2007</xref>; <xref ref-type="bibr" rid="bib40">Hetz, 2012</xref>), also activate Xrp1 and are thereby marked for elimination by more normal neighbors (<xref ref-type="fig" rid="fig11">Figure 11</xref>). It will be particularly interesting to determine whether any of these environmental perturbations could interfere with surveillance and removal of aneuploid cells, given the potential importance for tumor surveillance (<xref ref-type="bibr" rid="bib46">Ji et al., 2021</xref>).</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">Xrp1</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0261113</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpS12</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE: FBgn0286213</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpS18</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0010411</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpL27A</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0285948</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpS3</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0002622</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpS17</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0005533</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpL14</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0017579</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpL19</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0285950</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">RpL36</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0002579</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">TAF1B</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0037792</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">PPP1R15</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0034948</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">PERK</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0037327</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">Gcn2</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0019990</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">Irbp18</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0036126</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">eIF4G</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0023213</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">eEF2</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0000559</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">eIF6</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0034915</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">copia</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0013437</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">eEF1α1</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0284245</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">eIF5A</td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">FLYBASE:FBgn0285952</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Xrp1<sup>HA</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib10">Blanco et al., 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Strain maintained in Dr. Nicholas Baker’s lab.</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Xrp1<sup>M2-73</sup> allele</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref></td><td align="left" valign="bottom">FLYBASE:RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_81270">BDSC_81270</ext-link></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#81,270</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">RpS12 <sup>G97D</sup> allele</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib107">Tyler et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBal0193403</td><td align="left" valign="bottom">Strain maintained in Dr. Nicholas Baker’s lab.</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>Xrp1</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Perkins et al., 2015</xref></td><td align="left" valign="bottom">FLYBASE:RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_34521">BDSC_34521</ext-link></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#34,521</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>Xrp1</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0118620</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v 107,860</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>irbp18</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Perkins et al., 2015</xref></td><td align="left" valign="bottom">FLYBASE:RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_33652">BDSC_33652</ext-link></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#33,652</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>w</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Perkins et al., 2015</xref></td><td align="left" valign="bottom">FLYBASE:RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_33623">BDSC_33623</ext-link></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#33,623</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">arm-LacZ</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Vincent et al., 1994</xref></td><td align="left" valign="bottom">FLYBASE:FBal0040819</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Ubi-GFP</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib24">Davis et al., 1995</xref></td><td align="left" valign="bottom">FLYBASE:FBal0047085</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">M(2)56 F(mutating RpS18)</td><td align="left" valign="bottom">Laboratory of Y. Hiromi</td><td align="left" valign="bottom">FLYBASE:FBal0011916</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Df(1)R194 (deleting RpL36)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Duffy et al., 1996</xref></td><td align="left" valign="bottom">FLYBASE:FBab0024817</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P{RpL36+}</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib107">Tyler et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBal0193398</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">M{RpL19+}</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Df(2 R)M60E (deleting RpL19)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Baillon et al., 2018</xref></td><td align="left" valign="bottom">FLYBASE:FBab0001997</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">hs-FLP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib99">Struhl and Basler, 1993</xref></td><td align="left" valign="bottom">FLYBASE:FBtp0001101</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P{GAL4-Act5C(FRT.CD2).P}S</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib86">Pignoni and Zipursky, 1997</xref></td><td align="left" valign="bottom">FLYBASE:FBti0012408</td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#51,308</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P{neoFRT}42D</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib115">Xu and Rubin, 1993</xref></td><td align="left" valign="bottom">FLYBASE:FBti0141188</td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#1,802</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P{neoFRT}80B</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib115">Xu and Rubin, 1993</xref></td><td align="left" valign="bottom">FLYBASE:FBti0002073</td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#1988</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P{neoFRT}82B</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">FLYBASE:FBti0002074</td><td align="left" valign="bottom">Viable line derived from Bloomington Drosophila Stock Center lines BL5188 and BL30555</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>TAF1B</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Perkins et al., 2015</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_61957">BDSC_61957</ext-link></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> Stock Center#61,957</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>TAF1B</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0118760</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v105873</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>eIF6</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0116845</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v108094</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>eIF4G</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0095456</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v17002</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>eIF5A</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0121478</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v101513</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>eEF2</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0117284</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v107268</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>eEF1α1</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0121842</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v104502</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>PERK</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0141304</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center# v110278</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>PERK</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0093363</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v 16,427</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-dsRNA<sup>Gcn2</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Dietzl et al., 2007</xref></td><td align="left" valign="bottom">FLYBASE:FBti0118018</td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> Resource Center#v103976</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>RpS18</italic> mutation <italic>M</italic>(<italic>2</italic> R)<italic>56</italic> f</td><td align="left" valign="bottom">Laboratory of Y. Hiromi</td><td align="left" valign="bottom">FLYBASE:FBal0284387</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">RpS3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Burke and Basler, 1996</xref></td><td align="left" valign="bottom">Flybase: FBgn0002622</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>RpL27A</italic> Df(2 L)M24F11</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib66">Marygold et al., 2007</xref></td><td align="left" valign="bottom">Flybase: FBab0001492</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">RpS17 mutation M(3 L)67 C<sup>4</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib73">Morata and Ripoll, 1975</xref></td><td align="left" valign="bottom">Flybase: FBal0011935</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">en-Gal4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib77">Neufeld et al., 1998</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:BDSC_6356">BDSC_6356</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-S65T-GFP</td><td align="left" valign="bottom">FBrf0086268</td><td align="left" valign="bottom">FBtp0001403</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P[GAL4-Act5C(FRT.CD2).P]S</td><td align="left" valign="bottom">FBrf0221941</td><td align="left" valign="bottom">FBti0012408</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">P[UAS-His-RFP]3</td><td align="left" valign="bottom">FBrf0221941</td><td align="left" valign="bottom">FBti0152909</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-active-Dcp1 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat #9,578RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2721060">AB_2721060</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-XRP1(short)(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref></td><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">antiphospho-RpS6(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib90">Romero-Pozuelo et al., 2017</xref></td><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-p62 (rabbit polyclonal)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib87">Pircs et al., 2012</xref></td><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho-eIF2α (rabbit polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #44–728 GRRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2533736">AB_2533736</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-phospho-eIF2α (D9G8)(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #D9G8#3398 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10829234">AB_10829234</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HATag (mouse monoclonal)</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat #2,367RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10691311">AB_10691311</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-beta galactosidase (mAb40-1a) (mouse monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314509">AB_2314509</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Mouse IgG, Cy2</ext-link>(goat monoclonal)</td><td align="left" valign="bottom">Jackson Immunoreseach</td><td align="left" valign="bottom">Cat #115-225-166 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338746">AB_2338746</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Mouse IgG, Alexa Fluor 555</ext-link>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A28180 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2536164">AB_2536164</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Mouse IgG, Alexa Fluor 647</ext-link>(Goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A-21235 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535804">AB_2535804</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Mouse IgG, Alexa Fluor 488</ext-link>(Goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A-11001RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534069">AB_2534069</ext-link></td><td align="char" char="." valign="bottom">(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Rabbit Cy3,</ext-link>(Goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A-21244 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535812">AB_2535812</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Rabbit IgG, Alexa Fluor 555</ext-link>(Goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A21429 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535850">AB_2535850</ext-link></td><td align="char" char="." valign="bottom">(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Rabbit IgG, Alexa Fluor 647</ext-link>(Goat polyclonal)</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #A-21244 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535812">AB_2535812</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/antibody/product/A32723">anti-Guinea Pig Cy5</ext-link>(Donkey polyclonal)</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">Cat #706-175-148RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2340462">AB_2340462</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rRNA (mouse monoclonal Y10b)</td><td align="left" valign="bottom">Thermo Fisher Scientific<xref ref-type="bibr" rid="bib60">Lerner et al., 1981</xref></td><td align="left" valign="bottom">Cat #MA1-13017RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10979967">AB_10979967</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-dRpS12 (guinea-pig polyclonal)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib50">Kale et al., 2018</xref></td><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">rabbit anti-hRpL10Ab(rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat #SAB1101199; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10620774">AB_10620774</ext-link></td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Rack1(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat #D59D5RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10705522">AB_10705522</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-RpS9(rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat #ab117861 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10933850">AB_10933850</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RpL9(rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat #ab50384RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_882391">AB_882391</ext-link></td><td align="char" char="." valign="bottom">(1:100)</td></tr><tr><td align="left" valign="bottom">commercial assay, kit</td><td align="left" valign="bottom">Maxiscript T7 Transcription kit</td><td align="left" valign="bottom">Ambion</td><td align="left" valign="bottom">Cat #AM1312</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">ULTRAhyb-Oligo buffer</td><td align="left" valign="bottom">Ambion</td><td align="left" valign="bottom">Cat #AM8663</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay, kit</td><td align="left" valign="bottom">Click-iT Plus OPP Alexa Fluor 594 or 488 Protein Synthesis Assay Kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #C10457</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Biotin-16-UTP</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat #11388908910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNA Sample Loading Buffer</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat #R4268-5VL</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Heat inactivated Fetal Bovine Serum</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat #10082139</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Schneider’s <italic>Drosophila</italic> Medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat #21720024</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trizol</td><td align="left" valign="bottom">Ambion</td><td align="left" valign="bottom">Cat #15596–026</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Odyssey Blocking buffer (PBS)</td><td align="left" valign="bottom">Li-COR</td><td align="left" valign="bottom">Cat #927–40003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">18 S probe_Forward</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref></td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">GGTGCTGAAGCTTATGTAGC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">18 S probe_Reverse</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref></td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">TAATACGACTCACTATAGGGAGACAAAGGGCA GGGACG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">5.8 S probe_Forward</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref></td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">GCTTATATGAAACTAAGACATTTCG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">5.8 S probe_Reverse</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref></td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">TAATACGACTCACTATAGGGTACATAAC<break/>AGCAT GGACTGC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ITS2 probe_Forward</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- CTTTAATTAATTTTATAGTGCTGCTTGG-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ITS2 probe_reverse</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- TAATACGACTCACTATAGGGTTGT<break/>ATATAACTTTATCTTG-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">28 S probe_Forward</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’-GCAGAGAGATATGGTAGATGGGC –3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">28 S probe_reverse</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- TAATACGACTCACTATAGGGTTCCAC<break/>AATTGGCTACGTAACT-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ITS1 probe_Forward</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- GGAAGGATCATTATTGTATAATATC-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">ITS1 probe_Reverse</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- TAATACGACTCACTATAGGGATG<break/>ATTACCACACATTCG-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">7SL probe_Forward</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- TCGACTGGAAGGTTGGCAGCTTCTG-3’</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">7SL probe_Reverse</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">5’- TAATACGACTCACTATAGGGATTGTGG<break/>TCCAACCATATCG-3’</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">VECTASHIELD antifade mounting medium</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat #H-1000</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Nuclear Mask reagent</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #H10325</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line</td><td align="left" valign="bottom">S2-DGRC</td><td align="left" valign="bottom"><italic>Drosophila</italic> Genomics Resource Center (NIH Grant 2P40OD010949)</td><td align="left" valign="bottom">FLYBASE: FBtc0000006 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_TZ72">CVCL_TZ72</ext-link></td><td align="left" valign="bottom">Stock #6(<italic>D. melanogaster</italic> embryonic cell line)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Dual-Luciferase Reporter Assay System</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat #E1910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TransIT-2020 Transfection Reagent</td><td align="left" valign="bottom">Mirus Bio</td><td align="left" valign="bottom">Cat #MIR 5404</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 1+ strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGAGATTGCACAACGCTCATTGCAC<break/>AACGTTCATTGCACAACGGCAATTGCACAACG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 1 - strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGACGTTGTGCAATTGCCGTTGTGCAATG<break/>AACGTTGTGCAATGAGCGTTGTGCAATC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 2+ strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGAGCATGATGAAATAACATGCTCCATGA<break/>TGAAATAACATGTTCCATGATGAAATAACA<break/>TGGCACATGATGAAATAACATG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 2 - strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGACATGTTATTTCATCATGTGCCATGTTA<break/>TTTCATCATGGAACATGTTATTTCATCATG<break/>GAGCATGTTATTTCATCATGC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 3+ strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGAGATTACATCATGCTCATTACATC<break/>ATGTTCATTACATCATGGCAATTACATCATG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp target 3 - strand</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGACATGATGTAATTGCCATGATGTAATG<break/>AACATGATGTAATGAGCATGATGTAATC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp trgt 1+ strand shuffled</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGAGTGACAACTCAGCTCTGACAACTCAGT<break/>TCTGACAACTCAGGCATGACAACTCAG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp trgt 1 - strand shuffled</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGACTGAGTTGTCATGCCTGAGTTGTCAGAA<break/>CTGAGTTGTCAGAGCTGAGTTGTCAC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp trgt 2+ strand shuffled</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGAGTTCAAATCAATAGGAAGCTCTTCAAATCA<break/>ATAGGAAGTTCTTCAAATCAATAGGAAGGCATTC<break/>AAATCAATAGGAAG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom">Xrp trgt 2 - strand shuffled</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TCGACTTCCTATTGATTTGAATGCCTTCCTATT<break/>GATTTGAAGAACTTCCTATTGATTTGAAGAGC<break/>TTCCTATTGATTTGAAC</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-Promoter Vector</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat #E1761</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pAct5.1/V5-His C vector</td><td align="left" valign="bottom">Thermo Fischer Scientific</td><td align="left" valign="bottom">Cat #V411020</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pIS1 plasmid</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat #12,179</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pUAST vector</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Brand and Perrimon, 1993</xref></td><td align="left" valign="bottom">FLYBASE:FBmc0000383</td><td align="left" valign="bottom"><italic>Drosophila</italic> Genomics Resource Center#1,000</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-Rluc</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">p-GL3-H-T1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">p-GL3-H-T2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">p-GL3-H-T3</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">p-GL3-H-T1S</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">p-GL3-H-T2S</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-X-T1</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-X-T2</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-X-T3</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-X-T1S</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr><tr><td align="left" valign="bottom">recombinant DNA reagent</td><td align="left" valign="bottom">pGL3-X-T2S</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See Materials and Methods; Dr. Nicholas Baker’s lab</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental animals</title><p>Fly strains were generally maintained at 25 °C on yeast cornmeal agar. Yeast-glucose medium was generally used for mosaic experiments (<xref ref-type="bibr" rid="bib100">Sullivan et al., 2000</xref>). Sex of larvae dissected for most imaginal disc studies was not differentiated.</p></sec><sec id="s4-2"><title>Clonal analysis</title><p>Genetic mosaics were generated using the FLP/FRT system using inducible heat-shock FLP (hsFLP) transgenic strains. For making clones through mitotic recombination using inducible heat-shock FLP (hsFLP), larvae of <italic>Rp <sup>±</sup></italic>genotypes were subjected to 10–20 min heat shock at 37 °C, 60 ± 12 hours after egg laying (AEL) and dissected 72 hr later. For making clones by excision of a FRT cassette, larvae were subjected to 10–30 min heat shock at 37 °C (details in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), 36 ± 12 AEL for wild type background or 60 ± 12 hr AEL for <italic>Rp <sup>±</sup></italic>background, and dissected 72 hr later.</p></sec><sec id="s4-3"><title><italic>Drosophila</italic> stocks</title><p>Full genotypes for all the experiments are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The following genetic strains were used: UAS-PPP1R15 (BL76250), UAS-PERK-RNAi (v110278 and v16427), UAS-Gcn2-RNAi (v103976), TRE-dsRED, P[GAL4-Act5C(FRT.CD2). P]S, P[UAS-His-RFP]3 (isolated from BL51308), UAS-TAF1B-RNAi (BL61957 and v105783), UAS-PPP1R15-RNAi (v107545 and BL 33011), UAS-w-RNAi (BL33623), UAS-CG6272-RNAi (BL33652), UAS-Xbp1-EGFP (BL60731), UAS-eIF4G-RNAi (v17002), UAS-eEF2-RNAi (v107268), UAS-eEF1α1-RNAi (v104502), UAS-eIF5Α-RNAi (v101513), UAS-eIF6-RNAi (v108094), UAS-Bsk<sup>DN</sup> (BL9311). Other stocks are described in <xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>.</p></sec><sec id="s4-4"><title>Immunohistochemistry and antibody labeling</title><p>For most antibody labeling, imaginal discs were dissected from late 3rd instar larvae in 1xPBS buffer and fixed in 4% formaldehyde in 1 x PEM buffer (1xPEM:100 mM Pipes, 1 mM EGTA, 1 mM MgCl2, pH 6.9). For p-eIF2α and p-RpS6 detection, larvae were dissected in <italic>Drosophila</italic> S2 medium one by one and transferred immediately to fixative. Fixed imaginal discs were 3 x washed in PT (0.2% Triton X-100, 1xPBS) and blocked for 1 hr in PBT buffer (0.2% Triton X-100, 0.5% BSA, 1 x PBS). Discs were incubated in primary antibody in PBT overnight at 4 °C, washed three times with PT for 5–10 min each and incubated in secondary antibody in PBT for 3–4 hr at room temperature, and washed three times with PT for 5–10 min. After washes, samples were rinsed in 1 x PBS and the samples were incubated with the NuclearMask reagent (Thermoﬁsher, H10325) for 10–15 min at room temperature. After washing 2 x with 1 x PBS the imaginal discs were mounted in VECTASHIELD antifade mounting medium (Vector Laboratories, H-1000). In experiments that we wanted to parallel process control samples on the same tube (e.g. <xref ref-type="fig" rid="fig5">Figure 5C</xref> vs 5 J), we used male parents that had the genotypes hsFLP; TRE-dsRed/(PPP1R15 or Xrp1RNAi or PERKRNAi); act&gt;&gt; Gal4, UAS-GFP and cross them with females from the RNAi of interest. The genotypes in the same tube were discriminated using dsRed before the addition of the secondary antibody. We used the following antibodies for staining: rabbit anti-phospho-RpS6 at 1:200 (1:200) (<xref ref-type="bibr" rid="bib90">Romero-Pozuelo et al., 2017</xref>), rabbit anti-p62 (<xref ref-type="bibr" rid="bib87">Pircs et al., 2012</xref>), rabbit anti-phospho-eIF2α at 1:100 (Thermoﬁsher, 44–728 G, and Cell Signaling Technologies), rabbit anti-Xrp1 at 1:200 (<xref ref-type="bibr" rid="bib31">Francis et al., 2016</xref>), mouse anti-b-Galactosidase (J1e7, DSHB), rabbit anti-GFP, rabbit anti-active-Dcp1 (Cell Signaling Techonology Cat#9578, 1:100), Y10b(1:100)(Thermoﬁsher, MA1-13017), RpL9(1:100)(Abcam, ab50384),rabbit-anti-Rack1 (1:100) (Cell Signalling, D59D5), rabbit anti-hRpL10Ab (1:100) (Sigma, Cat# SAB1101199). Secondary Antibodies were Cy2- and Cy5- conjugates (Jackson Immunoresearch) or Alexa Fluor conjugates (Thermofisher). Previous experiments established that significant results could be obtained from five replicates, although many more were imaged in most cases. No calculations regarding sample sizes were performed. No outliers or divergent results were excluded from analysis.</p></sec><sec id="s4-5"><title>Image acquisition and processing</title><p>Confocal laser scanning images were acquired with a Leica Laser scanning microscope SP8 using 20 x and 40 x objectives. Images were processed using Image J1.44j and Adobe Photoshop CS5 Extended. Thoracic bristle images were recorded using Leica M205 FA and Leica Application Suite X.</p></sec><sec id="s4-6"><title>Measurement of in vivo translation</title><p>Translation was detected by the Click-iT Plus OPP Alexa Fluor 594 or 488 Protein Synthesis Assay Kit (Thermoﬁsher, C10457) as described earlier (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Larvae were inverted in Schneider’s <italic>Drosophila</italic> medium (containing 10% heat inactivated Fetal Bovine Serum, Gibco) and transferred in fresh medium containing 1:1000 (20 µM) of Click-iT OPP reagent. Samples were incubated at room temperature for 15 min and rinsed once with PBS. The samples were fixed in 4% formaldehyde in 1 x PEM buffer (100 mM Pipes, 1 mM EGTA, 1 mM MgCl2) for 20 min, washed once with 1 x PBS and subsequently washed with 0.5% Triton in 1 x PBS for 10 min and then incubated for 10 min with 3% BSA in 1 x PBS. The Click reaction took place in the dark at room temperature for 30 min. Samples were washed once with the rinse buffer of the Click reaction kit, 2 min with 3% BSA in 1 x PBS, incubated for 1 hr at room temperature with PBT (1 x PBS, 0.2% Triton, 0.5% BSA) and after that incubated overnight with the primary antibodies at 4°C. Samples were washed 3 x with PT buffer (1 x PBS, 0.2% Triton) and the secondary antibody was added for 2 hr in room temperature. After 3 x washes with PT and 1 x with 1 x PBS, the samples were incubated with the Nuclear Mask reagent (1:2000) of the Click-iT kit for 30 min. After washing 2 x with 1 x PBS the imaginal discs were mounted in Vectashield. Confocal laser scanning images were acquired with a Leica Laser scanning microscope SP8.</p></sec><sec id="s4-7"><title>Northern analysis</title><p>RNA extraction, northern blotting procedures, and 18 S, 5.8 S, tubulin and actin probeswere as described (<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>). Previous studies established that significant results could be obtained from three biological replicates. A biological replicate represents an independent RNA isolation, gel, and blot experiment.</p><p>The following primers were used to amplify the new probes in this paper:</p><p>ITS2 probe:</p><list list-type="simple"><list-item><p>5’- <named-content content-type="sequence">CTTTAATTAATTTTATAGTGCTGCTTGG-3</named-content>’</p></list-item><list-item><p>5’- <named-content content-type="sequence">TAATACGACTCACTATAGGGTTGTATATAACTTTATCTTG-3</named-content>’</p></list-item><list-item><p>28 S probe:</p></list-item><list-item><p>5’-<named-content content-type="sequence">GCAGAGAGATATGGTAGATGGGC -3</named-content>’</p></list-item><list-item><p>5’- <named-content content-type="sequence">TAATACGACTCACTATAGGGTTCCACAATTGGCTACGTAACT-3</named-content>’</p></list-item></list><p>ITS1 probe:</p><list list-type="simple"><list-item><p>5’- <named-content content-type="sequence">GGAAGGATCATTATTGTATAATATC-3</named-content>’</p></list-item><list-item><p>5’- <named-content content-type="sequence">TAATACGACTCACTATAGGGATGATTACCACACATTCG-3</named-content>’</p></list-item><list-item><p>7SL probe:</p></list-item><list-item><p>5’- <named-content content-type="sequence">TCGACTGGAAGGTTGGCAGCTTCTG-3</named-content>’</p></list-item><list-item><p>5’- <named-content content-type="sequence">TAATACGACTCACTATAGGGATTGTGGTCCAACCATATCG-3</named-content>’</p></list-item></list></sec><sec id="s4-8"><title>Plasmid cloning</title><p>All the new plasmids described below were confirmed by DNA sequencing.</p><p>Control <italic>Renilla</italic> luciferase plasmid: The pGL3-Promoter Vector (Promega) was modified by replacement of the SV40 promoter by the <italic>Drosophila</italic> actin promoter from the pAct5.1/V5-His C vector (Thermo Scientific), and the firefly luciferase coding sequence by the Renilla luciferase (RLuc) coding sequence from the pIS1 plasmid (Addgene), yielding the pGL3-Rluc plasmid.</p><p><italic>Firefly</italic> luciferase plasmids: The SV40 core promoter of the pGL3-Promoter Vector was by hsp70 and Xrp1core promoters, amplified from the pUAST vector (<italic>Drosophila</italic> Genomics Resource Center) and from wild-type <italic>Drosophila</italic> genomic DNA respectively, using primers with XhoI and HindIII restriction sites. The resulting pGL3-H and pGL3-X plasmids were digested with Xho1 for insertion of annealed complementary oligonucleotides containing multiple copies of Target 1, Target 2, Target 3, or shuffled Target one or Target two sequences, resulting in the p-GL3-H-T1, p-GL3-H-T2, p-GL3-H-T3, p-GL3-H-T1S, p-GL3-H-T2S, pGL3-X-T1, pGL3-X-T2, pGL3-X-T3, pGL3-X-T1S, and pGL3-X-T2S plasmids.</p><p>Inducible expression plasmids: The Xrp1 (with and without its 3’UTR sequence) and Irbp18 (CG6272) coding regions were amplified from pUAST-Xrp1-HA and pUAST-CG6272 (<xref ref-type="bibr" rid="bib10">Blanco et al., 2020</xref>), and inserted into pMT/V5-His A (Thermo Scientific) usingXhoI and SpeI target sites, resulting in three inducible protein plasmids: pMT-Xrp1<sup>HA</sup>Δ3’UTR, pMT-Xrp1<sup>HA</sup> and pMT-Irbp18<sup>V5/His</sup>. pMT-Xrp1<sup>HA</sup> was not used further as it did not express Xrp1 protein in S2 cells.</p></sec><sec id="s4-9"><title>S2 cell culture and luciferase assays</title><p><italic>Drosophila</italic> S2 cells from the <italic>Drosophila</italic> Genomics Resource Center (DGRC - stock#6) were cultured in Schneider’s medium (Thermo Scientific) supplemented with 10% Heat-Inactivated Fetal Bovine Serum (Thermo Scientific) at 25 °C following the <italic>General procedures for maintenance of Drosophila cell lines</italic> from the DGRC. For luciferase assays, S2 cells were plated in 24-well plates, 5 × 10<sup>5</sup> cells per well. After 24 hr cells were transfected with the indicated combination of control Rluc (0.15 ng/well), protein expression (15 ng/well) and target (4.5 ng/well) plasmids using TransIT-2020 Transfection Reagent (Mirus) following the manufacturer’s instructions. After 24 hr, copper sulfate was added to a final concentration of 0.35 mM. After a further 24 hr cells were lysed and <italic>Renilla</italic> and <italic>Firefly</italic> luciferases’ activity measured with a luminometer, following the instructions from the Dual-Luciferase Reporter Assay System (Promega). <italic>Firefly</italic> signal was normalized to the internal <italic>Renilla</italic> control. Each transfection was performed in triplicate, and experiments performed independently at least three times.</p></sec><sec id="s4-10"><title>mRNA-Seq Analysis</title><p>In order to interrogate the RNA-Seq data (GSE112864 and GSE124924)(<xref ref-type="bibr" rid="bib59">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Ji et al., 2019</xref>) for the presence and abundance of transposons, we firstly retrieved a list of the known <italic>Drosophila melanogaster</italic> transposons from FlyBase (<ext-link ext-link-type="uri" xlink:href="https://flybase.org/">https://flybase.org/</ext-link>) as well as the related FASTA sequences (version r6.41) for which a dedicated Bowtie2 index was constructed. Subsequently, we realigned the RNA-Seq FASTQ files to the transposons using Bowtie2 with default parameters, while restricting the output of unaligned reads (--no-unal option) for faster later quantification. After the alignment, a raw transposon read counts table was constructed using samtools. Final quantification was obtained with RPKM transformation using the RNA-Seq sample library sizes and the lengths of each transposon.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>This author made a significant contribution, Conceptualization, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>mRNA-seq data for transposable elements.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-71705-supp1-v3.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Genotypes, numbers, and heat-shock parameters for figures.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-71705-supp2-v3.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-71705-transrepform1-v3.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>mRNA-Seq data were analyzed from datasets available from GEO with accession numbers GSE112864 and GSE124924. All other data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 1, Figure 2, Figure 2-figure supplement 1, Figure 8-figure supplement 4, Figure 10 and Figure 10-figure supplement 1.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Folgado</surname><given-names>V</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Rimesso</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>RNA-seq analysis to assess transcriptional effects of Rp mutations in wing imaginal discs and their dependence on Xrp1</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112864">GSE112864</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>N</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Folgado</surname><given-names>V</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Rimesso</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>mRNA Seq analysis of <italic>Drosophila</italic> wing imaginal discs from Rp mutants and controls in the presence and absence of RpS12 mutations RpS12</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE124924">GSE124924</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Don Rio, Juhász Gábor and Aurelio Teleman for antibodies and Dirk Bohman, Katerina Papanikolopoulou, Hyung Don Ryoo, Efthimios Skoulakis and Eleni Tsakiri for other reagents. We thank Christos Delidakis, Nikolaos Konstantinides, Amit Kumar, Sudershana Nair, Venkateswara Reddy,Efthimios Skoulakis, and Deepika Vasudevan for comments on an earlier version of the manuscript. MK wants to specially thank Efthimios Skoulakis for hosting her research activities. We thank Andreas Stasinopoulos for discussions, Tao Wang for statistical advice, and Hyung Don Ryoo for sharing unpublished results. This work was supported by NIH grant GM120451 to NEB. <italic>Drosophila</italic> stocks were obtained from the Bloomington <italic>Drosophila</italic> Stock Center and Vienna Stock Resource Center (supported by NIH P40OD018537). Some confocal microscopy was performed in the Analytical Imaging Facility of the Albert Einstein College of Medicine (supported by the NCI P30CA013330) using the Leica SP8 microscope acquired through NIH SIG 1S10 OD023591, as well as a Leica TCS SP8X White Light Laser confocal system at Alexander Fleming Institute supported by the BIO-IMAGING-GR MIS 5002755. Some data in this paper are from a thesis submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the Biomedical Sciences, Albert Einstein College of Medicine.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akdemir</surname><given-names>F</given-names></name><name><surname>Christich</surname><given-names>A</given-names></name><name><surname>Sogame</surname><given-names>N</given-names></name><name><surname>Chapo</surname><given-names>J</given-names></name><name><surname>Abrams</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>p53 directs focused genomic responses in <italic>Drosophila</italic></article-title><source>Oncogene</source><volume>26</volume><fpage>5184</fpage><lpage>5193</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1210328</pub-id><pub-id pub-id-type="pmid">17310982</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>B</given-names></name><name><surname>Kos-Braun</surname><given-names>IC</given-names></name><name><surname>Henras</surname><given-names>AK</given-names></name><name><surname>Dez</surname><given-names>C</given-names></name><name><surname>Rueda</surname><given-names>MP</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gadal</surname><given-names>O</given-names></name><name><surname>Kos</surname><given-names>M</given-names></name><name><surname>Shore</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A ribosome assembly stress response regulates transcription to maintain proteome homeostasis</article-title><source>eLife</source><volume>8</volume><elocation-id>e45002</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45002</pub-id><pub-id pub-id-type="pmid">31124783</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspesi</surname><given-names>A</given-names></name><name><surname>Ellis</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rare ribosomopathies: insights into mechanisms of cancer</article-title><source>Nature Reviews. Cancer</source><volume>19</volume><fpage>228</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0105-0</pub-id><pub-id pub-id-type="pmid">30670820</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baillon</surname><given-names>L</given-names></name><name><surname>Germani</surname><given-names>F</given-names></name><name><surname>Rockel</surname><given-names>C</given-names></name><name><surname>Hilchenbach</surname><given-names>J</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Xrp1 is a transcription factor required for cell competition-driven elimination of loser cells</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>17712</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-36277-4</pub-id><pub-id pub-id-type="pmid">30531963</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>NE</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A potential link between p53, cell competition and ribosomopathy in mammals and in <italic>Drosophila</italic></article-title><source>Developmental Biology</source><volume>446</volume><fpage>17</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2018.11.018</pub-id><pub-id pub-id-type="pmid">30513308</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Emerging mechanisms of cell competition</article-title><source>Nature Reviews. Genetics</source><volume>21</volume><fpage>683</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1038/s41576-020-0262-8</pub-id><pub-id pub-id-type="pmid">32778819</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname><given-names>ME</given-names></name><name><surname>Dinan</surname><given-names>MP</given-names></name><name><surname>Langton</surname><given-names>PF</given-names></name><name><surname>Kucinski</surname><given-names>I</given-names></name><name><surname>Piddini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Proteotoxic stress is a driver of the loser status and cell competition</article-title><source>Nature Cell Biology</source><volume>23</volume><fpage>136</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-00627-0</pub-id><pub-id pub-id-type="pmid">33495633</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belasco</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>All things must pass: contrasts and commonalities in eukaryotic and bacterial mRNA decay</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>11</volume><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/nrm2917</pub-id><pub-id pub-id-type="pmid">20520623</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertolotti</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Hendershot</surname><given-names>LM</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response</article-title><source>Nature Cell Biology</source><volume>2</volume><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1038/35014014</pub-id><pub-id pub-id-type="pmid">10854322</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>JC</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Roles of C/EBP class bZip proteins in the growth and cell competition of Rp (‘Minute’) mutants in <italic>Drosophila</italic></article-title><source>eLife</source><volume>9</volume><elocation-id>e50535</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.50535</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>H</given-names></name><name><surname>Graham</surname><given-names>SJL</given-names></name><name><surname>Van der Aa</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Theunis</surname><given-names>K</given-names></name><name><surname>Fernandez Gallardo</surname><given-names>E</given-names></name><name><surname>Voet</surname><given-names>T</given-names></name><name><surname>Zernicka-Goetz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11165</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11165</pub-id><pub-id pub-id-type="pmid">27021558</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boring</surname><given-names>LF</given-names></name><name><surname>Sinervo</surname><given-names>B</given-names></name><name><surname>Schubiger</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Experimental phenocopy of a minute maternal-effect mutation alters blastoderm determination in embryos of <italic>Drosophila melanogaster</italic></article-title><source>Developmental Biology</source><volume>132</volume><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(89)90231-5</pub-id><pub-id pub-id-type="pmid">2494087</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulan</surname><given-names>L</given-names></name><name><surname>Andersen</surname><given-names>D</given-names></name><name><surname>Colombani</surname><given-names>J</given-names></name><name><surname>Boone</surname><given-names>E</given-names></name><name><surname>Léopold</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inter-Organ Growth Coordination Is Mediated by the Xrp1-Dilp8 Axis in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>49</volume><fpage>811</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.03.016</pub-id><pub-id pub-id-type="pmid">31006647</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development (Cambridge, England)</source><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1242/dev.118.2.401</pub-id><pub-id pub-id-type="pmid">8223268</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>CB</given-names></name><name><surname>Morgan</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="1923">1923</year><source>The Third-Chromosome Group of Mutant Characters of Drosophila melanogaster</source><publisher-loc>Washington</publisher-loc><publisher-name>Carnegie Institute Publication</publisher-name><pub-id pub-id-type="doi">10.5962/bhl.title.24013</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brina</surname><given-names>D</given-names></name><name><surname>Miluzio</surname><given-names>A</given-names></name><name><surname>Ricciardi</surname><given-names>S</given-names></name><name><surname>Biffo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression</article-title><source>Biochimica et Biophysica Acta</source><volume>1849</volume><fpage>830</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.09.010</pub-id><pub-id pub-id-type="pmid">25252159</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>B</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Roach</surname><given-names>FD</given-names></name><name><surname>Vasudevan</surname><given-names>D</given-names></name><name><surname>Ryoo</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The transcription factor Xrp1 is required for PERK-mediated antioxidant gene induction in <italic>Drosophila</italic></article-title><source>eLife</source><volume>10</volume><elocation-id>e74047</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.74047</pub-id><pub-id pub-id-type="pmid">34605405</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>R</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Hedgehog-dependent patterning in the <italic>Drosophila</italic> eye can occur in the absence of Dpp signaling</article-title><source>Developmental Biology</source><volume>179</volume><fpage>360</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1006/dbio.1996.0267</pub-id><pub-id pub-id-type="pmid">8903352</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapin</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Rynearson</surname><given-names>SG</given-names></name><name><surname>Hollien</surname><given-names>J</given-names></name><name><surname>Yandell</surname><given-names>M</given-names></name><name><surname>Metzstein</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>In vivo determination of direct targets of the nonsense-mediated decay pathway in <italic>Drosophila</italic></article-title><source>G3: Genes, Genomes, Genetics</source><volume>4</volume><fpage>485</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1534/g3.113.009357</pub-id><pub-id pub-id-type="pmid">24429422</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Mugler</surname><given-names>CF</given-names></name><name><surname>Keskin</surname><given-names>A</given-names></name><name><surname>Hodapp</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>LYL</given-names></name><name><surname>Weis</surname><given-names>K</given-names></name><name><surname>Mertins</surname><given-names>P</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Jovanovic</surname><given-names>M</given-names></name><name><surname>Brar</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Small and Large Ribosomal Subunit Deficiencies Lead to Distinct Gene Expression Signatures that Reflect Cellular Growth Rate</article-title><source>Molecular Cell</source><volume>73</volume><fpage>36</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.10.032</pub-id><pub-id pub-id-type="pmid">30503772</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choesmel</surname><given-names>V</given-names></name><name><surname>Bacqueville</surname><given-names>D</given-names></name><name><surname>Rouquette</surname><given-names>J</given-names></name><name><surname>Noaillac-Depeyre</surname><given-names>J</given-names></name><name><surname>Fribourg</surname><given-names>S</given-names></name><name><surname>Crétien</surname><given-names>A</given-names></name><name><surname>Leblanc</surname><given-names>T</given-names></name><name><surname>Tchernia</surname><given-names>G</given-names></name><name><surname>Da Costa</surname><given-names>L</given-names></name><name><surname>Gleizes</surname><given-names>P-E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Impaired ribosome biogenesis in Diamond-Blackfan anemia</article-title><source>Blood</source><volume>109</volume><fpage>1275</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-07-038372</pub-id><pub-id pub-id-type="pmid">17053056</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>L</given-names></name><name><surname>Narla</surname><given-names>A</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An update on the pathogenesis and diagnosis of Diamond-Blackfan anemia</article-title><source>F1000Research</source><volume>7</volume><elocation-id>F1000 Faculty Rev-1350</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.15542.1</pub-id><pub-id pub-id-type="pmid">30228860</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danilova</surname><given-names>N</given-names></name><name><surname>Gazda</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ribosomopathies: how a common root can cause a tree of pathologies</article-title><source>Disease Models &amp; Mechanisms</source><volume>8</volume><fpage>1013</fpage><lpage>1026</lpage><pub-id pub-id-type="doi">10.1242/dmm.020529</pub-id><pub-id pub-id-type="pmid">26398160</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>I</given-names></name><name><surname>Girdham</surname><given-names>CH</given-names></name><name><surname>O’Farrell</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A nuclear GFP that marks nuclei in living <italic>Drosophila</italic> embryos; maternal supply overcomes A delay in the appearance of zygotic fluorescence</article-title><source>Developmental Biology</source><volume>170</volume><fpage>726</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1006/dbio.1995.1251</pub-id><pub-id pub-id-type="pmid">7649398</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dever</surname><given-names>TE</given-names></name><name><surname>Green</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The elongation, termination, and recycling phases of translation in eukaryotes</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a013706</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a013706</pub-id><pub-id pub-id-type="pmid">22751155</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietzl</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Schnorrer</surname><given-names>F</given-names></name><name><surname>Su</surname><given-names>KC</given-names></name><name><surname>Barinova</surname><given-names>Y</given-names></name><name><surname>Fellner</surname><given-names>M</given-names></name><name><surname>Gasser</surname><given-names>B</given-names></name><name><surname>Kinsey</surname><given-names>K</given-names></name><name><surname>Oppel</surname><given-names>S</given-names></name><name><surname>Scheiblauer</surname><given-names>S</given-names></name><name><surname>Couto</surname><given-names>A</given-names></name><name><surname>Marra</surname><given-names>V</given-names></name><name><surname>Keleman</surname><given-names>K</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A genome-wide transgenic RNAi library for conditional gene inactivation in <italic>Drosophila</italic></article-title><source>Nature</source><volume>448</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/nature05954</pub-id><pub-id pub-id-type="pmid">17625558</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draptchinskaia</surname><given-names>N</given-names></name><name><surname>Gustavsson</surname><given-names>P</given-names></name><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Pettersson</surname><given-names>M</given-names></name><name><surname>Willig</surname><given-names>TN</given-names></name><name><surname>Dianzani</surname><given-names>I</given-names></name><name><surname>Ball</surname><given-names>S</given-names></name><name><surname>Tchernia</surname><given-names>G</given-names></name><name><surname>Klar</surname><given-names>J</given-names></name><name><surname>Matsson</surname><given-names>H</given-names></name><name><surname>Tentler</surname><given-names>D</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name><name><surname>Carlsson</surname><given-names>B</given-names></name><name><surname>Dahl</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia</article-title><source>Nature Genetics</source><volume>21</volume><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/5951</pub-id><pub-id pub-id-type="pmid">9988267</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>JB</given-names></name><name><surname>Wells</surname><given-names>J</given-names></name><name><surname>Gergen</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Dosage-sensitive maternal modifiers of the <italic>Drosophila</italic> segmentation gene runt</article-title><source>Genetics</source><volume>142</volume><fpage>839</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1093/genetics/142.3.839</pub-id><pub-id pub-id-type="pmid">8849891</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Cerca</surname><given-names>S</given-names></name><name><surname>Pöll</surname><given-names>G</given-names></name><name><surname>Gleizes</surname><given-names>P-E</given-names></name><name><surname>Tschochner</surname><given-names>H</given-names></name><name><surname>Milkereit</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function</article-title><source>Molecular Cell</source><volume>20</volume><fpage>263</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.005</pub-id><pub-id pub-id-type="pmid">16246728</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira-Cerca</surname><given-names>S</given-names></name><name><surname>Pöll</surname><given-names>G</given-names></name><name><surname>Kühn</surname><given-names>H</given-names></name><name><surname>Neueder</surname><given-names>A</given-names></name><name><surname>Jakob</surname><given-names>S</given-names></name><name><surname>Tschochner</surname><given-names>H</given-names></name><name><surname>Milkereit</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Analysis of the in vivo assembly pathway of eukaryotic 40S ribosomal proteins</article-title><source>Molecular Cell</source><volume>28</volume><fpage>446</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.09.029</pub-id><pub-id pub-id-type="pmid">17996708</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>MJ</given-names></name><name><surname>Roche</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>MJ</given-names></name><name><surname>Beall</surname><given-names>E</given-names></name><name><surname>Min</surname><given-names>B</given-names></name><name><surname>Panganiban</surname><given-names>RP</given-names></name><name><surname>Rio</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Drosophila</italic> IRBP bZIP heterodimer binds P-element DNA and affects hybrid dysgenesis</article-title><source>PNAS</source><volume>113</volume><fpage>13003</fpage><lpage>13008</lpage><pub-id pub-id-type="doi">10.1073/pnas.1613508113</pub-id><pub-id pub-id-type="pmid">27799520</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genuth</surname><given-names>NR</given-names></name><name><surname>Barna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Heterogeneity and specialized functions of translation machinery: from genes to organisms</article-title><source>Nature Reviews. Genetics</source><volume>19</volume><fpage>431</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/s41576-018-0008-z</pub-id><pub-id pub-id-type="pmid">29725087</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase</article-title><source>Nature</source><volume>397</volume><fpage>271</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1038/16729</pub-id><pub-id pub-id-type="pmid">9930704</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bertolotti</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Perk is essential for translational regulation and cell survival during the unfolded protein response</article-title><source>Molecular Cell</source><volume>5</volume><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1016/s1097-2765(00)80330-5</pub-id><pub-id pub-id-type="pmid">10882126</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Scheuner</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2alpha) dephosphorylation in mammalian development</article-title><source>PNAS</source><volume>106</volume><fpage>1832</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809632106</pub-id><pub-id pub-id-type="pmid">19181853</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijnen</surname><given-names>HF</given-names></name><name><surname>van Wijk</surname><given-names>R</given-names></name><name><surname>Pereboom</surname><given-names>TC</given-names></name><name><surname>Goos</surname><given-names>YJ</given-names></name><name><surname>Seinen</surname><given-names>CW</given-names></name><name><surname>van Oirschot</surname><given-names>BA</given-names></name><name><surname>van Dooren</surname><given-names>R</given-names></name><name><surname>Gastou</surname><given-names>M</given-names></name><name><surname>Giles</surname><given-names>RH</given-names></name><name><surname>van Solinge</surname><given-names>W</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Gazda</surname><given-names>HT</given-names></name><name><surname>Bierings</surname><given-names>MB</given-names></name><name><surname>Da Costa</surname><given-names>L</given-names></name><name><surname>MacInnes</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ribosomal protein mutations induce autophagy through S6 kinase inhibition of the insulin pathway</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004371</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004371</pub-id><pub-id pub-id-type="pmid">24875531</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henras</surname><given-names>AK</given-names></name><name><surname>Plisson-Chastang</surname><given-names>C</given-names></name><name><surname>O’Donohue</surname><given-names>MF</given-names></name><name><surname>Chakraborty</surname><given-names>A</given-names></name><name><surname>Gleizes</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An overview of pre-ribosomal RNA processing in eukaryotes</article-title><source>Wiley Interdisciplinary Reviews. RNA</source><volume>6</volume><fpage>225</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1002/wrna.1269</pub-id><pub-id pub-id-type="pmid">25346433</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetman</surname><given-names>M</given-names></name><name><surname>Slomnicki</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies</article-title><source>Journal of Neurochemistry</source><volume>148</volume><fpage>325</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1111/jnc.14576</pub-id><pub-id pub-id-type="pmid">30144322</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The unfolded protein response: controlling cell fate decisions under ER stress and beyond</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>89</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1038/nrm3270</pub-id><pub-id pub-id-type="pmid">22251901</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinnebusch</surname><given-names>AG</given-names></name><name><surname>Lorsch</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The mechanism of eukaryotic translation initiation: new insights and challenges</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a011544</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a011544</pub-id><pub-id pub-id-type="pmid">22815232</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>MP</given-names></name><name><surname>Foley</surname><given-names>PL</given-names></name><name><surname>Belasco</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Messenger RNA degradation in bacterial cells</article-title><source>Annual Review of Genetics</source><volume>48</volume><fpage>537</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-120213-092340</pub-id><pub-id pub-id-type="pmid">25292357</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Hussmann</surname><given-names>JA</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribosome Profiling: Global Views of Translation</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a032698</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a032698</pub-id><pub-id pub-id-type="pmid">30037969</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>RJ</given-names></name><name><surname>Hellen</surname><given-names>CUT</given-names></name><name><surname>Pestova</surname><given-names>TV</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The mechanism of eukaryotic translation initiation and principles of its regulation</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>11</volume><fpage>113</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1038/nrm2838</pub-id><pub-id pub-id-type="pmid">20094052</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Folgado</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Rimesso</surname><given-names>G</given-names></name><name><surname>Chuen</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Drosophila</italic> RpS12 controls translation, growth, and cell competition through Xrp1</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1008513</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008513</pub-id><pub-id pub-id-type="pmid">31841522</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Chuen</surname><given-names>J</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Baker</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cell competition removes segmental aneuploid cells from <italic>Drosophila</italic> imaginal disc-derived tissues based on ribosomal protein gene dose</article-title><source>eLife</source><volume>10</volume><elocation-id>e61172</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.61172</pub-id><pub-id pub-id-type="pmid">33847264</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joazeiro</surname><given-names>CAP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mechanisms and functions of ribosome-associated protein quality control</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>20</volume><fpage>368</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0118-2</pub-id><pub-id pub-id-type="pmid">30940912</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juven-Gershon</surname><given-names>T</given-names></name><name><surname>Kadonaga</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulation of gene expression via the core promoter and the basal transcriptional machinery</article-title><source>Developmental Biology</source><volume>339</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.08.009</pub-id><pub-id pub-id-type="pmid">19682982</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kale</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Apoptotic mechanisms during competition of ribosomal protein mutant cells: roles of the initiator caspases Dronc and Dream/Strica</article-title><source>Cell Death &amp; Differentiation</source><volume>22</volume><fpage>1300</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.218</pub-id><pub-id pub-id-type="pmid">25613379</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kale</surname><given-names>A</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Rimesso</surname><given-names>G</given-names></name><name><surname>Flibotte</surname><given-names>S</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ribosomal Protein S12e Has a Distinct Function in Cell Competition</article-title><source>Developmental Cell</source><volume>44</volume><fpage>42</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.12.007</pub-id><pub-id pub-id-type="pmid">29316439</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kampen</surname><given-names>KR</given-names></name><name><surname>Sulima</surname><given-names>SO</given-names></name><name><surname>Vereecke</surname><given-names>S</given-names></name><name><surname>De Keersmaecker</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hallmarks of ribosomopathies</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>1013</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz637</pub-id><pub-id pub-id-type="pmid">31350888</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajuria</surname><given-names>RK</given-names></name><name><surname>Munschauer</surname><given-names>M</given-names></name><name><surname>Ulirsch</surname><given-names>JC</given-names></name><name><surname>Fiorini</surname><given-names>C</given-names></name><name><surname>Ludwig</surname><given-names>LS</given-names></name><name><surname>McFarland</surname><given-names>SK</given-names></name><name><surname>Abdulhay</surname><given-names>NJ</given-names></name><name><surname>Specht</surname><given-names>H</given-names></name><name><surname>Keshishian</surname><given-names>H</given-names></name><name><surname>Mani</surname><given-names>DR</given-names></name><name><surname>Jovanovic</surname><given-names>M</given-names></name><name><surname>Ellis</surname><given-names>SR</given-names></name><name><surname>Fulco</surname><given-names>CP</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Schütz</surname><given-names>S</given-names></name><name><surname>Lian</surname><given-names>J</given-names></name><name><surname>Gripp</surname><given-names>KW</given-names></name><name><surname>Weinberg</surname><given-names>OK</given-names></name><name><surname>Pinkus</surname><given-names>GS</given-names></name><name><surname>Gehrke</surname><given-names>L</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Gazda</surname><given-names>HT</given-names></name><name><surname>Lee</surname><given-names>WY</given-names></name><name><surname>Panse</surname><given-names>VG</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Sankaran</surname><given-names>VG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis</article-title><source>Cell</source><volume>173</volume><fpage>90</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.02.036</pub-id><pub-id pub-id-type="pmid">29551269</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>BA</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Yeast Rrn7 and Human TAF1B Are TFIIB-Related RNA Polymerase I General Transcription Factors</article-title><source>Science</source><volume>333</volume><fpage>1637</fpage><lpage>1640</lpage><pub-id pub-id-type="doi">10.1126/science.1207699</pub-id><pub-id pub-id-type="pmid">21921198</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucinski</surname><given-names>I</given-names></name><name><surname>Dinan</surname><given-names>M</given-names></name><name><surname>Kolahgar</surname><given-names>G</given-names></name><name><surname>Piddini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic activation of JNK JAK/STAT and oxidative stress signalling causes the loser cell status</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>136</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00145-y</pub-id><pub-id pub-id-type="pmid">28743877</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambertsson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The minute genes in <italic>Drosophila</italic> and their molecular functions</article-title><source>Advances in Genetics</source><volume>38</volume><fpage>69</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/s0065-2660(08)60142-x</pub-id><pub-id pub-id-type="pmid">9677706</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langton</surname><given-names>PF</given-names></name><name><surname>Baumgartner</surname><given-names>ME</given-names></name><name><surname>Logeay</surname><given-names>R</given-names></name><name><surname>Piddini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Xrp1 and Irbp18 trigger a feed-forward loop of proteotoxic stress to induce the loser status</article-title><source>PLOS Genetics</source><volume>17</volume><elocation-id>e1009946</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009946</pub-id><pub-id pub-id-type="pmid">34914692</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laplante</surname><given-names>M</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>mTOR signaling in growth control and disease</article-title><source>Cell</source><volume>149</volume><fpage>274</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.03.017</pub-id><pub-id pub-id-type="pmid">22500797</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawlor</surname><given-names>K</given-names></name><name><surname>Pérez-Montero</surname><given-names>S</given-names></name><name><surname>Lima</surname><given-names>A</given-names></name><name><surname>Rodríguez</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional versus metabolic control of cell fitness during cell competition</article-title><source>Seminars in Cancer Biology</source><volume>63</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2019.05.010</pub-id><pub-id pub-id-type="pmid">31102668</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Kiparaki</surname><given-names>M</given-names></name><name><surname>Blanco</surname><given-names>J</given-names></name><name><surname>Folgado</surname><given-names>V</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Rimesso</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition</article-title><source>Developmental Cell</source><volume>46</volume><fpage>456</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.07.003</pub-id><pub-id pub-id-type="pmid">30078730</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>EA</given-names></name><name><surname>Lerner</surname><given-names>MR</given-names></name><name><surname>Janeway</surname><given-names>CA</given-names></name><name><surname>Steitz</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease</article-title><source>PNAS</source><volume>78</volume><fpage>2737</fpage><lpage>2741</lpage><pub-id pub-id-type="doi">10.1073/pnas.78.5.2737</pub-id><pub-id pub-id-type="pmid">6789322</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yasumura</surname><given-names>D</given-names></name><name><surname>Cohen</surname><given-names>HR</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Panning</surname><given-names>B</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Lavail</surname><given-names>MM</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>IRE1 signaling affects cell fate during the unfolded protein response</article-title><source>Science (New York, N.Y.)</source><volume>318</volume><fpage>944</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1126/science.1146361</pub-id><pub-id pub-id-type="pmid">17991856</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>EO</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Alternative pathways in the processing of ribosomal RNA precursor in <italic>Drosophila melanogaster</italic></article-title><source>Journal of Molecular Biology</source><volume>138</volume><fpage>873</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(80)90070-4</pub-id><pub-id pub-id-type="pmid">6774101</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The hallmarks of aging</article-title><source>Cell</source><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malzer</surname><given-names>E</given-names></name><name><surname>Szajewska-Skuta</surname><given-names>M</given-names></name><name><surname>Dalton</surname><given-names>LE</given-names></name><name><surname>Thomas</surname><given-names>SE</given-names></name><name><surname>Hu</surname><given-names>N</given-names></name><name><surname>Skaer</surname><given-names>H</given-names></name><name><surname>Lomas</surname><given-names>DA</given-names></name><name><surname>Crowther</surname><given-names>DC</given-names></name><name><surname>Marciniak</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coordinate regulation of eIF2α phosphorylation by PPP1R15 and GCN2 is required during <italic>Drosophila</italic> development</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>1406</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1242/jcs.117614</pub-id><pub-id pub-id-type="pmid">23418347</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques-Reis</surname><given-names>M</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Role of cell competition in ageing</article-title><source>Developmental Biology</source><volume>476</volume><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.03.009</pub-id><pub-id pub-id-type="pmid">33753080</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marygold</surname><given-names>SJ</given-names></name><name><surname>Roote</surname><given-names>J</given-names></name><name><surname>Reuter</surname><given-names>G</given-names></name><name><surname>Lambertsson</surname><given-names>A</given-names></name><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Millburn</surname><given-names>GH</given-names></name><name><surname>Harrison</surname><given-names>PM</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Kenmochi</surname><given-names>N</given-names></name><name><surname>Kaufman</surname><given-names>TC</given-names></name><name><surname>Leevers</surname><given-names>SJ</given-names></name><name><surname>Cook</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The ribosomal protein genes and Minute loci of <italic>Drosophila melanogaster</italic></article-title><source>Genome Biology</source><volume>8</volume><elocation-id>R216</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2007-8-10-r216</pub-id><pub-id pub-id-type="pmid">17927810</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matyunina</surname><given-names>LV</given-names></name><name><surname>Jordan</surname><given-names>IK</given-names></name><name><surname>McDonald</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Naturally occurring variation in copia expression is due to both element (cis) and host (trans) regulatory variation</article-title><source>PNAS</source><volume>93</volume><fpage>7097</fpage><lpage>7102</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.14.7097</pub-id><pub-id pub-id-type="pmid">8692951</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm</article-title><source>Trends in Genetics</source><volume>33</volume><fpage>448</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.04.001</pub-id><pub-id pub-id-type="pmid">28457629</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>JF</given-names></name><name><surname>Matyunina</surname><given-names>LV</given-names></name><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Jordan</surname><given-names>IK</given-names></name><name><surname>Bowen</surname><given-names>NJ</given-names></name><name><surname>Miller</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>LTR retrotransposons and the evolution of eukaryotic enhancers</article-title><source>Genetica</source><volume>100</volume><fpage>3</fpage><lpage>13</lpage></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamee</surname><given-names>LM</given-names></name><name><surname>Brodsky</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>p53-independent apoptosis limits DNA damage-induced aneuploidy</article-title><source>Genetics</source><volume>182</volume><fpage>423</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1534/genetics.109.102327</pub-id><pub-id pub-id-type="pmid">19364807</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>EW</given-names></name><name><surname>Green</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ribosomopathies: There’s strength in numbers</article-title><source>Science</source><volume>358</volume><elocation-id>eaan2755</elocation-id><pub-id pub-id-type="doi">10.1126/science.aan2755</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Ryoo</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The unfolded protein response in metazoan development</article-title><source>Journal of Cell Science</source><volume>132</volume><elocation-id>jcs217216</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.217216</pub-id><pub-id pub-id-type="pmid">30770479</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morata</surname><given-names>G</given-names></name><name><surname>Ripoll</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Minutes: mutants of <italic>Drosophila</italic> autonomously affecting cell division rate</article-title><source>Developmental Biology</source><volume>42</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(75)90330-9</pub-id><pub-id pub-id-type="pmid">1116643</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morata</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cell competition: A historical perspective</article-title><source>Developmental Biology</source><volume>476</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.02.012</pub-id><pub-id pub-id-type="pmid">33775694</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mount</surname><given-names>SM</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Complete nucleotide sequence of the <italic>Drosophila</italic> transposable element copia: homology between copia and retroviral proteins</article-title><source>Molecular and Cellular Biology</source><volume>5</volume><fpage>1630</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1128/mcb.5.7.1630-1638.1985</pub-id><pub-id pub-id-type="pmid">2410772</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>R</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Sanaki</surname><given-names>Y</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell Competition Is Driven by Autophagy</article-title><source>Developmental Cell</source><volume>51</volume><fpage>99</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.08.018</pub-id><pub-id pub-id-type="pmid">31543447</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neufeld</surname><given-names>TP</given-names></name><name><surname>de la Cruz</surname><given-names>AF</given-names></name><name><surname>Johnston</surname><given-names>LA</given-names></name><name><surname>Edgar</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Coordination of growth and cell division in the <italic>Drosophila</italic> wing</article-title><source>Cell</source><volume>93</volume><fpage>1183</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81462-2</pub-id><pub-id pub-id-type="pmid">9657151</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochi</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Nagata</surname><given-names>R</given-names></name><name><surname>Wakasa</surname><given-names>N</given-names></name><name><surname>Nakano</surname><given-names>R</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cell competition is driven by Xrp1-mediated phosphorylation of eukaryotic initiation factor 2α</article-title><source>PLOS Genetics</source><volume>17</volume><elocation-id>e1009958</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009958</pub-id><pub-id pub-id-type="pmid">34871307</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Liao</surname><given-names>G</given-names></name><name><surname>Niemann</surname><given-names>H</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Computational analysis of core promoters in the <italic>Drosophila</italic> genome</article-title><source>Genome Biology</source><volume>3</volume><elocation-id>RESEARCH0087</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2002-3-12-research0087</pub-id><pub-id pub-id-type="pmid">12537576</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>ER</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name><name><surname>Tarlé</surname><given-names>SA</given-names></name><name><surname>Glaser</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute</article-title><source>Development (Cambridge, England)</source><volume>131</volume><fpage>3907</fpage><lpage>3920</lpage><pub-id pub-id-type="doi">10.1242/dev.01268</pub-id><pub-id pub-id-type="pmid">15289434</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakos-Zebrucka</surname><given-names>K</given-names></name><name><surname>Koryga</surname><given-names>I</given-names></name><name><surname>Mnich</surname><given-names>K</given-names></name><name><surname>Ljujic</surname><given-names>M</given-names></name><name><surname>Samali</surname><given-names>A</given-names></name><name><surname>Gorman</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The integrated stress response</article-title><source>EMBO Reports</source><volume>17</volume><fpage>1374</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.15252/embr.201642195</pub-id><pub-id pub-id-type="pmid">27629041</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>PH</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name><name><surname>Schulze</surname><given-names>KL</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The <italic>Drosophila</italic> deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagy</article-title><source>The Journal of Cell Biology</source><volume>185</volume><fpage>1181</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1083/jcb.200904161</pub-id><pub-id pub-id-type="pmid">19546244</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelava</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Watkins</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The importance of ribosome production, and the 5S RNP-MDM2 pathway, in health and disease</article-title><source>Biochemical Society Transactions</source><volume>44</volume><fpage>1086</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1042/BST20160106</pub-id><pub-id pub-id-type="pmid">27528756</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>LA</given-names></name><name><surname>Holderbaum</surname><given-names>L</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Sopko</surname><given-names>R</given-names></name><name><surname>McCall</surname><given-names>K</given-names></name><name><surname>Yang-Zhou</surname><given-names>D</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Shim</surname><given-names>H-S</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Housden</surname><given-names>A</given-names></name><name><surname>Foos</surname><given-names>M</given-names></name><name><surname>Randkelv</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>C</given-names></name><name><surname>Namgyal</surname><given-names>P</given-names></name><name><surname>Villalta</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>L-P</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Huan-Huan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fujiyama</surname><given-names>A</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Ayers</surname><given-names>K</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Czech</surname><given-names>B</given-names></name><name><surname>Neumuller</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Cavallaro</surname><given-names>A</given-names></name><name><surname>Hibbard</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>D</given-names></name><name><surname>Cooley</surname><given-names>L</given-names></name><name><surname>Hannon</surname><given-names>GJ</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><name><surname>Parks</surname><given-names>A</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>J-Q</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Transgenic RNAi Project at Harvard Medical School: Resources and Validation</article-title><source>Genetics</source><volume>201</volume><fpage>843</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.180208</pub-id><pub-id pub-id-type="pmid">26320097</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>BP</given-names></name><name><surname>Miller</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ribosome-associated quality control of membrane proteins at the endoplasmic reticulum</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs251983</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.251983</pub-id><pub-id pub-id-type="pmid">33247003</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignoni</surname><given-names>F</given-names></name><name><surname>Zipursky</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Induction of <italic>Drosophila</italic> eye development by decapentaplegic</article-title><source>Development (Cambridge, England)</source><volume>124</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1242/dev.124.2.271</pub-id><pub-id pub-id-type="pmid">9053304</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pircs</surname><given-names>K</given-names></name><name><surname>Nagy</surname><given-names>P</given-names></name><name><surname>Varga</surname><given-names>A</given-names></name><name><surname>Venkei</surname><given-names>Z</given-names></name><name><surname>Erdi</surname><given-names>B</given-names></name><name><surname>Hegedus</surname><given-names>K</given-names></name><name><surname>Juhasz</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Advantages and limitations of different p62-based assays for estimating autophagic activity in <italic>Drosophila</italic></article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e44214</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044214</pub-id><pub-id pub-id-type="pmid">22952930</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pöll</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><name><surname>Jakovljevic</surname><given-names>J</given-names></name><name><surname>Neueder</surname><given-names>A</given-names></name><name><surname>Jakob</surname><given-names>S</given-names></name><name><surname>Woolford</surname><given-names>JL</given-names><suffix>Jr</suffix></name><name><surname>Tschochner</surname><given-names>H</given-names></name><name><surname>Milkereit</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>rRNA maturation in yeast cells depleted of large ribosomal subunit proteins</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e8249</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0008249</pub-id><pub-id pub-id-type="pmid">20011513</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recasens-Alvarez</surname><given-names>C</given-names></name><name><surname>Alexandre</surname><given-names>C</given-names></name><name><surname>Kirkpatrick</surname><given-names>J</given-names></name><name><surname>Nojima</surname><given-names>H</given-names></name><name><surname>Huels</surname><given-names>DJ</given-names></name><name><surname>Snijders</surname><given-names>AP</given-names></name><name><surname>Vincent</surname><given-names>J-P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition</article-title><source>Nature Cell Biology</source><volume>23</volume><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-00626-1</pub-id><pub-id pub-id-type="pmid">33495632</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Pozuelo</surname><given-names>J</given-names></name><name><surname>Demetriades</surname><given-names>C</given-names></name><name><surname>Schroeder</surname><given-names>P</given-names></name><name><surname>Teleman</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CycD/Cdk4 and Discontinuities in Dpp Signaling Activate TORC1 in the <italic>Drosophila</italic> Wing Disc</article-title><source>Developmental Cell</source><volume>42</volume><fpage>376</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.07.019</pub-id><pub-id pub-id-type="pmid">28829945</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>8</volume><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/nrm2199</pub-id><pub-id pub-id-type="pmid">17565364</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>P</given-names></name><name><surname>Eyler</surname><given-names>DE</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Dever</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypusine-containing protein eIF5A promotes translation elongation</article-title><source>Nature</source><volume>459</volume><fpage>118</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/nature08034</pub-id><pub-id pub-id-type="pmid">19424157</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuller</surname><given-names>AP</given-names></name><name><surname>Wu</surname><given-names>CC-C</given-names></name><name><surname>Dever</surname><given-names>TE</given-names></name><name><surname>Buskirk</surname><given-names>AR</given-names></name><name><surname>Green</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>eIF5A Functions Globally in Translation Elongation and Termination</article-title><source>Molecular Cell</source><volume>66</volume><fpage>194</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.03.003</pub-id><pub-id pub-id-type="pmid">28392174</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Vattem</surname><given-names>KM</given-names></name><name><surname>Sood</surname><given-names>R</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Stramm</surname><given-names>L</given-names></name><name><surname>Wek</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control</article-title><source>Molecular and Cellular Biology</source><volume>18</volume><fpage>7499</fpage><lpage>7509</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.12.7499</pub-id><pub-id pub-id-type="pmid">9819435</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Parameters of cell competition in the compartments of the wing disc of <italic>Drosophila</italic></article-title><source>Developmental Biology</source><volume>69</volume><fpage>182</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/0012-1606(79)90284-7</pub-id><pub-id pub-id-type="pmid">446891</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sneddon</surname><given-names>A</given-names></name><name><surname>Flavell</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The transcriptional control regions of the copia retrotransposon</article-title><source>Nucleic Acids Research</source><volume>17</volume><fpage>4025</fpage><lpage>4035</lpage><pub-id pub-id-type="doi">10.1093/nar/17.11.4025</pub-id><pub-id pub-id-type="pmid">2472602</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanki</surname><given-names>NR</given-names></name><name><surname>Stadanlick</surname><given-names>JE</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Duc</surname><given-names>A-C</given-names></name><name><surname>Lee</surname><given-names>S-Y</given-names></name><name><surname>Lauritsen</surname><given-names>JPH</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Wiest</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>197</volume><fpage>2280</fpage><lpage>2289</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600815</pub-id><pub-id pub-id-type="pmid">27489283</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sone</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Larese</surname><given-names>J</given-names></name><name><surname>Ryoo</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A modified UPR stress sensing system reveals A novel tissue distribution of IRE1/XBP1 activity during normal <italic>Drosophila</italic> development</article-title><source>Cell Stress &amp; Chaperones</source><volume>18</volume><fpage>307</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1007/s12192-012-0383-x</pub-id><pub-id pub-id-type="pmid">23160805</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struhl</surname><given-names>G</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Organizing activity of wingless protein in <italic>Drosophila</italic></article-title><source>Cell</source><volume>72</volume><fpage>527</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90072-x</pub-id><pub-id pub-id-type="pmid">8440019</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>W</given-names></name><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Hawley</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>Drosophila Protocols</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sykiotis</surname><given-names>GP</given-names></name><name><surname>Bohmann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>14</volume><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.12.002</pub-id><pub-id pub-id-type="pmid">18194654</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>E</given-names></name><name><surname>Ferreira-Cerca</surname><given-names>S</given-names></name><name><surname>Hurt</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Eukaryotic ribosome biogenesis at a glance</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>4815</fpage><lpage>4821</lpage><pub-id pub-id-type="doi">10.1242/jcs.111948</pub-id><pub-id pub-id-type="pmid">24172536</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiu</surname><given-names>GC</given-names></name><name><surname>Kerr</surname><given-names>CH</given-names></name><name><surname>Forester</surname><given-names>CM</given-names></name><name><surname>Krishnarao</surname><given-names>PS</given-names></name><name><surname>Rosenblatt</surname><given-names>HD</given-names></name><name><surname>Raj</surname><given-names>N</given-names></name><name><surname>Lantz</surname><given-names>TC</given-names></name><name><surname>Zhulyn</surname><given-names>O</given-names></name><name><surname>Bowen</surname><given-names>ME</given-names></name><name><surname>Shokat</surname><given-names>L</given-names></name><name><surname>Attardi</surname><given-names>LD</given-names></name><name><surname>Ruggero</surname><given-names>D</given-names></name><name><surname>Barna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A p53-dependent translational program directs tissue-selective phenotypes in A model of ribosomopathies</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2089</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.06.013</pub-id><pub-id pub-id-type="pmid">34242585</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trainor</surname><given-names>PA</given-names></name><name><surname>Dixon</surname><given-names>J</given-names></name><name><surname>Dixon</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Treacher Collins syndrome: etiology, pathogenesis and prevention</article-title><source>European Journal of Human Genetics</source><volume>17</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2008.221</pub-id><pub-id pub-id-type="pmid">19107148</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukada</surname><given-names>J</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Kominato</surname><given-names>Y</given-names></name><name><surname>Auron</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation</article-title><source>Cytokine</source><volume>54</volume><fpage>6</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2010.12.019</pub-id><pub-id pub-id-type="pmid">21257317</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tye</surname><given-names>BW</given-names></name><name><surname>Commins</surname><given-names>N</given-names></name><name><surname>Ryazanova</surname><given-names>LV</given-names></name><name><surname>Wühr</surname><given-names>M</given-names></name><name><surname>Springer</surname><given-names>M</given-names></name><name><surname>Pincus</surname><given-names>D</given-names></name><name><surname>Churchman</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Proteotoxicity from aberrant ribosome biogenesis compromises cell fitness</article-title><source>eLife</source><volume>8</volume><elocation-id>e43002</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43002</pub-id><pub-id pub-id-type="pmid">30843788</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyler</surname><given-names>DM</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zhuo</surname><given-names>N</given-names></name><name><surname>Pellock</surname><given-names>B</given-names></name><name><surname>Baker</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genes affecting cell competition in <italic>Drosophila</italic></article-title><source>Genetics</source><volume>175</volume><fpage>643</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.061929</pub-id><pub-id pub-id-type="pmid">17110495</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>JP</given-names></name><name><surname>Girdham</surname><given-names>CH</given-names></name><name><surname>O’Farrell</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>A Cell-Autonomous, Ubiquitous Marker for the Analysis of <italic>Drosophila</italic> Genetic Mosaics</article-title><source>Developmental Biology</source><volume>164</volume><fpage>328</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1006/dbio.1994.1203</pub-id><pub-id pub-id-type="pmid">8026635</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishwakarma</surname><given-names>M</given-names></name><name><surname>Piddini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Outcompeting cancer</article-title><source>Nature Reviews Cancer</source><volume>20</volume><fpage>187</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0231-8</pub-id><pub-id pub-id-type="pmid">31932757</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation</article-title><source>Science</source><volume>334</volume><fpage>1081</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1126/science.1209038</pub-id><pub-id pub-id-type="pmid">22116877</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome</article-title><source>Advances in Biological Regulation</source><volume>67</volume><fpage>109</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.jbior.2017.09.002</pub-id><pub-id pub-id-type="pmid">28942353</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wek</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of eIF2α Kinases in Translational Control and Adaptation to Cellular Stress</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a032870</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a032870</pub-id><pub-id pub-id-type="pmid">29440070</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Matyunina</surname><given-names>LV</given-names></name><name><surname>McDonald</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>An enhancer region within the copia untranslated leader contains binding sites for <italic>Drosophila</italic> regulatory proteins</article-title><source>Gene</source><volume>209</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/s0378-1119(98)00048-1</pub-id><pub-id pub-id-type="pmid">9524274</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolford</surname><given-names>JL</given-names></name><name><surname>Baserga</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ribosome biogenesis in the yeast <italic>Saccharomyces cerevisiae</italic></article-title><source>Genetics</source><volume>195</volume><fpage>643</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1534/genetics.113.153197</pub-id><pub-id pub-id-type="pmid">24190922</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Analysis of genetic mosaics in developing and adult <italic>Drosophila</italic> tissues</article-title><source>Development (Cambridge, England)</source><volume>117</volume><fpage>1223</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1242/dev.117.4.1223</pub-id><pub-id pub-id-type="pmid">8404527</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarchuk</surname><given-names>O</given-names></name><name><surname>Jacques</surname><given-names>N</given-names></name><name><surname>Guillerez</surname><given-names>J</given-names></name><name><surname>Dreyfus</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Interdependence of translation, transcription and mRNA degradation in the lacZ gene</article-title><source>Journal of Molecular Biology</source><volume>226</volume><fpage>581</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(92)90617-s</pub-id><pub-id pub-id-type="pmid">1507217</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>LJ</given-names></name><name><surname>Christensen</surname><given-names>RG</given-names></name><name><surname>Kazemian</surname><given-names>M</given-names></name><name><surname>Hull</surname><given-names>CJ</given-names></name><name><surname>Enuameh</surname><given-names>MS</given-names></name><name><surname>Basciotta</surname><given-names>MD</given-names></name><name><surname>Brasefield</surname><given-names>JA</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Asriyan</surname><given-names>Y</given-names></name><name><surname>Lapointe</surname><given-names>DS</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Wolfe</surname><given-names>SA</given-names></name><name><surname>Brodsky</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FlyFactorSurvey: a database of <italic>Drosophila</italic> transcription factor binding specificities determined using the bacterial one-hybrid system</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D111</fpage><lpage>D117</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq858</pub-id><pub-id pub-id-type="pmid">21097781</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Zielke</surname><given-names>N</given-names></name><name><surname>Vähärautio</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Myc-Dependent Cell Competition and Proliferative Response Requires Induction of the Ribosome Biogenesis Regulator Peter Pan</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.05.06.080283</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71705.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.07.12.452023" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.07.12.452023"/></front-stub><body><p>This paper will be of broad interest to biologists and has potential clinical relevance. It reveals that defects in ribosome biogenesis or function lead to PERK-phosphorylation of eIF2alpha and render cells vulnerable to cell competition by wild-type neighbors. Cell competition requires induction of the transcription factor Xrp1 in the mutant cell. Thus, the authors demonstrate that Xrp1 is the master regulator of cell competition. A series of compelling experimental manipulations dissecting the epistatic relationship between ribosome defects, Xrp1, eIF2alpha phosphorylation and cell competition support the key claims of the paper.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71705.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.07.12.452023">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.07.12.452023v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Erika A Bach as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by James Manley as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Experimental:</p><p>1. A key conclusion of the paper is that &quot;interrupting the translation cycle activates Xrp-1 dependent cell death independently of diminished translation&quot;. Most of the data supporting this conclusion are contained in Figure 7 and its supplement, and some of these images are not compelling. Specifically, in Figure 7A,D,G the GFP-positive UAS-PPP1R15, UAS-eEF2RNAi loser clones are very large, encompassing most of the field of the of view. In these clones, p-eIF2alpha is not upregulated. However, in Figure 7D,C,E,F,H,I, these same clones in the same genetic background are very small and are obviously being outcompeted. Why is there such a huge discrepancy in clone size across panels? Furthermore, the level of p-eIF2alpha was not monitored in other depletions of translation factors in Figure 7, Supplement 1, panels A-D. First, the authors need to provide better examples for p-eIF2alpha in Figure 7A,D,G. Second, they need to provide representative examples of p-eIF2alpha in Figure 7, Supplement 1, panels A-D. Third, they need to provide some quantification of the p-eIF2alpha results in Figure 7A,D,G and Figure 7, Supplement 1, panels A-D. Fourth, they need to provide representative examples of OPP in Figure 7, Supplement 1, panels A-D.</p><p>2. The authors need to quantify some of the results, including (a) p-eiF2alpha results mentioned in point #1; (b) penetrance of Rp/+ phenotypes; (c) northern blot results in Figure 2.</p><p>3. The authors need to prove that larger p-eiF2alpha spots in discs are dividing cells by co-staining with pHH3.</p><p>4. They need to supply missing controls. For Figure 3, please supply WT clones in a wild-type background treated with OPP and p-eiF2alpha antibody. For Figure 7, please supply UAS-PPP1R15 flip-out clones alone labelled with p-eiF2alpha, OPP and Dcp-1.</p><p>5. They need to prove with higher magnification that Xrp1 is excluded from the nucleolus.</p><p>6. They need to test Ire1 activation (i.e., Xbp1-GFP) and GstD1-GFP induction in Rp/+ clones, not just in Rp/+ heterozygous backgrounds.</p><p>7. The authors need to clarify in the manuscript how competition can be independent of translation because their data clearly show that when competition occurs, the loser clone has <italic>both</italic> elevated Xrp1 and lower translation. While the authors conclude that being a loser is determined solely by upregulation of Xrp1 and is independent of relative translation rate, in every case they show where there is competition, the translation rate is lower in the loser clone (see Figure 7B,E,H). In some of those manipulations, when they remove Xrp1, the same mutant can have a higher or unchanged translation rate as wild-type (Figure 3, Supplement 1 panel G', L', Figure 5K', Figure 7T'). The authors' work does demonstrate that having differences in translation alone (without Xrp1 differences) cannot induce cell competition. However, their work does <italic>not</italic> show that differences in Xrp1 without differences in translation can cause competition.</p><p>8. The authors need to discuss their new findings in the context of previously published work on how Xrp1 impacts translation. While the reviewers are aware that overexpression of Xrp1 is lethal (Baillon et al., Sci Reports 2018), the authors do not discuss the fact that Xrp1 translation is <italic>induced</italic> in loser cells where overall translation is <italic>lower</italic>. The reviewers agree that figuring out the mechanism by which Xrp1 is induced under restrictive translation conditions is outside the scope of this work. However, given point 7 above, the authors must acknowledge these unknowns explicitly in the discussion.</p><p>Editorial – The manuscript lacks clarity in several places. Please modify the revised manuscript as per the specific reviewer's comments.</p><p>1. The abstract and the introduction need revision (see R2).</p><p>2. The narrative describing the results in Figure 7 that are essential to the paper are not described in sufficient detail. Please expand the text in lines 426-445 to include the rationale for the experiments, the observations and the conclusions.</p><p>3. In the Discussion, the authors should discuss the observation that p-eiF2alpha is both upstream and downstream of Xrp1 and whether there is a feedback loop?</p><p>4. The authors should speculate in the Discussion about what is downstream of Xrp1 that causes WT neighbors to outcompete less competitive cells.</p><p>5. The authors need to address whether they have previously shown that clonal over-expression of Xrp1 causes cell competition without any other perturbation. If this experiment has been done in a previous publication from the lab, it needs to be discussed in the context of the model.</p><p>6. The authors need to discuss in a few sentences why increased Xrp1 expression occurs throughout the &quot;loser&quot; clone but competitive death only occurs at the clone boundaries.</p><p>7. The authors should soften the conclusion of reduction of LSU levels in Rp/+ because they tested only two subunits. The same request is made for the effect of LSUs on proteotoxicity (line 334).</p><p>8. The authors should explain the seemingly contradictory observations that Dcp1 is observed outside and inside clone boundaries (Figure 6F', J') and also within clones (Figure 7 supplement 2B', D', J') but the model holds that competitive death should be at the boundaries.</p><p>9. The authors should acknowledge that p-eIF2alpha is not a constant entity and can vary in non-stress conditions like circadian rhythm.</p><p>10. Many typos need to be corrected.</p><p>Figure labeling:</p><p>1. Genotypes need to be better labelled in some figures (like Figure 1). The authors should avoid using the terms <italic>labelled</italic> and <italic>unlabeled</italic> and instead refer to the cells in mosaic discs as white or black. Every figure panel should have written on it some version of the genotype.</p><p>2. Genotypes should be in the figure legends themselves, in addition to Table S2. In other words, it should be easy for the reader to know the genotype of the labelled (white) cells and the unlabeled (black) cells.</p><p>3. Many figures need arrows, etc, to help the reader under the data.</p><p>4. In all of the source data excel files, please use first row to indicate the relevant figure to which these data refer.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. Phospho-eiF2alpha is both upstream and downstream of Xrp1 – can the authors please comment on this in the Discussion. Is this a feedback loop?</p><p>2. Can the authors speculate in the Discussion about what is downstream of Xrp1 that causes WT neighbors to outcompete less competitive cells? For example, do the authors think that there is a cell surface receptor recognized by WT cells? Something else.</p><p>3. The authors need to quantify phospho-eiF2alpha results. At a minimum, they should report in a supplementary table the number of clones scored, the number of wing discs scored, and whether the clone boundary always coincides with the phospho-eiF2alpha result.</p><p>4. The authors need to prove that the larger phosphor-eiF2alpha spots in discs are dividing cells. They need to co-stain with phospho-Histone H3.</p><p>5. Reporting on penetrance of Rp/+ phenotypes – the authors need to report the number of discs examined and whether all discs/clones of the same genotype displayed similar results.</p><p>6. Genotypes need to be better labelled in some figures (like Figure 1). and should be in the figure legends themselves, in addition to Table S2. It should be easy for the reader to know the genotype of the labelled (white) cells and the unlabeled (black) cells. In fact, the authors should avoid using the terms labelling and unlabeled and instead refer to the cells in mosaic discs as white or black.</p><p>7. In all of the source data excel files, please use first row to indicate the relevant figure to which these data refer.</p><p>8. Figure 3 is missing controls. Please add to this figure panels of WT clones in a wild-type background treated with OPP and phospho-eiF2alpha antibody.</p><p>9. There is a discordance between lines 295-297 and lines 1013-1014. The former states that phosphor-eiF2alpha levels were decreased in Rp+/- cells when Xrp1 was heterozygous, white the latter states the opposite. This needs to be clarified.</p><p>10. Perk mRNA is up 1.5x, but this may not mean 1.5x protein. Is there a reliable PERK antibody to use to test this?</p><p>11. Figure 7 – please supply panels in this figure of missing control PPP1R15 flip-out clone alone labelled with p-eiF2alpha, OPP and Dcp-1.</p><p>12. P values greater than 1: In several places there are Padj values that are greater than 1. This is not possible. Probability cannot be greater than 1. This problem occurs on Lines 863, 866, 1222, 1227. Please address this.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Overall, this study makes important progress in the field of cell competition as described in the public comments. I'd like to note that application of their results is limited to minute-mediated cell competition as of now, and also in lower organisms since there is no clear homolog of Xrp1 in higher species. I am cautiously enthusiastic about the publication of the study in <italic>eLife</italic> with some recommendations for improvement as listed below:</p><p>1. The manuscript suffers from lack of clarity, particularly in the abstract and introduction where it is unclear what known/published data are and what are the new findings. e.g. in the abstract: &quot;The changes in ribosomal subunit levels observed are not sufficient for these effects, which all depend on the AT hook, bZip domain protein Xrp1.&quot; is a finding of this manuscripts but reads as though it is a previous known. There are also several grammatical errors that made the manuscript difficult to follow e.g. line 65 &quot;the regulation of translation are important targets of cellular regulation&quot; does not quite communicate effectively. I recommend that the authors consider revising linguistic aspects of the manuscript.</p><p>2. To strengthen the authors' conclusion that Xrp1 is required for cell competition due to reduced translation, it would be useful to test if this also holds true when there is a duplication of an Rp rather than loss of a copy of Rp.</p><p>3. The authors claim that &quot;SSU components are generally reduced in RpS+/- cells and levels of SSU components are generally reduced in RpS+/- cells and RpL27A+/- cells, whereas LSU levels are only reduced in RpL27A+/- cells&quot; (Line 217) is not fully supported by their data since they test only two LSU proteins (L27, L14) which differ from each other. This conclusion needs to be either toned down or more LSU minutes should be tested to derive a well-supported general principle. The same goes for the effect of LSUs on proteotoxicity (line 334).</p><p>4. According to the legend, the imaginal disc images in Figure 1 have been captured at different confocal planes- it is unclear why this was done and why maximum projections were not used to keep imaging consistent across samples.</p><p>5. To effectively conclude that levels of pre-rRNA increase when Xrp1 is mutated (line 247), the northern blots in Figure 2 need to be quantified. As presented, the differences are not appreciable particularly when normalized to tubulin.</p><p>6. The modulation of rRNA biogenesis intermediates using TAF1B knockdown to reduce levels of pre-rRNA is a sledge-hammer approach at best which has multiple secondary effects (admittedly including reducing translation as demonstrated by them)- thus does not shed much light on if the accumulation of the aberrant rRNA intermediates effects cell competition or is simply an artefact of the experiment.</p><p>7. As stated in the public review point 2, the staining with fibrillarin in Figure 2 is not of sufficient quality to conclude that Xrp1 has no nucleolar localization.</p><p>8. As stated in the public review points 3 and 5, the stress reporters Xbp1-GFP and GstD1-GFP need to be tested in Rp+/- clones in order to exclude or establish a role for Ire1 and Xrp1 in the induction of the respective reporters during cell competition. In the absence of these, the conclusions are speculative at best.</p><p>9. One of the novel findings of the manuscript is that translation differences caused by non-Rp factors can also lead to cell competition and they demonstrate this by depleting eIF2, eIF4G, eIF6, eEF2, eEF1α1, or eIF5A in clones. To the best of my knowledge, none of these factors show minute-like phenotypes or haploinsufficiencies. Further in some conditions of translation factor knockdowns, there is extensive Dcp1 staining well outside the clone boundaries (Figure 6F', J') and also within clones (Figure 7 supplement 2B', D', J'), which is contrary to competition-induced death at boundaries. It would be helpful if the authors explain these seemingly contradictory observations.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The model advocated by the authors predicts that a clone overexpressing Xrp1 should be able to cause cell competition without any other perturbation. If his experiment has been done in a previous publication from the lab, it needs to be discussed in the context of the model. It would also seem that increased Xrp1 expression occurs throughout the &quot;loser&quot; clone and we still need to understand why the death occurs at boundaries. The authors could add a few sentences about this in the discussion.</p><p>The main point I raised in the &quot;public review&quot; could be addressed by asking whether co-expression of Myc and Xrp1 in a FLP-out clone might convert cells from winners to losers. If this combination results in increased translation compared to wild-type cells but still results in their elimination , it would show clearly that reduced translation is not necessary for elimination by cell competition. (This experiment may not work).</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by James Manley (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>1. Rebuttal #1 refers to OPP labeling in Figure 8, Supplement 2 B,F,H,K but these images do not have OPP labeling. Please clarify.</p><p>2. Rebuttal #6. The motivation, experimental approach and results for Figure 5, Supplement 3 are not clear, but this is an important figure. An entire figure with many clone genotypes cannot be accurately described to a broad scientific audience in 2 sentences (lines 430-433). Please rewrite this section so that it clearly explains motivation, experimental approach, and what data specific results allowed you to conclude that eIP2alpha &quot;hyper-phosphorylation&quot; was not necessary for cell completion. Please also explain hyper-phosphorylation of eIF2alpha since it is the first time you are using this term.</p><p>3. Lines 496-497. Figure 8, figure supplement 3I – there is still cell death in this panel but it is inaccurately described as &quot;Xrp1 depletion eliminated cell death&quot;. I suggest that you change this phrase to &quot;strongly reduced&quot; instead of &quot;eliminated&quot;.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71705.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Experimental:</p><p>1. A key conclusion of the paper is that &quot;interrupting the translation cycle activates Xrp-1 dependent cell death independently of diminished translation&quot;. Most of the data supporting this conclusion are contained in Figure 7 and its supplement, and some of these images are not compelling. Specifically, in Figure 7A,D,G the GFP-positive UAS-PPP1R15, UAS-eEF2RNAi loser clones are very large, encompassing most of the field of the of view. In these clones, p-eIF2alpha is not upregulated. However, in Figure 7D,C,E,F,H,I, these same clones in the same genetic background are very small and are obviously being outcompeted. Why is there such a huge discrepancy in clone size across panels? Furthermore, the level of p-eIF2alpha was not monitored in other depletions of translation factors in Figure 7, Supplement 1, panels A-D. First, the authors need to provide better examples for p-eIF2alpha in Figure 7A,D,G. Second, they need to provide representative examples of p-eIF2alpha in Figure 7, Supplement 1, panels A-D. Third, they need to provide some quantification of the p-eIF2alpha results in Figure 7A,D,G and Figure 7, Supplement 1, panels A-D. Fourth, they need to provide representative examples of OPP in Figure 7, Supplement 1, panels A-D.</p></disp-quote><p>First, we replaced Figure 8A,D,G with better examples (Figure 7 has become Figure 8). Secondly, we added images of p-eIF2a in Figure 8 Supplement 1 panels A, D, G, J, M, and Figure 8 Supplement 2 panels A, D, G, J. Thirdly, we quantified p-eIF2a levels from multiple genotypes from Figure 7 and 8. The results are shown in Figure 8 Supplement 3. Fourthly, we added representative examples of OPP labeling for the genotypes in Figure 8 supplement 1. These are shown in Figure 8 Supplement 1 panels B,E,H,K,N, and Figure 8 Supplement 2 panels B,E,H,K.</p><disp-quote content-type="editor-comment"><p>2. The authors need to quantify some of the results, including (a) p-eiF2alpha results mentioned in point #1; (b) penetrance of Rp/+ phenotypes; (c) northern blot results in Figure 2.</p></disp-quote><p>a) p-eIF2a levels have now been quantified as described in point #1 above; b) Rp/+ phenotypes were all 100% penetrant unless otherwise noted. Number of discs examined is now listed in Supplementary file 2. c) We removed the reference to changing rRNA levels, as we now think this might have another cause.</p><disp-quote content-type="editor-comment"><p>3. The authors need to prove that larger p-eiF2alpha spots in discs are dividing cells by co-staining with pHH3.</p></disp-quote><p>We found that a different antibody to p-eIF2a does not label mitotic cells, so we have not pursued this aspect of the labeling further. We mention this discrepancy between antibodies in the text, please see lines 1232-1236.</p><disp-quote content-type="editor-comment"><p>4. They need to supply missing controls. For Figure 3, please supply WT clones in a wild-type background treated with OPP and p-eiF2alpha antibody. For Figure 7, please supply UAS-PPP1R15 flip-out clones alone labelled with p-eiF2alpha, OPP and Dcp-1.</p></disp-quote><p>We added control wild type clones in a wild type background labelled for p-eIF2a (Figure 3 supplement 1M) and OPP (Figure 3 supplement 1N). We added PPP1R15 flip out clones (and control w RNAi clones) labelled for p-eIF2a, OPP, and cell death (Figure 8 figure supplement 1 panels A-F).</p><disp-quote content-type="editor-comment"><p>5. They need to prove with higher magnification that Xrp1 is excluded from the nucleolus.</p></disp-quote><p>It had not been our intention to imply that Xrp1 does not enter the nucleolus. Rather, another group has claimed that in wild type cells Xrp1 is found only in the nucleolus, then released into the nucleus in Rp mutants. Our intention was to show that Xrp1 is not concentrated in the nucleolus (or anywhere else in the cell, in wild type cells), not that it cannot enter the nucleolus. We rewrote the section about nucleolar Xrp1 to eliminate the confusion. Please see lines 300-306.</p><disp-quote content-type="editor-comment"><p>6. They need to test Ire1 activation (i.e., Xbp1-GFP) and GstD1-GFP induction in Rp/+ clones, not just in Rp/+ heterozygous backgrounds.</p></disp-quote><p>We added GstD-LacZ expression in Rp/+ wing discs containing clones depleted for Xrp1 as Figure 6 figure supplement 2. We were unable to obtain Rp+/- clones in the Xbp-1 background in time.</p><disp-quote content-type="editor-comment"><p>7. The authors need to clarify in the manuscript how competition can be independent of translation because their data clearly show that when competition occurs, the loser clone has both elevated Xrp1 and lower translation. While the authors conclude that being a loser is determined solely by upregulation of Xrp1 and is independent of relative translation rate, in every case they show where there is competition, the translation rate is lower in the loser clone (see Figure 7B,E,H). In some of those manipulations, when they remove Xrp1, the same mutant can have a higher or unchanged translation rate as wild-type (Figure 3, Supplement 1 panel G', L', Figure 5K', Figure 7T'). The authors' work does demonstrate that having differences in translation alone (without Xrp1 differences) cannot induce cell competition. However, their work does not show that differences in Xrp1 without differences in translation can cause competition.</p></disp-quote><p>We added an experiment that tests the requirement for global translation differences in cell competition as Figure 5 figure supplement 3. The data shows that translation differences are not required for cell competition. Please see lines 430-433.</p><disp-quote content-type="editor-comment"><p>8. The authors need to discuss their new findings in the context of previously published work on how Xrp1 impacts translation. While the reviewers are aware that overexpression of Xrp1 is lethal (Baillon et al., Sci Reports 2018), the authors do not discuss the fact that Xrp1 translation is induced in loser cells where overall translation is lower. The reviewers agree that figuring out the mechanism by which Xrp1 is induced under restrictive translation conditions is outside the scope of this work. However, given point 7 above, the authors must acknowledge these unknowns explicitly in the discussion.</p></disp-quote><p>We added discussion of how Xrp1 might be translated under conditions where most translation is shut down. Please see lines 718-720.</p><disp-quote content-type="editor-comment"><p>Editorial – The manuscript lacks clarity in several places. Please modify the revised manuscript as per the specific reviewer's comments.</p><p>1. The abstract and the introduction need revision (see R2).</p></disp-quote><p>We revised the abstract and introduction significantly, including issues raised by the reviewer, and reviewed the rest of the manuscript also. We added commas to the sentence beginning “Ribosome biogenesis, and the regulation of translation, are important targets of cellular regulation…”. Please see lines 75-79.</p><disp-quote content-type="editor-comment"><p>2. The narrative describing the results in Figure 7 that are essential to the paper are not described in sufficient detail. Please expand the text in lines 426-445 to include the rationale for the experiments, the observations and the conclusions.</p></disp-quote><p>This request might refer to comment #9 by reviewer 2 that none of the translation factors examined is known to be haploinsufficient or show Minute-like phenotypes. We have now included the haplo-sufficient nature of the genes encoding these factors to the manuscript. Please see lines 441-448. This supports our initial decision to knock down these factors to inhibit translation independently of the Minute phenotype, rather than contradicting it.</p><disp-quote content-type="editor-comment"><p>3. In the Discussion, the authors should discuss the observation that p-eiF2alpha is both upstream and downstream of Xrp1 and whether there is a feedback loop?</p></disp-quote><p>We have now added an experiment that tests the contribution of positive feedback between Perk and Xrp1 to translation in Rp mutants. The data are shown in Figure 6, with related data in Figure 6 figure supplements 1 and 2. These data show that the potential feed-forward loop is not essential. Please see lines 413-429 of the article.</p><disp-quote content-type="editor-comment"><p>4. The authors should speculate in the Discussion about what is downstream of Xrp1 that causes WT neighbors to outcompete less competitive cells.</p></disp-quote><p>We propose the model that one or more transcriptional targets of Xrp1 are the cause of cell competition, and added new data that shows this includes repetitive elements (Figure 10P,Q, Figure 10 Supplement 3, Supplementary Table1). Please see lines 802810.</p><disp-quote content-type="editor-comment"><p>5. The authors need to address whether they have previously shown that clonal over-expression of Xrp1 causes cell competition without any other perturbation. If this experiment has been done in a previous publication from the lab, it needs to be discussed in the context of the model.</p></disp-quote><disp-quote content-type="editor-comment"><p>6. The authors need to discuss in a few sentences why increased Xrp1 expression occurs throughout the &quot;loser&quot; clone but competitive death only occurs at the clone boundaries.</p></disp-quote><p>We added another sentence about this to the discussion. Please see lines 808-810. There is not much to say, however, as this is one of the questions outstanding in the field.</p><disp-quote content-type="editor-comment"><p>7. The authors should soften the conclusion of reduction of LSU levels in Rp/+ because they tested only two subunits. The same request is made for the effect of LSUs on proteotoxicity (line 334).</p></disp-quote><p>We softened the conclusions regarding LSU levels by stating only that there might be differences between LSU and SSU mutations (lines 213-218, 235-241, 535-539), and similarly regarding LSU mutants and autophagy (lines 358-363).</p><disp-quote content-type="editor-comment"><p>8. The authors should explain the seemingly contradictory observations that Dcp1 is observed outside and inside clone boundaries (Figure 6F', J') and also within clones (Figure 7 supplement 2B', D', J') but the model holds that competitive death should be at the boundaries.</p></disp-quote><p>This appearance of non-autonomy was mostly due to variations in GFP level making the genotype of dying cells unclear in some of the panels. We adjusted these panels and replaced some that were confusing (Figure 7 and Figure 7 figure supplement 1). We added a new enlarged figure to make the genotypes of dying cells more clear (Figure 7 figure supplement 2). We have adjusted or replaced several panels that were misleading. The large majority of the cell death affects the mutant cells, there is not much death outside clone boundaries.</p><disp-quote content-type="editor-comment"><p>9. The authors should acknowledge that p-eIF2alpha is not a constant entity and can vary in non-stress conditions like circadian rhythm.</p></disp-quote><p>We now mention that proteotoxic stress is not the only factor affecting eIF2a phosphorylation level (line 315-318). It does not seem worth mentioning circadian rhythm specifically, since the changes we describe are spatial, not temporal.</p><disp-quote content-type="editor-comment"><p>10. Many typos need to be corrected.</p></disp-quote><p>We have proofread the revised manuscript, in particular rewriting the discussion significantly.</p><disp-quote content-type="editor-comment"><p>Figure labeling:</p><p>1. Genotypes need to be better labelled in some figures (like Figure 1). The authors should avoid using the terms labelled and unlabeled and instead refer to the cells in mosaic discs as white or black. Every figure panel should have written on it some version of the genotype.</p></disp-quote><p>Genotype labels were changed in Figure 1 and its supplements. Every figure panel now has the genotypes indicated, except that we do not always replicate this where an extra panel is added to highlight one channel that has already been shown and labeled in a multichannel image. We replaced or qualified the terms ‘labeled’ and ‘unlabeled’ in all the figure legends.</p><disp-quote content-type="editor-comment"><p>2. Genotypes should be in the figure legends themselves, in addition to Table S2. In other words, it should be easy for the reader to know the genotype of the labelled (white) cells and the unlabeled (black) cells.</p></disp-quote><p>We made these changes</p><disp-quote content-type="editor-comment"><p>3. Many figures need arrows, etc, to help the reader under the data.</p></disp-quote><p>We added some arrows, eg in Figure 5 supplement 2.</p><disp-quote content-type="editor-comment"><p>4. In all of the source data excel files, please use first row to indicate the relevant figure to which these data refer.</p></disp-quote><p>We added these titles to the source data files</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>[…]</p><p>12. P values greater than 1: In several places there are Padj values that are greater than 1. This is not possible. Probability cannot be greater than 1. This problem occurs on Lines 863, 866, 1222, 1227. Please address this.</p></disp-quote><p>Adjusted P value apparently &gt;1 arise because of the multiple testing correction. As the reviewer notes, P&gt;1 is impossible, and the convention is to set these adjusted values = 1, as we have now done. Previously, we had just reported the exact output of the software package. Please see lines 1063, 1066, 1738, 1742, 1821.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>1. Rebuttal #1 refers to OPP labeling in Figure 8, Supplement 2 B,F,H,K but these images do not have OPP labeling. Please clarify.</p></disp-quote><p>Our apologies, we meant to refer to Figure 8, Supplement 3 B,F,H,K.</p><disp-quote content-type="editor-comment"><p>2. Rebuttal #6. The motivation, experimental approach and results for Figure 5, Supplement 3 are not clear, but this is an important figure. An entire figure with many clone genotypes cannot be accurately described to a broad scientific audience in 2 sentences (lines 430-433). Please rewrite this section so that it clearly explains motivation, experimental approach, and what data specific results allowed you to conclude that eIP2alpha &quot;hyper-phosphorylation&quot; was not necessary for cell completion. Please also explain hyper-phosphorylation of eIF2alpha since it is the first time you are using this term.</p></disp-quote><p>We have expanded this section to describe Figure 5, supplement 3 more fully, and removed the phrase “hyper-phosphorylation”, as we had not intended to imply anything unique about the phosphorylation in this genotype. Please see lines 431-441.</p><disp-quote content-type="editor-comment"><p>3. Lines 496-497. Figure 8, figure supplement 3I – there is still cell death in this panel but it is inaccurately described as &quot;Xrp1 depletion eliminated cell death&quot;. I suggest that you change this phrase to &quot;strongly reduced&quot; instead of &quot;eliminated&quot;.</p></disp-quote><p>We changed this to “Xrp1 depletion eliminated or strongly reduced cell death”. Please see lines 504-506.</p></body></sub-article></article>